RPS-BLAST 2.2.26 [Sep-21-2011]
Database: CDD.v3.10
44,354 sequences; 10,937,602 total letters
Searching..................................................done
Query= psy2843
(113 letters)
>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine
Kinase, C-ros. Protein Tyrosine Kinases (PTK) family;
C-ros and Drosophila Sevenless proteins; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. The
proto-oncogene c-ros encodes an orphan receptor tyr
kinase (RTK) with an unknown ligand. RTKs contain an
extracellular ligand-binding domain, a transmembrane
region, and an intracellular tyr kinase domain. RTKs are
usually activated through ligand binding, which causes
dimerization and autophosphorylation of the
intracellular tyr kinase catalytic domain. C-ros is
expressed in embryonic cells of the kidney, intestine
and lung, but disappears soon after birth. It persists
only in the adult epididymis. Male mice bearing inactive
mutations of c-ros lack the initial segment of the
epididymis and are infertile. The Drosophila protein,
Sevenless, is required for the specification of the R7
photoreceptor cell during eye development.
Length = 269
Score = 101 bits (254), Expect = 8e-28
Identities = 41/53 (77%), Positives = 46/53 (86%), Gaps = 1/53 (1%)
Query: 1 MHFVHRDLAARNCLVSCLD-PKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
MHF+HRDLAARNCLVS R+VKIGDFGLARDIY++DYY+KEGEGLLPV
Sbjct: 125 MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like
Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK)
family; Insulin Receptor (InsR) subfamily; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). The InsR subfamily
is composed of InsR, Insulin-like Growth Factor-1
Receptor (IGF-1R), and similar proteins. PTKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. InsR and
IGF-1R are receptor tyr kinases (RTKs) composed of two
alphabeta heterodimers. Binding of the ligand (insulin,
IGF-1, or IGF-2) to the extracellular alpha subunit
activates the intracellular tyr kinase domain of the
transmembrane beta subunit. Receptor activation leads to
autophosphorylation, stimulating downstream kinase
activities, which initiate signaling cascades and
biological function. InsR and IGF-1R, which share 84%
sequence identity in their kinase domains, display
physiologically distinct yet overlapping functions in
cell growth, differentiation, and metabolism. InsR
activation leads primarily to metabolic effects while
IGF-1R activation stimulates mitogenic pathways. In
cells expressing both receptors, InsR/IGF-1R hybrids are
found together with classical receptors. Both receptors
can interact with common adaptor molecules such as IRS-1
and IRS-2.
Length = 277
Score = 90.9 bits (226), Expect = 1e-23
Identities = 33/51 (64%), Positives = 39/51 (76%), Gaps = 4/51 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV
Sbjct: 139 KFVHRDLAARNCMVA----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine
Kinases, Anaplastic Lymphoma Kinase and Leukocyte
Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family;
Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine
(tyr) Kinase (LTK); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to tyr
residues in protein substrates. ALK and LTK are orphan
receptor tyr kinases (RTKs) whose ligands are not yet
well-defined. RTKs contain an extracellular
ligand-binding domain, a transmembrane region, and an
intracellular tyr kinase domain. They are usually
activated through ligand binding, which causes
dimerization and autophosphorylation of the
intracellular tyr kinase catalytic domain. ALK appears
to play an important role in mammalian neural
development as well as visceral muscle differentiation
in Drosophila. ALK is aberrantly expressed as fusion
proteins, due to chromosomal translocations, in about
60% of anaplastic large cell lymphomas (ALCLs). ALK
fusion proteins are also found in rare cases of diffuse
large B cell lymphomas (DLBCLs). LTK is mainly expressed
in B lymphocytes and neuronal tissues. It is important
in cell proliferation and survival. Transgenic mice
expressing TLK display retarded growth and high
mortality rate. In addition, a polymorphism in mouse and
human LTK is implicated in the pathogenesis of systemic
lupus erythematosus.
Length = 277
Score = 87.9 bits (218), Expect = 2e-22
Identities = 31/51 (60%), Positives = 40/51 (78%), Gaps = 1/51 (1%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
HF+HRD+AARNCL++C P R+ KI DFG+ARDIYR YY+K G +LP+
Sbjct: 136 HFIHRDIAARNCLLTCKGPG-RVAKIADFGMARDIYRASYYRKGGRAMLPI 185
>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase.
Length = 258
Score = 87.6 bits (218), Expect = 2e-22
Identities = 32/52 (61%), Positives = 39/52 (75%), Gaps = 4/52 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+FVHRDLAARNCLV+ +VKI DFGL+RDIY +DYY+K G G LP+
Sbjct: 121 KNFVHRDLAARNCLVTEN----LVVKISDFGLSRDIYEDDYYRKRGGGKLPI 168
>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases.
Protein Tyrosine Kinase (PTK) family, catalytic domain.
This PTKc family is part of a larger superfamily that
includes the catalytic domains of protein
serine/threonine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase (PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. They can be classified
into receptor and non-receptor tyr kinases. PTKs play
important roles in many cellular processes including,
lymphocyte activation, epithelium growth and
maintenance, metabolism control, organogenesis
regulation, survival, proliferation, differentiation,
migration, adhesion, motility, and morphogenesis.
Receptor tyr kinases (RTKs) are integral membrane
proteins which contain an extracellular ligand-binding
region, a transmembrane segment, and an intracellular
tyr kinase domain. RTKs are usually activated through
ligand binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain, leading to intracellular signaling.
Some RTKs are orphan receptors with no known ligands.
Non-receptor (or cytoplasmic) tyr kinases are
distributed in different intracellular compartments and
are usually multi-domain proteins containing a catalytic
tyr kinase domain as well as various regulatory domains
such as SH3 and SH2. PTKs are usually autoinhibited and
require a mechanism for activation. In many PTKs, the
phosphorylation of tyr residues in the activation loop
is essential for optimal activity. Aberrant expression
of PTKs is associated with many development
abnormalities and cancers.
Length = 262
Score = 83.0 bits (206), Expect = 1e-20
Identities = 30/52 (57%), Positives = 38/52 (73%), Gaps = 4/52 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
FVHRDLAARNCLV + +VKI DFGL+RD+Y +DYY+K+ G LP+
Sbjct: 124 KKFVHRDLAARNCLVG----EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine
Kinases, Tropomyosin Related Kinases. Protein Tyrosine
Kinase (PTK) family; Tropomyosin Related Kinase (Trk)
subfamily; catalytic (c) domain. The Trk subfamily
consists of TrkA, TrkB, TrkC, and similar proteins. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Trk
subfamily members are receptor tyr kinases (RTKs)
containing an extracellular region with arrays of
leucine-rich motifs flanked by two cysteine-rich
clusters followed by two immunoglobulin-like domains, a
transmembrane segment, and an intracellular catalytic
domain. Binding to their ligands, the nerve growth
factor (NGF) family of neutrotrophins, leads to Trk
receptor oligomerization and activation of the catalytic
domain. Trk receptors are mainly expressed in the
peripheral and central nervous systems. They play
important roles in cell fate determination, neuronal
survival and differentiation, as well as in the
regulation of synaptic plasticity. Altered expression of
Trk receptors is associated with many human diseases.
Length = 280
Score = 81.7 bits (202), Expect = 5e-20
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
HFVHRDLA RNCLV +VKIGDFG++RD+Y DYY+ G +LP+
Sbjct: 142 HFVHRDLATRNCLVGY----DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain.
Phosphotransferases. Tyrosine-specific kinase subfamily.
Length = 257
Score = 81.0 bits (201), Expect = 7e-20
Identities = 30/52 (57%), Positives = 39/52 (75%), Gaps = 5/52 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+F+HRDLAARNCLV + +VKI DFGL+RD+Y +DYY+K G G LP+
Sbjct: 121 KNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRG-GKLPI 167
>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity.
Phosphotransferases. The specificity of this class of
kinases can not be predicted. Possible dual-specificity
Ser/Thr/Tyr kinase.
Length = 258
Score = 78.7 bits (195), Expect = 4e-19
Identities = 30/52 (57%), Positives = 39/52 (75%), Gaps = 5/52 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+F+HRDLAARNCLV + +VKI DFGL+RD+Y +DYYK +G G LP+
Sbjct: 122 KNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYKVKG-GKLPI 168
>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine
Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK)
family; Insulin Receptor (InsR); catalytic (c) domain.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. InsR is a
receptor tyr kinase (RTK) that is composed of two
alphabeta heterodimers. Binding of the insulin ligand to
the extracellular alpha subunit activates the
intracellular tyr kinase domain of the transmembrane
beta subunit. Receptor activation leads to
autophosphorylation, stimulating downstream kinase
activities, which initiate signaling cascades and
biological function. InsR signaling plays an important
role in many cellular processes including glucose
homeostasis, glycogen synthesis, lipid and protein
metabolism, ion and amino acid transport, cell cycle and
proliferation, cell differentiation, gene transcription,
and nitric oxide synthesis. Insulin resistance, caused
by abnormalities in InsR signaling, has been described
in diabetes, hypertension, cardiovascular disease,
metabolic syndrome, heart failure, and female
infertility.
Length = 288
Score = 75.4 bits (185), Expect = 1e-17
Identities = 33/52 (63%), Positives = 39/52 (75%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 140 FVHRDLAARNCMVA----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine
Kinases, Receptor tyrosine kinase-like Orphan Receptors.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor (Ror) subfamily; catalytic
(c) domain. The Ror subfamily consists of Ror1, Ror2,
and similar proteins. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Ror proteins are orphan
receptor tyr kinases (RTKs) containing an extracellular
region with immunoglobulin-like, cysteine-rich, and
kringle domains, a transmembrane segment, and an
intracellular catalytic domain. Ror RTKs are unrelated
to the nuclear receptor subfamily called
retinoid-related orphan receptors (RORs). RTKs are
usually activated through ligand binding, which causes
dimerization and autophosphorylation of the
intracellular tyr kinase catalytic domain. Ror kinases
are expressed in many tissues during development. They
play important roles in bone and heart formation.
Mutations in human Ror2 result in two different bone
development genetic disorders, recessive Robinow
syndrome and brachydactyly type B. Drosophila Ror is
expressed only in the developing nervous system during
neurite outgrowth and neuronal differentiation,
suggesting a role for Drosophila Ror in neural
development. More recently, mouse Ror1 and Ror2 have
also been found to play an important role in regulating
neurite growth in central neurons. Ror1 and Ror2 are
believed to have some overlapping and redundant
functions.
Length = 283
Score = 74.0 bits (182), Expect = 4e-17
Identities = 32/51 (62%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
HFVHRDLAARNCLV + VKI DFGL+RDIY DYY+ + + LLPV
Sbjct: 144 HFVHRDLAARNCLVG----EGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine
Kinase, Tropomyosin Related Kinase A. Protein Tyrosine
Kinase (PTK) family; Tropomyosin Related Kinase A
(TrkA); catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. TrkA is a member of the
Trk subfamily of proteins, which are receptor tyr
kinases (RTKs) containing an extracellular region with
arrays of leucine-rich motifs flanked by two
cysteine-rich clusters followed by two
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. Binding of TrkA
to its ligand, nerve growth factor (NGF), results in
receptor oligomerization and activation of the catalytic
domain. TrkA is expressed mainly in neural-crest-derived
sensory and sympathetic neurons of the peripheral
nervous system, and in basal forebrain cholinergic
neurons of the central nervous system. It is critical
for neuronal growth, differentiation and survival.
Alternative TrkA splicing has been implicated as a
pivotal regulator of neuroblastoma (NB) behavior. Normal
TrkA expression is associated with better NB prognosis,
while the hypoxia-regulated TrkAIII splice variant
promotes NB pathogenesis and progression. Aberrant TrkA
expression has also been demonstrated in non-neural
tumors including prostate, breast, lung, and pancreatic
cancers.
Length = 280
Score = 73.5 bits (180), Expect = 6e-17
Identities = 30/52 (57%), Positives = 38/52 (73%), Gaps = 4/52 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+HFVHRDLA RNCLV + +VKIGDFG++RDIY DYY+ G +LP+
Sbjct: 141 LHFVHRDLATRNCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine
Kinases, Discoidin Domain Receptors. Protein Tyrosine
Kinase (PTK) family; Discoidin Domain Receptor (DDR)
subfamily; catalytic (c) domain. The DDR subfamily
consists of homologs of mammalian DDR1, DDR2, and
similar proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
DDR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular discoidin homology domain, a
transmembrane segment, an extended juxtamembrane region,
and an intracellular catalytic domain. The binding of
the ligand, collagen, to DDRs results in a slow but
sustained receptor activation. DDRs regulate cell
adhesion, proliferation, and extracellular matrix
remodeling. They have been linked to a variety of human
cancers including breast, colon, ovarian, brain, and
lung. There is no evidence showing that DDRs act as
transforming oncogenes. They are more likely to play a
role in the regulation of tumor growth and metastasis.
Length = 296
Score = 73.2 bits (180), Expect = 7e-17
Identities = 27/52 (51%), Positives = 37/52 (71%), Gaps = 4/52 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
++FVHRDLA RNCLV Y I KI DFG++R++Y +DYY+ +G LP+
Sbjct: 149 LNFVHRDLATRNCLVGK---NYTI-KIADFGMSRNLYSSDYYRVQGRAPLPI 196
>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine
Kinase, Insulin-like Growth Factor-1 Receptor. Protein
Tyrosine Kinase (PTK) family; Insulin-like Growth
Factor-1 Receptor (IGF-1R); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. IGF-1R is
a receptor tyr kinases (RTK) that is composed of two
alphabeta heterodimers. Binding of the ligand (IGF-1 or
IGF-2) to the extracellular alpha subunit activates the
intracellular tyr kinase domain of the transmembrane
beta subunit. Receptor activation leads to
autophosphorylation, which stimulates downstream kinase
activities and biological function. IGF-1R signaling is
important in the differentiation, growth, and survival
of normal cells. In cancer cells, where it is frequently
overexpressed, IGF-1R is implicated in proliferation,
the suppression of apoptosis, invasion, and metastasis.
IGF-1R is being developed as a therapeutic target in
cancer treatment.
Length = 277
Score = 72.4 bits (177), Expect = 1e-16
Identities = 33/52 (63%), Positives = 40/52 (76%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
FVHRDLAARNC+V+ + VKIGDFG+ RDIY DYY+K G+GLLPV +
Sbjct: 140 FVHRDLAARNCMVA----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine
Kinases, Fibroblast Growth Factor Receptors. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor (FGFR) subfamily; catalytic (c) domain. The
FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4,
and similar proteins. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K).PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. FGFR subfamily members
are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with three
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding of
FGFRs to their ligands, the FGFs, and to heparin/heparan
sulfate (HS) results in the formation of a ternary
complex, which leads to receptor dimerization and
activation, and intracellular signaling. There are at
least 23 FGFs and four types of FGFRs. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. FGF/FGFR signaling is
important in the regulation of embryonic development,
homeostasis, and regenerative processes. Depending on
the cell type and stage, FGFR signaling produces diverse
cellular responses including proliferation, growth
arrest, differentiation, and apoptosis. Aberrant
signaling leads to many human diseases such as skeletal,
olfactory, and metabolic disorders, as well as cancer.
Length = 293
Score = 68.6 bits (168), Expect = 4e-15
Identities = 28/49 (57%), Positives = 35/49 (71%), Gaps = 4/49 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+HRDLAARN LV+ + ++KI DFGLARDI+ DYY+K G LPV
Sbjct: 154 IHRDLAARNVLVT----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPV 198
>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine
Kinase, Discoidin Domain Receptor 2. Protein Tyrosine
Kinase (PTK) family; mammalian Discoidin Domain Receptor
2 (DDR2) and homologs; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. DDR2 is a
member of the DDR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular discoidin
homology domain, a transmembrane segment, an extended
juxtamembrane region, and an intracellular catalytic
domain. The binding of the ligand, collagen, to DDRs
results in a slow but sustained receptor activation.
DDR2 binds mostly to fibrillar collagens. More recently,
it has been reported to also bind collagen X. DDR2 is
widely expressed in many tissues with the highest levels
found in skeletal muscle, skin, kidney and lung. It is
important in cell proliferation and development. Mice,
with a deletion of DDR2, suffer from dwarfism and
delayed healing of epidermal wounds. DDR2 also
contributes to collagen (type I) regulation by
inhibiting fibrillogenesis and altering the morphology
of collagen fibers. It is also expressed in immature
dendritic cells (DCs), where it plays a role in DC
activation and function.
Length = 296
Score = 68.0 bits (166), Expect = 8e-15
Identities = 26/52 (50%), Positives = 37/52 (71%), Gaps = 4/52 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
++FVHRDLA RNCLV K +KI DFG++R++Y DYY+ +G +LP+
Sbjct: 149 LNFVHRDLATRNCLVG----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPI 196
>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine
Kinase, Muscle-specific kinase. Protein Tyrosine Kinase
(PTK) family; Muscle-specific kinase (Musk); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Musk is a receptor tyr kinase (RTK) containing an
extracellular region with four immunoglobulin-like
domains and a cysteine-rich cluster, a transmembrane
segment, and an intracellular catalytic domain. Musk is
expressed and concentrated in the postsynaptic membrane
in skeletal muscle. It is essential for the
establishment of the neuromuscular junction (NMJ), a
peripheral synapse that conveys signals from motor
neurons to muscle cells. Agrin, a large proteoglycan
released from motor neurons, stimulates Musk
autophosphorylation and activation, leading to the
clustering of acetylcholine receptors (AChRs). To date,
there is no evidence to suggest that agrin binds
directly to Musk. Mutations in AChR, Musk and other
partners are responsible for diseases of the NMJ, such
as the autoimmune syndrome myasthenia gravis.
Length = 288
Score = 67.2 bits (164), Expect = 1e-14
Identities = 27/51 (52%), Positives = 33/51 (64%), Gaps = 4/51 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
FVHRDLA RNCLV + +VKI DFGL+R+IY DYYK +P+
Sbjct: 150 KFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKASENDAIPI 196
>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine
Kinase, Tropomyosin Related Kinase C. Protein Tyrosine
Kinase (PTK) family; Tropomyosin Related Kinase C
(TrkC); catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. TrkC is a member of the
Trk subfamily of proteins, which are receptor tyr
kinases (RTKs) containing an extracellular region with
arrays of leucine-rich motifs flanked by two
cysteine-rich clusters followed by two
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. Binding of TrkC
to its ligand, neurotrophin 3 (NT3), results in receptor
oligomerization and activation of the catalytic domain.
TrkC is broadly expressed in the nervous system and in
some non-neural tissues including the developing heart.
NT3/TrkC signaling plays an important role in the
innervation of the cardiac conducting system and the
development of smooth muscle cells. Mice deficient with
NT3 and TrkC have multiple heart defects. NT3/TrkC
signaling is also critical for the development and
maintenance of enteric neurons that are important for
the control of gut peristalsis.
Length = 291
Score = 67.3 bits (164), Expect = 1e-14
Identities = 29/53 (54%), Positives = 37/53 (69%), Gaps = 4/53 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HFVHRDLA RNCLV +VKIGDFG++RD+Y DYY+ G +LP+ +
Sbjct: 143 HFVHRDLATRNCLVG----ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 191
>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine
Kinase, Tropomyosin Related Kinase B. Protein Tyrosine
Kinase (PTK) family; Tropomyosin Related Kinase B
(TrkB); catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. TrkB is a member of the
Trk subfamily of proteins, which are receptor tyr
kinases (RTKs) containing an extracellular region with
arrays of leucine-rich motifs flanked by two
cysteine-rich clusters followed by two
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. Binding of TrkB
to its ligands, brain-derived neurotrophic factor (BDNF)
or neurotrophin 4 (NT4), results in receptor
oligomerization and activation of the catalytic domain.
TrkB is broadly expressed in the nervous system and in
some non-neural tissues. It plays important roles in
cell proliferation, differentiation, and survival.
BDNF/Trk signaling plays a key role in regulating
activity-dependent synaptic plasticity. TrkB also
contributes to protection against gp120-induced neuronal
cell death. TrkB overexpression is associated with poor
prognosis in neuroblastoma (NB) and other human cancers.
It acts as a suppressor of anoikis (detachment-induced
apoptosis) and contributes to tumor metastasis.
Length = 288
Score = 67.0 bits (163), Expect = 1e-14
Identities = 29/53 (54%), Positives = 38/53 (71%), Gaps = 4/53 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
HFVHRDLA RNCLV + +VKIGDFG++RD+Y DYY+ G +LP+ +
Sbjct: 140 HFVHRDLATRNCLVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine
Kinases, Met and Ron. Protein Tyrosine Kinase (PTK)
family; Met and Ron; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Met and
Ron are receptor tyr kinases (RTKs) composed of an
alpha-beta heterodimer. The extracellular alpha chain is
disulfide linked to the beta chain, which contains an
extracellular ligand-binding region with a sema domain,
a PSI domain and four IPT repeats, a transmembrane
segment, and an intracellular catalytic domain. Binding
to their ligands leads to receptor dimerization,
autophosphorylation, activation, and intracellular
signaling. Met binds to the ligand, hepatocyte growth
factor/scatter factor (HGF/SF), and is also called the
HGF receptor. HGF/Met signaling plays a role in growth,
transformation, cell motility, invasion, metastasis,
angiogenesis, wound healing, and tissue regeneration.
Aberrant expression of Met through mutations or gene
amplification is associated with many human cancers
including hereditary papillary renal and gastric
carcinomas. The ligand for Ron is macrophage stimulating
protein (MSP). Ron signaling is important in regulating
cell motility, adhesion, proliferation, and apoptosis.
Aberrant Ron expression is implicated in tumorigenesis
and metastasis.
Length = 262
Score = 63.3 bits (154), Expect = 3e-13
Identities = 29/52 (55%), Positives = 33/52 (63%), Gaps = 6/52 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYK--KEGEGLLPV 52
FVHRDLAARNC+ LD + VK+ DFGLARDIY +YY LPV
Sbjct: 119 FVHRDLAARNCM---LDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166
>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine
Kinase, Discoidin Domain Receptor 1. Protein Tyrosine
Kinase (PTK) family; mammalian Discoidin Domain Receptor
1 (DDR1) and homologs; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. DDR1 is a
member of the DDR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular discoidin
homology domain, a transmembrane segment, an extended
juxtamembrane region, and an intracellular catalytic
domain. The binding of the ligand, collagen, to DDRs
results in a slow but sustained receptor activation.
DDR1 binds to all collagens tested to date (types I-IV).
It is widely expressed in many tissues. It is abundant
in the brain and is also found in keratinocytes, colonic
mucosa epithelium, lung epithelium, thyroid follicles,
and the islets of Langerhans. During embryonic
development, it is found in the developing
neuroectoderm. DDR1 is a key regulator of cell
morphogenesis, differentiation and proliferation. It is
important in the development of the mammary gland, the
vasculator and the kidney. DDR1 is also found in human
leukocytes, where it facilitates cell adhesion,
migration, maturation, and cytokine production.
Length = 304
Score = 63.4 bits (154), Expect = 3e-13
Identities = 25/52 (48%), Positives = 37/52 (71%), Gaps = 4/52 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
++FVHRDLA RNCLV + +KI DFG++R++Y DYY+ +G +LP+
Sbjct: 157 LNFVHRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPI 204
>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain
Receptor-like Protein Tyrosine Kinases. Protein
Tyrosine Kinase (PTK) family; Discoidin Domain Receptor
(DDR)-like proteins; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. DDR-like
proteins are members of the DDR subfamily, which are
receptor tyr kinases (RTKs) containing an extracellular
discoidin homology domain, a transmembrane segment, an
extended juxtamembrane region, and an intracellular
catalytic domain. The binding of the ligand, collagen,
to DDRs results in a slow but sustained receptor
activation. DDRs regulate cell adhesion, proliferation,
and extracellular matrix remodeling. They have been
linked to a variety of human cancers including breast,
colon, ovarian, brain, and lung. There is no evidence
showing that DDRs act as transforming oncogenes. They
are more likely to play a role in the regulation of
tumor growth and metastasis.
Length = 295
Score = 62.7 bits (152), Expect = 5e-13
Identities = 27/52 (51%), Positives = 37/52 (71%), Gaps = 4/52 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
++FVHRDLA RNCLV Y I KI DFG++R++Y DYY+ +G +LP+
Sbjct: 148 LNFVHRDLATRNCLV---GNHYTI-KIADFGMSRNLYSGDYYRIQGRAVLPI 195
>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine
Kinases, Vascular Endothelial Growth Factor Receptors.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor (VEGFR) subfamily;
catalytic (c) domain. The VEGFR subfamily consists of
VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. In
VEGFR3, the fifth Ig-like domain is replaced by a
disulfide bridge. The binding of VEGFRs to their
ligands, the VEGFs, leads to receptor dimerization,
activation, and intracellular signaling. There are five
VEGF ligands in mammals, which bind, in an overlapping
pattern to the three VEGFRs, which can form homo or
heterodimers. VEGFRs regulate the cardiovascular system.
They are critical for vascular development during
embryogenesis and blood vessel formation in adults. They
induce cellular functions common to other growth factor
receptors such as cell migration, survival, and
proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta
growth factor (PLGF). It regulates monocyte and
macrophage migration, vascular permeability,
haematopoiesis, and the recruitment of haematopietic
progenitor cells from the bone marrow.
Length = 337
Score = 61.8 bits (150), Expect = 1e-12
Identities = 26/49 (53%), Positives = 36/49 (73%), Gaps = 4/49 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+
Sbjct: 195 IHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase,
REarranged during Transfection protein. Protein
Tyrosine Kinase (PTK) family; RET (REarranged during
Transfection) protein; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. RET is a
receptor tyr kinase (RTK) containing an extracellular
region with four cadherin-like repeats, a
calcium-binding site, and a cysteine-rich domain, a
transmembrane segment, and an intracellular catalytic
domain. It is part of a multisubunit complex that binds
glial-derived neurotropic factor (GDNF) family ligands
(GFLs) including GDNF, neurturin, artemin, and
persephin. GFLs bind RET along with four GPI-anchored
coreceptors, bringing two RET molecules together,
leading to autophosphorylation, activation, and
intracellular signaling. RET is essential for the
development of the sympathetic, parasympathetic and
enteric nervous systems, and the kidney. RET disruption
by germline mutations causes diseases in humans
including congenital aganglionosis of the
gastrointestinal tract (Hirschsprung's disease) and
three related inherited cancers: multiple endocrine
neoplasia type 2A (MEN2A), MEN2B, and familial medullary
thyroid carcinoma (FMTC).
Length = 290
Score = 61.1 bits (148), Expect = 2e-12
Identities = 31/62 (50%), Positives = 40/62 (64%), Gaps = 7/62 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVI 60
M VHRDLAARN LV+ + R +KI DFGL+RD+Y D Y K +G +PV + + I
Sbjct: 146 MKLVHRDLAARNVLVA----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKW---MAI 198
Query: 61 ES 62
ES
Sbjct: 199 ES 200
>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 1. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 1 (FGFR1); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR1 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Alternative splicing of
FGFR1 transcripts produces a variety of isoforms, which
are differentially expressed in cells. FGFR1 binds the
ligands, FGF1 and FGF2, with high affinity and has also
been reported to bind FGF4, FGF6, and FGF9. FGFR1
signaling is critical in the control of cell migration
during embryo development. It promotes cell
proliferation in fibroblasts. Nuclear FGFR1 plays a role
in the regulation of transcription. Mutations,
insertions or deletions of FGFR1 have been identified in
patients with Kallman's syndrome (KS), an inherited
disorder characterized by hypogonadotropic hypogonadism
and loss of olfaction. Aberrant FGFR1 expression has
been found in some human cancers including 8P11
myeloproliferative syndrome (EMS), breast cancer, and
pancreatic adenocarcinoma.
Length = 307
Score = 60.4 bits (146), Expect = 4e-12
Identities = 29/51 (56%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARDI+ DYYKK G LPV +
Sbjct: 162 IHRDLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKW 208
>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 4. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 4 (FGFR4); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR4 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Unlike other FGFRs,
there is only one splice form of FGFR4. It binds FGF1,
FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective
ligand for FGFR4. Although disruption of FGFR4 in mice
causes no obvious phenotype, in vivo inhibition of FGFR4
in cultured skeletal muscle cells resulted in an arrest
of muscle progenitor differentiation. FGF6 and FGFR4 are
uniquely expressed in myofibers and satellite cells.
FGF6/FGFR4 signaling appears to play a key role in the
regulation of muscle regeneration. A polymorphism in
FGFR4 is found in head and neck squamous cell carcinoma.
Length = 314
Score = 59.6 bits (144), Expect = 8e-12
Identities = 27/51 (52%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLAR ++ DYYKK G LPV +
Sbjct: 156 IHRDLAARNVLVTEDN----VMKIADFGLARGVHDIDYYKKTSNGRLPVKW 202
>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 2. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 2 (FGFR2); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR2 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. There are many splice
variants of FGFR2 which show differential expression and
binding to FGF ligands. Disruption of either FGFR2 or
FGFR2b is lethal in mice, due to defects in the placenta
or severe impairment of tissue development including
lung, limb, and thyroid, respectively. Disruption of
FGFR2c in mice results in defective bone and skull
development. Genetic alterations of FGFR2 are associated
with many human skeletal disorders including Apert
syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and
Pfeiffer syndrome.
Length = 304
Score = 59.3 bits (143), Expect = 9e-12
Identities = 28/51 (54%), Positives = 35/51 (68%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARD+ DYYKK G LPV +
Sbjct: 159 IHRDLAARNVLVT----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKW 205
>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Src kinase subfamily; catalytic (c) domain. Src
subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr,
Fyn, Yrk, and Yes. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Src (or c-Src) proteins are cytoplasmic (or
non-receptor) tyr kinases which are anchored to the
plasma membrane. They contain an N-terminal SH4 domain
with a myristoylation site, followed by SH3 and SH2
domains, a tyr kinase domain, and a regulatory
C-terminal region containing a conserved tyr. They are
activated by autophosphorylation at the tyr kinase
domain, but are negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. They were identified as the first
proto-oncogene products, and they regulate cell
adhesion, invasion, and motility in cancer cells and
tumor vasculature, contributing to cancer progression
and metastasis. Src kinases are overexpressed in a
variety of human cancers, making them attractive targets
for therapy. They are also implicated in acute
inflammatory responses and osteoclast function. Src,
Fyn, Yes, and Yrk are widely expressed, while Blk, Lck,
Hck, Fgr, and Lyn show a limited expression pattern.
Length = 261
Score = 58.5 bits (142), Expect = 2e-11
Identities = 22/46 (47%), Positives = 30/46 (65%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDLAARN LV + + KI DFGLAR I ++Y +EG
Sbjct: 122 RNYIHRDLAARNILVG----ENLVCKIADFGLARLIEDDEYTAREG 163
>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine
Kinase, Fibroblast Growth Factor Receptor 3. Protein
Tyrosine Kinase (PTK) family; Fibroblast Growth Factor
Receptor 3 (FGFR3); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FGFR3 is
part of the FGFR subfamily, which are receptor tyr
kinases (RTKs) containing an extracellular
ligand-binding region with three immunoglobulin-like
domains, a transmembrane segment, and an intracellular
catalytic domain. The binding of FGFRs to their ligands,
the FGFs, results in receptor dimerization and
activation, and intracellular signaling. The binding of
FGFs to FGFRs is promiscuous, in that a receptor may be
activated by several ligands and a ligand may bind to
more that one type of receptor. Many FGFR3 splice
variants have been reported with the IIIb and IIIc
isoforms being the predominant forms. FGFR3 IIIc is the
isoform expressed in chondrocytes, the cells affected in
dwarfism, while IIIb is expressed in epithelial cells.
FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and
FGF23. It is a negative regulator of long bone growth.
In the cochlear duct and in the lens, FGFR3 is involved
in differentiation while it appears to have a role in
cell proliferation in epithelial cells. Germline
mutations in FGFR3 are associated with skeletal
disorders including several forms of dwarfism. Some
missense mutations are associated with multiple myeloma
and carcinomas of the bladder and cervix. Overexpression
of FGFR3 is found in thyroid carcinoma.
Length = 334
Score = 58.9 bits (142), Expect = 2e-11
Identities = 28/51 (54%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN LV+ + ++KI DFGLARD++ DYYKK G LPV +
Sbjct: 156 IHRDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKW 202
>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine
Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine
Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4);
pseudokinase domain. The PTKc (catalytic domain) family,
to which this subfamily belongs, includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. CCK4,
also called protein tyrosine kinase 7 (PTK7), is an
orphan receptor tyr kinase (RTK) containing an
extracellular region with seven immunoglobulin domains,
a transmembrane segment, and an intracellular inactive
pseudokinase domain. Studies in mice reveal that CCK4 is
essential for neural development. Mouse embryos
containing a truncated CCK4 die perinatally and display
craniorachischisis, a severe form of neural tube defect.
The mechanism of action of the CCK4 pseudokinase is
still unknown. Other pseudokinases such as HER3 rely on
the activity of partner RTKs.
Length = 275
Score = 58.2 bits (141), Expect = 2e-11
Identities = 23/42 (54%), Positives = 29/42 (69%), Gaps = 4/42 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYK 43
FVHRDLAARNCLVS R VK+ L++D+Y ++YYK
Sbjct: 137 RFVHRDLAARNCLVS----SQREVKVSLLSLSKDVYNSEYYK 174
>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine
Kinases, Platelet Derived Growth Factor Receptors.
Protein Tyrosine Kinase (PTK) family; Platelet Derived
Growth Factor Receptor (PDGFR) subfamily; catalytic (c)
domain. The PDGFR subfamily consists of PDGFR alpha,
PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
PDGFR subfamily members are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
five immunoglobulin-like domains, a transmembrane
segment, and an intracellular catalytic domain. PDGFR
kinase domains are autoinhibited by their juxtamembrane
regions containing tyr residues. The binding to their
ligands leads to receptor dimerization, trans
phosphorylation and activation, and intracellular
signaling. PDGFR subfamily receptors are important in
the development of a variety of cells. PDGFRs are
expressed in a many cells including fibroblasts,
neurons, endometrial cells, mammary epithelial cells,
and vascular smooth muscle cells. PDGFR signaling is
critical in normal embryonic development, angiogenesis,
and wound healing. PDGFRs transduce mitogenic signals
for connective tissue cells and are important for cell
shape and motility. Kit is important in the development
of melanocytes, germ cells, mast cells, hematopoietic
stem cells, the interstitial cells of Cajal, and the
pacemaker cells of the GI tract. CSF-1R signaling is
critical in the regulation of macrophages and
osteoclasts. Mammalian FLT3 plays an important role in
the survival, proliferation, and differentiation of stem
cells.
Length = 302
Score = 57.9 bits (140), Expect = 3e-11
Identities = 26/49 (53%), Positives = 32/49 (65%), Gaps = 4/49 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+HRDLAARN L++ +IVKI DFGLARDI + Y +G LPV
Sbjct: 163 IHRDLAARNVLLT----HGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Axl subfamily; catalytic (c) domain. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). The Axl subfamily
consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and
similar proteins. PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Axl subfamily members
are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with two
immunoglobulin-like domains followed by two fibronectin
type III repeats, a transmembrane segment, and an
intracellular catalytic domain. Binding to their
ligands, Gas6 and protein S, leads to receptor
dimerization, autophosphorylation, activation, and
intracellular signaling. Axl subfamily members are
implicated in a variety of cellular effects including
survival, proliferation, migration, and phagocytosis.
They are also associated with several types of cancer as
well as inflammatory, autoimmune, vascular, and kidney
diseases. Mer is named after its original reported
expression pattern (monocytes, epithelial, and
reproductive tissues). It is required for the ingestion
of apoptotic cells by phagocytes such as macrophages,
retinal pigment epithelial cells, and dendritic cells.
Mer is also important in maintaining immune homeostasis.
Length = 273
Score = 56.0 bits (135), Expect = 1e-10
Identities = 25/60 (41%), Positives = 36/60 (60%), Gaps = 7/60 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIES 62
F+HRDLAARNC+ L + + DFGL++ IY DYY++ +PV + + IES
Sbjct: 134 FIHRDLAARNCM---LREDMTVC-VADFGLSKKIYSGDYYRQGRIAKMPVKW---IAIES 186
>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like
Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK)
family; Human Fyn-related kinase (Frk) and similar
proteins; catalytic (c) domain. The PTKc family is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Frk and
Srk are members of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases contain an N-terminal SH4 domain with a
myristoylation site, followed by SH3 and SH2 domains, a
tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr. They are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Src
proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Frk, also known as Rak, is specifically
expressed in liver, lung, kidney, intestine, mammary
glands, and the islets of Langerhans. Rodent homologs
were previously referred to as GTK (gastrointestinal tyr
kinase), BSK (beta-cell Src-like kinase), or IYK
(intestinal tyr kinase). Studies in mice reveal that Frk
is not essential for viability. It plays a role in the
signaling that leads to cytokine-induced beta-cell death
in Type I diabetes. It also regulates beta-cell number
during embryogenesis and early in life.
Length = 261
Score = 55.9 bits (135), Expect = 2e-10
Identities = 22/46 (47%), Positives = 29/46 (63%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDLAARN LV + I K+ DFGLAR I + Y +EG
Sbjct: 122 QNYIHRDLAARNVLVG----ENNICKVADFGLARVIKEDIYEAREG 163
>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine
Kinase, Vascular Endothelial Growth Factor Receptor 2.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR2 (or Flk1) is a member of the VEGFR subfamily of
proteins, which are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. The
binding of VEGFRs to their ligands, the VEGFs, leads to
receptor dimerization, activation, and intracellular
signaling. The carboxyl terminus of VEGFR2 plays an
important role in its autophosphorylation and
activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD
and VEGFE. VEGFR2 signaling is implicated in all aspects
of normal and pathological vascular endothelial cell
biology. It induces a variety of cellular effects
including migration, survival, and proliferation. It is
critical in regulating embryonic vascular development
and angiogenesis. VEGFR2 is the major signal transducer
in pathological angiogenesis including cancer and
diabetic retinopathy, and is a target for inhibition in
cancer therapy.
Length = 343
Score = 55.8 bits (134), Expect = 2e-10
Identities = 26/51 (50%), Positives = 37/51 (72%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G+ LP+ +
Sbjct: 201 IHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247
>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine
Kinase, Vascular Endothelial Growth Factor Receptor 3.
Protein Tyrosine Kinase (PTK) family; Vascular
Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
VEGFR3 (or Flt4) is a member of the VEGFR subfamily of
proteins, which are receptor tyr kinases (RTKs)
containing an extracellular ligand-binding region with
seven immunoglobulin (Ig)-like domains, a transmembrane
segment, and an intracellular catalytic domain. In
VEGFR3, the fifth Ig-like domain is replaced by a
disulfide bridge. The binding of VEGFRs to their
ligands, the VEGFs, leads to receptor dimerization,
activation, and intracellular signaling. VEGFR3
preferentially binds the ligands VEGFC and VEGFD. VEGFR3
is essential for lymphatic endothelial cell (EC)
development and function. It has been shown to regulate
adaptive immunity during corneal transplantation. VEGFR3
is upregulated on blood vascular ECs in pathological
conditions such as vascular tumors and the periphery of
solid tumors. It plays a role in cancer progression and
lymph node metastasis. Missense mutations in the VEGFR3
gene are associated with primary human lymphedema.
Length = 338
Score = 55.8 bits (134), Expect = 2e-10
Identities = 26/51 (50%), Positives = 36/51 (70%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+HRDLAARN L+S + +VKI DFGLARDIY++ Y ++G LP+ +
Sbjct: 196 IHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242
>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine
Kinase, Receptor tyrosine kinase-like Orphan Receptor 1.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor 1 (Ror1); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ror
proteins are orphan receptor tyr kinases (RTKs)
containing an extracellular region with
immunoglobulin-like, cysteine-rich, and kringle domains,
a transmembrane segment, and an intracellular catalytic
domain. Ror RTKs are unrelated to the nuclear receptor
subfamily called retinoid-related orphan receptors
(RORs). RTKs are usually activated through ligand
binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain. Ror kinases are expressed in many
tissues during development. Avian Ror1 was found to be
involved in late limb development. Studies in mice
reveal that Ror1 is important in the regulation of
neurite growth in central neurons, as well as in
respiratory development. Loss of Ror1 also enhances the
heart and skeletal abnormalities found in Ror2-deficient
mice.
Length = 283
Score = 55.4 bits (133), Expect = 2e-10
Identities = 33/88 (37%), Positives = 46/88 (52%), Gaps = 18/88 (20%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIES 62
FVH+DLAARN L+ + VKI D GL+R+IY DYY+ + + LLP+
Sbjct: 145 FVHKDLAARNILIG----EQLHVKISDLGLSREIYSADYYRVQPKSLLPI---------- 190
Query: 63 KNRSVPFRPELCVYGPLADIDSIKKVGI 90
R +P PE +YG + I G+
Sbjct: 191 --RWMP--PEAIMYGKFSSDSDIWSFGV 214
>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine
Kinase, Colony-Stimulating Factor-1 Receptor. Protein
Tyrosine Kinase (PTK) family; Colony-Stimulating
Factor-1 Receptor (CSF-1R); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. CSF-1R,
also called c-Fms, is a member of the Platelet Derived
Growth Factor Receptor (PDGFR) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular ligand-binding region with five
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding of
CSF-1R to its ligand, CSF-1, leads to receptor
dimerization, trans phosphorylation and activation, and
intracellular signaling. CSF-1R signaling is critical in
the regulation of macrophages and osteoclasts. It leads
to increases in gene transcription and protein
translation, and induces cytoskeletal remodeling. CSF-1R
signaling leads to a variety of cellular responses
including survival, proliferation, and differentiation
of target cells. It plays an important role in innate
immunity, tissue development and function, and the
pathogenesis of some diseases including atherosclerosis
and cancer. CSF-1R signaling is also implicated in
mammary gland development during pregnancy and
lactation. Aberrant CSF-1/CSF-1R expression correlates
with tumor cell invasiveness, poor clinical prognosis,
and bone metastasis in breast cancer. Although the
structure of the human CSF-1R catalytic domain is known,
it is excluded from this specific alignment model
because it contains a deletion in its sequence.
Length = 374
Score = 55.6 bits (134), Expect = 3e-10
Identities = 24/49 (48%), Positives = 31/49 (63%), Gaps = 4/49 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+HRD+AARN L++ R+ KI DFGLARDI + Y +G LPV
Sbjct: 234 IHRDVAARNVLLTDG----RVAKICDFGLARDIMNDSNYVVKGNARLPV 278
>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine
Kinase-like Protein Tyrosine Kinases. Protein Tyrosine
Kinase (PTK) family; Spleen Tyrosine Kinase (Syk)
subfamily; catalytic (c) domain. The Syk subfamily is
composed of Syk, ZAP-70, Shark, and similar proteins.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Syk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing two Src homology 2 (SH2) domains
N-terminal to the catalytic tyr kinase domain. They are
involved in the signaling downstream of activated
receptors (including B-cell, T-cell, and Fc receptors)
that contain ITAMs (immunoreceptor tyr activation
motifs), leading to processes such as cell
proliferation, differentiation, survival, adhesion,
migration, and phagocytosis. Syk is important in B-cell
receptor (BCR) signaling, while Zap-70 is primarily
expressed in T-cells and NK cells, and is a crucial
component in T-cell receptor (TCR) signaling. Syk also
plays a central role in Fc receptor-mediated
phagocytosis in the adaptive immune system. Shark is
exclusively expressed in ectodermally derived epithelia,
and is localized preferentially to the apical surface of
the epithelial cells, it may play a role in a signaling
pathway for epithelial cell polarity.
Length = 257
Score = 54.3 bits (131), Expect = 5e-10
Identities = 23/52 (44%), Positives = 32/52 (61%), Gaps = 5/52 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPV 52
HFVHRDLAARN L+ ++ KI DFG++R + +DYY+ G P+
Sbjct: 115 HFVHRDLAARNVLL--VNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPL 162
>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase,
Abelson kinase. Protein Tyrosine Kinase (PTK) family;
Abelson (Abl) kinase; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Abl (or
c-Abl) is a ubiquitously-expressed cytoplasmic (or
nonreceptor) tyr kinase that contains SH3, SH2, and tyr
kinase domains in its N-terminal region, as well as
nuclear localization motifs, a putative DNA-binding
domain, and F- and G-actin binding domains in its
C-terminal tail. It also contains a short autoinhibitory
cap region in its N-terminus. Abl is normally inactive
and requires phosphorylation and myristoylation for
activation. Abl function depends on its subcellular
localization. In the cytoplasm, Abl plays a role in cell
proliferation and survival. In response to DNA damage or
oxidative stress, Abl is transported to the nucleus
where it induces apoptosis. In chronic myelogenous
leukemia (CML) patients, an aberrant translocation
results in the replacement of the first exon of Abl with
the BCR (breakpoint cluster region) gene. The resulting
BCR-Abl fusion protein is constitutively active and
associates into tetramers, resulting in a hyperactive
kinase sending a continuous signal. This leads to
uncontrolled proliferation, morphological transformation
and anti-apoptotic effects. BCR-Abl is the target of
selective inhibitors, such as imatinib (Gleevec), used
in the treatment of CML. Abl2, also known as ARG
(Abelson-related gene), is thought to play a cooperative
role with Abl in the proper development of the nervous
system. The Tel-ARG fusion protein, resulting from
reciprocal translocation between chromosomes 1 and 12,
is associated with acute myeloid leukemia (AML). The TEL
gene is a frequent fusion partner of other tyr kinase
oncogenes, including Tel/Abl, Tel/PDGFRbeta, and
Tel/Jak2, found in patients with leukemia and
myeloproliferative disorders.
Length = 263
Score = 54.1 bits (130), Expect = 6e-10
Identities = 22/51 (43%), Positives = 30/51 (58%), Gaps = 5/51 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+F+HRDLAARNCLV + +VK+ DFGL+R + D Y P+
Sbjct: 124 NFIHRDLAARNCLVG----ENHLVKVADFGLSR-LMTGDTYTAHAGAKFPI 169
>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine
Kinases, Apoptosis-associated tyrosine kinases. Protein
Tyrosine Kinase (PTK) family; Apoptosis-associated
tyrosine kinase (Aatyk) subfamily; catalytic (c) domain.
The Aatyk subfamily is also referred to as the lemur
tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1
(Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and
similar proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Aatyk proteins are mostly receptor tyr kinases (RTKs)
containing a transmembrane segment and a long C-terminal
cytoplasmic tail with a catalytic domain. Aatyk1 does
not contain a transmembrane segment and is a cytoplasmic
(or nonreceptor) kinase. Aatyk proteins are classified
as tyr kinases based on overall sequence similarity and
the phylogenetic tree. However, analysis of catalytic
residues suggests that Aatyk proteins may be
multispecific kinases, functioning also as
serine/threonine kinases. They are involved in neural
differentiation, nerve growth factor (NGF) signaling,
apoptosis, and spermatogenesis.
Length = 269
Score = 53.4 bits (128), Expect = 1e-09
Identities = 23/61 (37%), Positives = 33/61 (54%), Gaps = 4/61 (6%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
F+H DLA RNC + D VKIGD+GLA + Y DYY + +P+ + ++E
Sbjct: 120 DFIHSDLALRNCQL-TADLS---VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 62 S 62
Sbjct: 176 I 176
>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine
Kinase, Platelet Derived Growth Factor Receptor alpha.
Protein Tyrosine Kinase (PTK) family; Platelet Derived
Growth Factor Receptor (PDGFR) alpha; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. PDGFR
alpha is a receptor tyr kinase (RTK) containing an
extracellular ligand-binding region with five
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding to
its ligands, the PDGFs, leads to receptor dimerization,
trans phosphorylation and activation, and intracellular
signaling. PDGFR alpha forms homodimers or heterodimers
with PDGFR beta, depending on the nature of the PDGF
ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha
homodimerization. PDGFR signaling plays many roles in
normal embryonic development and adult physiology. PDGFR
alpha signaling is important in the formation of lung
alveoli, intestinal villi, mesenchymal dermis, and hair
follicles, as well as in the development of
oligodendrocytes, retinal astrocytes, neural crest
cells, and testicular cells. Aberrant PDGFR alpha
expression is associated with some human cancers.
Mutations in PDGFR alpha have been found within a subset
of gastrointestinal stromal tumors (GISTs). An active
fusion protein FIP1L1-PDGFR alpha, derived from
interstitial deletion, is associated with idiopathic
hypereosinophilic syndrome (HES) and chronic
eosinophilic leukemia (CEL).
Length = 400
Score = 53.5 bits (128), Expect = 1e-09
Identities = 27/51 (52%), Positives = 34/51 (66%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
VHRDLAARN L++ + +IVKI DFGLARDI + Y +G LPV +
Sbjct: 259 VHRDLAARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKW 305
>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine
Kinase, Platelet Derived Growth Factor Receptor beta.
Protein Tyrosine Kinase (PTK) family; Platelet Derived
Growth Factor Receptor (PDGFR) beta; catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. PDGFR
beta is a receptor tyr kinase (RTK) containing an
extracellular ligand-binding region with five
immunoglobulin-like domains, a transmembrane segment,
and an intracellular catalytic domain. The binding to
its ligands, the PDGFs, leads to receptor dimerization,
trans phosphorylation and activation, and intracellular
signaling. PDGFR beta forms homodimers or heterodimers
with PDGFR alpha, depending on the nature of the PDGF
ligand. PDGF-BB and PDGF-DD induce PDGFR beta
homodimerization. PDGFR signaling plays many roles in
normal embryonic development and adult physiology. PDGFR
beta signaling leads to a variety of cellular effects
including the stimulation of cell growth and chemotaxis,
as well as the inhibition of apoptosis and GAP
junctional communication. It is critical in normal
angiogenesis as it is involved in the recruitment of
pericytes and smooth muscle cells essential for vessel
stability. Aberrant PDGFR beta expression is associated
with some human cancers. The continuously-active fusion
proteins of PDGFR beta with COL1A1 and TEL are
associated with dermatofibrosarcoma protuberans (DFSP)
and a subset of chronic myelomonocytic leukemia (CMML),
respectively.
Length = 401
Score = 53.1 bits (127), Expect = 2e-09
Identities = 26/51 (50%), Positives = 34/51 (66%), Gaps = 4/51 (7%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
VHRDLAARN L+ + ++VKI DFGLARDI R+ Y +G LP+ +
Sbjct: 261 VHRDLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKW 307
>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase,
Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK)
family; Focal Adhesion Kinase (FAK); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. FAK is a
cytoplasmic (or nonreceptor) tyr kinase that contains an
autophosphorylation site and a FERM domain at the
N-terminus, a central tyr kinase domain, proline-rich
regions, and a C-terminal FAT (focal adhesion targeting)
domain. FAK activity is dependent on integrin-mediated
cell adhesion, which facilitates N-terminal
autophosphorylation. Full activation is achieved by the
phosphorylation of its two adjacent A-loop tyrosines.
FAK is important in mediating signaling initiated at
sites of cell adhesions and at growth factor receptors.
Through diverse molecular interactions, FAK functions as
a biosensor or integrator to control cell motility. It
is a key regulator of cell survival, proliferation,
migration and invasion, and thus plays an important role
in the development and progression of cancer. Src binds
to autophosphorylated FAK forming the FAK-Src dual
kinase complex, which is activated in a wide variety of
tumor cells and generates signals promoting growth and
metastasis. FAK is being developed as a target for
cancer therapy.
Length = 270
Score = 52.8 bits (127), Expect = 2e-09
Identities = 27/52 (51%), Positives = 33/52 (63%), Gaps = 5/52 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
FVHRD+AARN LVS D VK+GDFGL+R + YYK +G LP+
Sbjct: 126 KRFVHRDIAARNVLVSSPD----CVKLGDFGLSRYLEDESYYKAS-KGKLPI 172
>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine
Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family;
Tyro3; catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tyro3 (or Sky) is a
member of the Axl subfamily, which is composed of
receptor tyr kinases (RTKs) containing an extracellular
ligand-binding region with two immunoglobulin-like
domains followed by two fibronectin type III repeats, a
transmembrane segment, and an intracellular catalytic
domain. Binding to their ligands, Gas6 and protein S,
leads to receptor dimerization, autophosphorylation,
activation, and intracellular signaling. Tyro3 is
predominantly expressed in the central nervous system
and the brain, and functions as a neurotrophic factor.
It is also expressed in osteoclasts and has a role in
bone resorption.
Length = 273
Score = 52.6 bits (126), Expect = 3e-09
Identities = 23/53 (43%), Positives = 35/53 (66%), Gaps = 4/53 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
+F+HRDLAARNC+++ + V + DFGL++ IY DYY++ LPV +
Sbjct: 133 NFIHRDLAARNCMLN----ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinases, Janus kinases. Protein Tyrosine
Kinase (PTK) family; Janus kinase (Jak) subfamily;
catalytic (c) domain (repeat 2). The Jak subfamily is
composed of Jak1, Jak2, Jak3, TYK2, and similar
proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Jak subfamily proteins are cytoplasmic (or nonreceptor)
tyr kinases containing an N-terminal FERM domain,
followed by a Src homology 2 (SH2) domain, a
pseudokinase domain, and a C-terminal tyr kinase
catalytic domain. Most Jaks are expressed in a wide
variety of tissues, except for Jak3, which is expressed
only in hematopoietic cells. Jaks are crucial for
cytokine receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Jaks are also involved in regulating the surface
expression of some cytokine receptors. The Jak-STAT
pathway is involved in many biological processes
including hematopoiesis, immunoregulation, host defense,
fertility, lactation, growth, and embryogenesis.
Length = 284
Score = 52.0 bits (125), Expect = 4e-09
Identities = 23/53 (43%), Positives = 30/53 (56%), Gaps = 5/53 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI-YRNDYYKKEGEGLLPV 52
++HRDLAARN LV +VKI DFGLA+ + DYY + G P+
Sbjct: 128 QRYIHRDLAARNILVE----SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine
Kinase, Activated Cdc42-associated kinase. Protein
Tyrosine Kinase (PTK) family; Activated Cdc42-associated
kinase (Ack) subfamily; catalytic (c) domain. Ack
subfamily members include Ack1, thirty-eight-negative
kinase 1 (Tnk1), and similar proteins. The PTKc family
is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ack
subfamily members are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal catalytic domain, an
SH3 domain, a Cdc42-binding CRIB domain, and a
proline-rich region. They are mainly expressed in brain
and skeletal tissues and are involved in the regulation
of cell adhesion and growth, receptor degradation, and
axonal guidance. Ack1 is also associated with
androgen-independent prostate cancer progression. Tnk1
regulates TNFalpha signaling and may play an important
role in cell death.
Length = 257
Score = 51.6 bits (124), Expect = 5e-09
Identities = 23/45 (51%), Positives = 29/45 (64%), Gaps = 5/45 (11%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN-DYYKKE 45
F+HRDLAARN L++ VKIGDFGL R + +N D+Y E
Sbjct: 117 RFIHRDLAARNILLA----SDDKVKIGDFGLMRALPQNEDHYVME 157
>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Tyrosine kinase expressed in hepatocellular carcinoma
(Tec) subfamily; catalytic (c) domain. The Tec subfamily
is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk
(Txk), and similar proteins. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tec kinases are
cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with
similarity to Src kinases in that they contain Src
homology protein interaction domains (SH3, SH2)
N-terminal to the catalytic tyr kinase domain. Unlike
Src kinases, most Tec subfamily members (except Rlk)
also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, some
members contain the Tec homology (TH) domain, which
contains proline-rich and zinc-binding regions. Tec
kinases form the second largest subfamily of nRTKs and
are expressed mainly by haematopoietic cells, although
Tec and Bmx are also found in endothelial cells. B-cells
express Btk and Tec, while T-cells express Itk, Txk, and
Tec. Collectively, Tec kinases are expressed in a
variety of myeloid cells such as mast cells, platelets,
macrophages, and dendritic cells. Each Tec kinase shows
a distinct cell-type pattern of expression. The function
of Tec kinases in lymphoid cells have been studied
extensively. They play important roles in the
development, differentiation, maturation, regulation,
survival, and function of B-cells and T-cells. Mutations
in Btk cause the severe B-cell immunodeficiency,
X-linked agammaglobulinaemia (XLA).
Length = 256
Score = 51.3 bits (123), Expect = 6e-09
Identities = 22/44 (50%), Positives = 29/44 (65%), Gaps = 4/44 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
F+HRDLAARNCLV + +VK+ DFGLAR + + Y +G
Sbjct: 121 FIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQG 160
>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase,
Kit. Protein Tyrosine Kinase (PTK) family; Kit (or
c-Kit); catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Kit is a member of the
Platelet Derived Growth Factor Receptor (PDGFR)
subfamily of proteins, which are receptor tyr kinases
(RTKs) containing an extracellular ligand-binding region
with five immunoglobulin-like domains, a transmembrane
segment, and an intracellular catalytic domain. The
binding of Kit to its ligand, the stem-cell factor
(SCF), leads to receptor dimerization, trans
phosphorylation and activation, and intracellular
signaling. Kit is important in the development of
melanocytes, germ cells, mast cells, hematopoietic stem
cells, the interstitial cells of Cajal, and the
pacemaker cells of the GI tract. Kit signaling is
involved in major cellular functions including cell
survival, proliferation, differentiation, adhesion, and
chemotaxis. Mutations in Kit, which result in
constitutive ligand-independent activation, are found in
human cancers such as gastrointestinal stromal tumor
(GIST) and testicular germ cell tumor (TGCT). The
aberrant expression of Kit and/or SCF is associated with
other tumor types such as systemic mastocytosis and
cancers of the breast, neurons, lung, prostate, colon,
and rectum. Although the structure of the human Kit
catalytic domain is known, it is excluded from this
specific alignment model because it contains a deletion
in its sequence.
Length = 375
Score = 51.4 bits (123), Expect = 7e-09
Identities = 26/49 (53%), Positives = 31/49 (63%), Gaps = 4/49 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+HRDLAARN L++ RI KI DFGLARDI + Y +G LPV
Sbjct: 236 IHRDLAARNILLT----HGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase,
Axl. Protein Tyrosine Kinase (PTK) family; Axl;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Axl is a member of the
Axl subfamily, which is composed of receptor tyr kinases
(RTKs) containing an extracellular ligand-binding region
with two immunoglobulin-like domains followed by two
fibronectin type III repeats, a transmembrane segment,
and an intracellular catalytic domain. Binding to their
ligands, Gas6 and protein S, leads to receptor
dimerization, autophosphorylation, activation, and
intracellular signaling. Axl is widely expressed in a
variety of organs and cells including epithelial,
mesenchymal, hematopoietic, as well as non-transformed
cells. Axl signaling is important in many cellular
functions such as survival, anti-apoptosis,
proliferation, migration, and adhesion. Axl was
originally isolated from patients with chronic
myelogenous leukemia and a chronic myeloproliferative
disorder. Axl is overexpressed in many human cancers
including colon, squamous cell, thyroid, breast, and
lung carcinomas.
Length = 272
Score = 50.8 bits (121), Expect = 9e-09
Identities = 25/60 (41%), Positives = 38/60 (63%), Gaps = 7/60 (11%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIES 62
F+HRDLAARNC+++ + V + DFGL++ IY DYY++ +PV + + IES
Sbjct: 133 FIHRDLAARNCMLN----ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW---IAIES 185
>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine
Kinase, Receptor tyrosine kinase-like Orphan Receptor 2.
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine
kinase-like Orphan Receptor 2 (Ror2); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ror
proteins are orphan receptor tyr kinases (RTKs)
containing an extracellular region with
immunoglobulin-like, cysteine-rich, and kringle domains,
a transmembrane segment, and an intracellular catalytic
domain. Ror RTKs are unrelated to the nuclear receptor
subfamily called retinoid-related orphan receptors
(RORs). RTKs are usually activated through ligand
binding, which causes dimerization and
autophosphorylation of the intracellular tyr kinase
catalytic domain. Ror2 plays important roles in skeletal
and heart formation. Ror2-deficient mice show widespread
bone abnormalities, ventricular defects in the heart,
and respiratory dysfunction. Mutations in human Ror2
result in two different bone development genetic
disorders, recessive Robinow syndrome and brachydactyly
type B. Ror2 is also implicated in neural development.
Length = 283
Score = 50.8 bits (121), Expect = 9e-09
Identities = 34/83 (40%), Positives = 41/83 (49%), Gaps = 19/83 (22%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
H VH+DLA RN LV D VKI D GL R++Y DYYK G LLP+ +
Sbjct: 144 HVVHKDLATRNVLV--FDKLN--VKISDLGLFREVYAADYYKLMGNSLLPIRW------- 192
Query: 62 SKNRSVPFRPELCVYGPLADIDS 84
PE +YG + IDS
Sbjct: 193 -------MSPEAIMYGKFS-IDS 207
>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine
Kinases, Tyrosine kinase expressed in hepatocellular
carcinoma and Resting lymphocyte kinase. Protein
Tyrosine Kinase (PTK) family; Tyrosine kinase expressed
in hepatocellular carcinoma (Tec) and Resting lymphocyte
kinase (Rlk); catalytic (c) domain. The PTKc family is
part of a larger superfamily, that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Tec and
Rlk (also named Txk) are members of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. Instead of PH, Rlk
contains an N-terminal cysteine-rich region. In addition
to PH, Tec also contains the Tec homology (TH) domain
with proline-rich and zinc-binding regions. Tec kinases
are expressed mainly by haematopoietic cells. Tec is
more widely-expressed than other Tec subfamily kinases.
It is found in endothelial cells, both B- and T-cells,
and a variety of myeloid cells including mast cells,
erythroid cells, platelets, macrophages and neutrophils.
Rlk is expressed in T-cells and mast cell lines. Tec and
Rlk are both key components of T-cell receptor (TCR)
signaling. They are important in TCR-stimulated
proliferation, IL-2 production and phopholipase C-gamma1
activation.
Length = 256
Score = 50.2 bits (120), Expect = 2e-08
Identities = 21/44 (47%), Positives = 28/44 (63%), Gaps = 4/44 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
F+HRDLAARNCLVS +VK+ DFG+ R + ++Y G
Sbjct: 121 FIHRDLAARNCLVSSTG----VVKVSDFGMTRYVLDDEYTSSSG 160
>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein
Tyrosine Kinases, Apoptosis-associated tyrosine kinases
1 and 3. Protein Tyrosine Kinase (PTK) family;
Apoptosis-associated tyrosine kinase 1 (Aatyk1) and
Aatyk3; catalytic (c) domain. The PTKc family is part of
a larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Aatyk1 and Aatyk3 are
members of the Aatyk subfamily of proteins. Aatyk3 is a
receptor kinase containing a transmembrane segment and a
long C-terminal cytoplasmic tail with a catalytic
domain. Aatyk1 has a similar domain arrangement but
without the transmembrane segment and is thus, a
cytoplasmic (or nonreceptor) kinase. The expression of
Aatyk1 (also referred simply as Aatyk) is upregulated
during growth arrest and apoptosis in myeloid cells.
Aatyk1 has been implicated in neural differentiation,
and is a regulator of the Na-K-2Cl cotransporter, a
membrane protein involved in cell proliferation and
survival, epithelial transport, and blood pressure
control. The function of Aatyk3 is still unknown.
Length = 269
Score = 50.3 bits (120), Expect = 2e-08
Identities = 35/111 (31%), Positives = 49/111 (44%), Gaps = 26/111 (23%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
+F+H DLA RNCL++ VKIGD+GL+ + Y+ DYY +
Sbjct: 120 NFIHSDLALRNCLLT----ADLTVKIGDYGLSHNKYKEDYY-----------------VT 158
Query: 62 SKNRSVPFR---PELC--VYGPLADIDSIKKVGINKIGTICPNYFVLQCMP 107
VP R PEL V+G L +D K+ + +G F L P
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase,
Interleukin-2-inducible T-cell Kinase. Protein Tyrosine
Kinase (PTK) family; Interleukin-2 (IL-2)-inducible
T-cell kinase (Itk); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Itk (also
known as Tsk or Emt) is a member of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, Itk
contains the Tec homology (TH) domain containing one
proline-rich region and a zinc-binding region. Tec
kinases are expressed mainly by haematopoietic cells.
Itk is expressed in T-cells and mast cells, and is
important in their development and differentiation. Of
the three Tec kinases expressed in T-cells, Itk plays
the predominant role in T-cell receptor (TCR) signaling.
It is activated by phosphorylation upon TCR crosslinking
and is involved in the pathway resulting in
phospholipase C-gamma1 activation and actin
polymerization. It also plays a role in the downstream
signaling of the T-cell costimulatory receptor CD28, the
T-cell surface receptor CD2, and the chemokine receptor
CXCR4. In addition, Itk is crucial for the development
of T-helper(Th)2 effector responses.
Length = 256
Score = 49.9 bits (119), Expect = 2e-08
Identities = 23/64 (35%), Positives = 33/64 (51%), Gaps = 5/64 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIES 62
+HRDLAARNCLV + ++VK+ DFG+ R + + Y G PV ++ V
Sbjct: 121 VIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTK-FPVKWSSPEVFSF 175
Query: 63 KNRS 66
S
Sbjct: 176 SKYS 179
>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine
Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic
(c) domain (repeat 2). The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tyk2 is a member of the
Janus kinase (Jak) subfamily of proteins, which are
cytoplasmic (or nonreceptor) tyr kinases containing an
N-terminal FERM domain, followed by a Src homology 2
(SH2) domain, a pseudokinase domain, and a C-terminal
tyr kinase catalytic domain. Jaks are crucial for
cytokine receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Tyk2 is widely expressed in many tissues. It is involved
in signaling via the cytokine receptors IFN-alphabeta,
IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell
surface urokinase receptor (uPAR) signaling and plays a
role in modulating vascular smooth muscle cell (VSMC)
functional behavior in response to injury. Tyk2 is also
important in dendritic cell function and T helper (Th)1
cell differentiation. A homozygous mutation of Tyk2 was
found in a patient with hyper-IgE syndrome (HIES), a
primary immunodeficiency characterized by recurrent skin
abscesses, pneumonia, and elevated serum IgE. This
suggests that Tyk2 may play important roles in multiple
cytokine signaling involved in innate and adaptive
immunity.
Length = 283
Score = 49.9 bits (119), Expect = 2e-08
Identities = 28/64 (43%), Positives = 42/64 (65%), Gaps = 6/64 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR-NDYYKKEGEGLLPVS-FAITVV 59
H++HRDLAARN L+ R+VKIGDFGLA+ + ++YY+ +G PV +A+ +
Sbjct: 127 HYIHRDLAARNVLLD----NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 60 IESK 63
E+K
Sbjct: 183 KENK 186
>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Fes subfamily; catalytic (c) domain. Fes subfamily
members include Fes (or Fps), Fer, and similar proteins.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Fes
subfamily proteins are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal region with FCH
(Fes/Fer/CIP4 homology) and coiled-coil domains,
followed by a SH2 domain, and a C-terminal catalytic
domain. The genes for Fes (feline sarcoma) and Fps
(Fujinami poultry sarcoma) were first isolated from
tumor-causing retroviruses. The viral oncogenes encode
chimeric Fes proteins consisting of Gag sequences at the
N-termini, resulting in unregulated tyr kinase activity.
Fes and Fer kinases play roles in haematopoiesis,
inflammation and immunity, growth factor signaling,
cytoskeletal regulation, cell migration and adhesion,
and the regulation of cell-cell interactions. Fes and
Fer show redundancy in their biological functions.
Length = 251
Score = 47.1 bits (112), Expect = 2e-07
Identities = 20/49 (40%), Positives = 30/49 (61%), Gaps = 4/49 (8%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+HRDLAARNCLV + ++KI DFG++R+ Y +G +P+
Sbjct: 115 IHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDGLKQIPI 159
>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth
Factor Receptor-like Protein Tyrosine Kinases. Protein
Tyrosine Kinase (PTK) family; Epidermal Growth Factor
Receptor (EGFR) subfamily; catalytic (c) domain. EGFR
(HER, ErbB) subfamily members include EGFR (HER1,
ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and
similar proteins. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
The EGFR proteins are receptor tyr kinases (RTKs)
containing an extracellular EGF-related ligand-binding
region, a transmembrane helix, and a cytoplasmic region
with a tyr kinase domain and a regulatory C-terminal
tail. Unlike other tyr kinases, phosphorylation of the
activation loop of EGFR proteins is not critical to
their activation. Instead, they are activated by
ligand-induced dimerization, resulting in the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. Collectively, they can recognize a variety of
ligands including EGF, TGFalpha, and neuregulins, among
others. All four subfamily members can form homo- or
heterodimers. HER3 contains an impaired kinase domain
and depends on its heterodimerization partner for
activation. EGFR subfamily members are involved in
signaling pathways leading to a broad range of cellular
responses including cell proliferation, differentiation,
migration, growth inhibition, and apoptosis. Gain of
function alterations, through their overexpression,
deletions, or point mutations in their kinase domains,
have been implicated in various cancers. These receptors
are targets of many small molecule inhibitors and
monoclonal antibodies used in cancer therapy.
Length = 279
Score = 47.0 bits (112), Expect = 2e-07
Identities = 25/52 (48%), Positives = 32/52 (61%), Gaps = 6/52 (11%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN-DYYKKEGEGLLPV 52
VHRDLAARN LV P++ VKI DFGLA+ + + Y EG G +P+
Sbjct: 129 RLVHRDLAARNVLVK--TPQH--VKITDFGLAKLLDVDEKEYHAEG-GKVPI 175
>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine
Kinase, Tie2. Protein Tyrosine Kinase (PTK) family;
Tie2; catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie2 is a receptor tyr
kinase (RTK) containing an extracellular region, a
transmembrane segment, and an intracellular catalytic
domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie2 is expressed
mainly in endothelial cells and hematopoietic stem
cells. It is also found in a subset of tumor-associated
monocytes and eosinophils. The angiopoietins (Ang-1 to
Ang-4) serve as ligands for Tie2. The binding of Ang-1
to Tie2 leads to receptor autophosphorylation and
activation, promoting cell migration and survival. In
contrast, Ang-2 binding to Tie2 does not result in the
same response, suggesting that Ang-2 may function as an
antagonist. Tie2 signaling plays key regulatory roles in
vascular integrity and quiescence, and in inflammation.
Length = 303
Score = 46.9 bits (111), Expect = 2e-07
Identities = 30/66 (45%), Positives = 38/66 (57%), Gaps = 10/66 (15%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
F+HRDLAARN LV + + KI DFGL+R + Y K+ G LPV + + IE
Sbjct: 144 QFIHRDLAARNILVG----ENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW---MAIE 193
Query: 62 SKNRSV 67
S N SV
Sbjct: 194 SLNYSV 199
>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine
Kinases, Bruton's tyrosine kinase and Bone marrow kinase
on the X chromosome. Protein Tyrosine Kinase (PTK)
family; Bruton's tyrosine kinase (Btk) and Bone marrow
kinase on the X chromosome (Bmx); catalytic (c) domain.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Btk and
Bmx (also named Etk) are members of the Tec subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases with similarity to Src kinases in that they
contain Src homology protein interaction domains (SH3,
SH2) N-terminal to the catalytic tyr kinase domain.
Unlike Src kinases, most Tec subfamily members (except
Rlk) also contain an N-terminal pleckstrin homology (PH)
domain, which binds the products of PI3K and allows
membrane recruitment and activation. In addition, Btk
contains the Tec homology (TH) domain with proline-rich
and zinc-binding regions. Tec kinases are expressed
mainly by haematopoietic cells. Btk is expressed in
B-cells, and a variety of myeloid cells including mast
cells, platelets, neutrophils, and dendrictic cells. It
interacts with a variety of partners, from cytosolic
proteins to nuclear transcription factors, suggesting a
diversity of functions. Stimulation of a diverse array
of cell surface receptors, including antigen engagement
of the B-cell receptor (BCR), leads to PH-mediated
membrane translocation of Btk and subsequent
phosphorylation by Src kinase and activation. Btk plays
an important role in the life cycle of B-cells including
their development, differentiation, proliferation,
survival, and apoptosis. Mutations in Btk cause the
primary immunodeficiency disease, X-linked
agammaglobulinaemia (XLA) in humans. Bmx is primarily
expressed in bone marrow and the arterial endothelium,
and plays an important role in ischemia-induced
angiogenesis. It facilitates arterial growth, capillary
formation, vessel maturation, and bone marrow-derived
endothelial progenitor cell mobilization.
Length = 256
Score = 46.4 bits (110), Expect = 4e-07
Identities = 21/45 (46%), Positives = 27/45 (60%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
F+HRDLAARNCLV VK+ DFGL+R + ++Y G
Sbjct: 120 QFIHRDLAARNCLVD----DQGCVKVSDFGLSRYVLDDEYTSSVG 160
>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine
Kinase, Tie1. Protein Tyrosine Kinase (PTK) family;
Tie1; catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie1 is a receptor tyr
kinase (RTK) containing an extracellular region, a
transmembrane segment, and an intracellular catalytic
domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie receptors are
specifically expressed in endothelial cells and
hematopoietic stem cells. No specific ligand has been
identified for Tie1, although the angiopoietin, Ang-1,
binds to Tie1 through integrins at high concentrations.
In vivo studies of Tie1 show that it is critical in
vascular development.
Length = 297
Score = 46.2 bits (109), Expect = 5e-07
Identities = 30/66 (45%), Positives = 37/66 (56%), Gaps = 10/66 (15%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
F+HRDLAARN LV + KI DFGL+R + Y K+ G LPV + + IE
Sbjct: 139 QFIHRDLAARNVLVG----ENLASKIADFGLSRG---EEVYVKKTMGRLPVRW---MAIE 188
Query: 62 SKNRSV 67
S N SV
Sbjct: 189 SLNYSV 194
>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein
Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family;
Ephrin Receptor (EphR) subfamily; catalytic (c) domain.
The PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). They can be classified into two classes (EphA
and EphB), according to their extracellular sequences,
which largely correspond to binding preferences for
either GPI-anchored ephrin-A ligands or transmembrane
ephrin-B ligands. Vertebrates have ten EphA and six EhpB
receptors, which display promiscuous ligand interactions
within each class. EphRs contain an ephrin binding
domain and two fibronectin repeats extracellularly, a
transmembrane segment, and a cytoplasmic tyr kinase
domain. Binding of the ephrin ligand to EphR requires
cell-cell contact since both are anchored to the plasma
membrane. This allows ephrin/EphR dimers to form,
leading to the activation of the intracellular tyr
kinase domain. The resulting downstream signals occur
bidirectionally in both EphR-expressing cells (forward
signaling) and ephrin-expressing cells (reverse
signaling). The main effect of ephrin/EphR interaction
is cell-cell repulsion or adhesion. Ephrin/EphR
signaling is important in neural development and
plasticity, cell morphogenesis and proliferation,
cell-fate determination, embryonic development, tissue
patterning, and angiogenesis.
Length = 266
Score = 45.0 bits (107), Expect = 1e-06
Identities = 18/36 (50%), Positives = 25/36 (69%), Gaps = 4/36 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
M++VHRDLAARN LV+ + K+ DFGL+R +
Sbjct: 125 MNYVHRDLAARNILVN----SNLVCKVSDFGLSRRL 156
>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine
Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK)
family; Src-related kinase lacking C-terminal regulatory
tyrosine and N-terminal myristylation sites (Srm) and
breast tumor kinase (Brk, also called protein tyrosine
kinase 6); catalytic (c) domains. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Srm and
Brk are a member of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases in general contain an N-terminal SH4 domain with
a myristoylation site, followed by SH3 and SH2 domains,
a tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr; they are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Srm and
Brk however, lack the N-terminal myristylation sites.
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Brk has been found to be overexpressed
in a majority of breast tumors.
Length = 261
Score = 45.1 bits (107), Expect = 1e-06
Identities = 19/41 (46%), Positives = 25/41 (60%), Gaps = 5/41 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYY 42
+ +HRDLAARN LV + K+ DFGLAR + + D Y
Sbjct: 124 NSIHRDLAARNILV---GEDL-VCKVADFGLAR-LIKEDVY 159
>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src
kinase-like Protein Tyrosine Kinases. Protein Tyrosine
Kinase (PTK) family; C-terminal Src kinase (Csk)
subfamily; catalytic (c) domain. The Csk subfamily is
composed of Csk, Chk, and similar proteins. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. To inhibit Src kinases,
Csk and Chk are translocated to the membrane via binding
to specific transmembrane proteins, G-proteins, or
adaptor proteins near the membrane. Csk catalyzes the
tyr phosphorylation of the regulatory C-terminal tail of
Src kinases, resulting in their inactivation. Chk
inhibit Src kinases using a noncatalytic mechanism by
simply binding to them. As negative regulators of Src
kinases, Csk and Chk play important roles in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression.
Length = 256
Score = 45.1 bits (107), Expect = 1e-06
Identities = 19/33 (57%), Positives = 24/33 (72%), Gaps = 4/33 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARD 35
FVHRDLAARN LVS + + K+ DFGLA++
Sbjct: 123 FVHRDLAARNVLVS----EDLVAKVSDFGLAKE 151
>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase,
Hematopoietic cell kinase. Protein Tyrosine Kinase
(PTK) family; Hematopoietic cell kinase (Hck); catalytic
(c) domain. The PTKc family is part of a larger
superfamily that includes the catalytic domains of other
kinases such as protein serine/threonine kinases, RIO
kinases, and phosphoinositide 3-kinase (PI3K). PTKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to tyrosine (tyr) residues in protein substrates.
Hck is a member of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases contain an N-terminal SH4 domain with a
myristoylation site, followed by SH3 and SH2 domains, a
tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr. They are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Src
proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Hck is present in myeloid and lymphoid
cells that play a role in the development of cancer. It
may be important in the oncogenic signaling of the
protein Tel-Abl, which induces a chronic myelogenous
leukemia (CML)-like disease. Hck also acts as a negative
regulator of granulocyte colony-stimulating factor
(G-CSF)-induced proliferation of granulocytic
precursors, suggesting a possible role in the
development of acute myeloid leukemia (AML). In
addition, Hck is essential in regulating the
degranulation of polymorphonuclear leukocytes (PMNs).
Genetic polymorphisms affect the expression level of
Hck, which affects PMN mediator release and influences
the development of chronic obstructive pulmonary disease
(COPD).
Length = 260
Score = 44.6 bits (105), Expect = 1e-06
Identities = 22/45 (48%), Positives = 28/45 (62%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS + KI DFGLAR I N+Y +EG
Sbjct: 122 NYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREG 162
>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the
Protein Tyrosine Kinases, Janus kinases 2 and 3.
Protein Tyrosine Kinase (PTK) family; Janus kinase 2
(Jak2) and Jak3; catalytic (c) domain (repeat 2). The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Jak2 and
Jak3 are members of the Janus kinase (Jak) subfamily of
proteins, which are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal FERM domain, followed
by a Src homology 2 (SH2) domain, a pseudokinase domain,
and a C-terminal catalytic tyr kinase domain. Jaks are
crucial for cytokine receptor signaling. They are
activated by autophosphorylation upon cytokine-induced
receptor aggregation, and subsequently trigger
downstream signaling events such as the phosphorylation
of signal transducers and activators of transcription
(STATs). Jak2 is widely expressed in many tissues while
Jak3 is expressed only in hematopoietic cells. Jak2 is
essential for the signaling of hormone-like cytokines
such as growth hormone, erythropoietin, thrombopoietin,
and prolactin, as well as some IFNs and cytokines that
signal through the IL-3 and gp130 receptors. Jak3 binds
the shared receptor subunit common gamma chain and thus,
is essential in the signaling of cytokines that use it
such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.
Disruption of Jak2 in mice results in an embryonic
lethal phenotype with multiple defects including
erythropoietic and cardiac abnormalities. It is the only
Jak gene that results in a lethal phenotype when
disrupted in mice. A mutation in the pseudokinase domain
of Jak2, V617F, is present in many myeloproliferative
diseases, including almost all patients with
polycythemia vera, and 50% of patients with essential
thrombocytosis and myelofibrosis. Jak3 is important in
lymphoid development and myeloid cell differentiation.
Inactivating mutations in Jak3 have been reported in
humans with severe combined immunodeficiency (SCID).
Length = 284
Score = 44.8 bits (106), Expect = 1e-06
Identities = 24/51 (47%), Positives = 33/51 (64%), Gaps = 5/51 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN-DYYKKEGEGLLPV 52
+VHRDLA RN LV + + R VKIGDFGL + + ++ +YYK G P+
Sbjct: 129 YVHRDLATRNILV---ESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI 175
>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to
tyrosine kinase). Protein Tyrosine Kinase (PTK) family;
Receptor related to tyrosine kinase (Ryk); pseudokinase
domain. The PTKc (catalytic domain) family to which this
subfamily belongs, is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Ryk is a
receptor tyr kinase (RTK) containing an extracellular
region with two leucine-rich motifs, a transmembrane
segment, and an intracellular inactive pseudokinase
domain. The extracellular region of Ryk shows homology
to the N-terminal domain of Wnt inhibitory factor-1
(WIF) and serves as the ligand (Wnt) binding domain of
Ryk. Ryk is expressed in many different tissues both
during development and in adults, suggesting a
widespread function. It acts as a chemorepulsive axon
guidance receptor of Wnt glycoproteins and is
responsible for the establishment of axon tracts during
the development of the central nervous system. In
addition, studies in mice reveal that Ryk is essential
in skeletal, craniofacial, and cardiac development.
Thus, it appears Ryk is involved in signal transduction
despite its lack of kinase activity. Ryk may function as
an accessory protein that modulates the signals coming
from catalytically active partner RTKs such as the Eph
receptors.
Length = 280
Score = 44.3 bits (105), Expect = 2e-06
Identities = 17/39 (43%), Positives = 28/39 (71%), Gaps = 4/39 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYY 42
+H+D+AARNC+ +D + + VKI D L+RD++ DY+
Sbjct: 139 IHKDIAARNCV---IDEELQ-VKITDNALSRDLFPMDYH 173
>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine
Kinases, Lymphocyte-specific kinase and Blk. Protein
Tyrosine Kinase (PTK) family; Lck and Blk kinases;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Lck (lymphocyte-specific
kinase) and Blk are members of the Src subfamily of
proteins, which are cytoplasmic (or non-receptor) tyr
kinases. Src kinases contain an N-terminal SH4 domain
with a myristoylation site, followed by SH3 and SH2
domains, a tyr kinase domain, and a regulatory
C-terminal region containing a conserved tyr. They are
activated by autophosphorylation at the tyr kinase
domain, but are negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
Src proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Lck is expressed in T-cells and natural
killer (NK) cells. It plays a critical role in T-cell
maturation, activation, and T-cell receptor (TCR)
signaling. Lck phosphorylates ITAM (immunoreceptor tyr
activation motif) sequences on several subunits of TCRs,
leading to the activation of different second messenger
cascades. Phosphorylated ITAMs serve as binding sites
for other signaling factor such as Syk and ZAP-70,
leading to their activation and propagation of
downstream events. In addition, Lck regulates
drug-induced apoptosis by interfering with the
mitochondrial death pathway. The apototic role of Lck is
independent of its primary function in T-cell signaling.
Blk is expressed specifically in B-cells. It is involved
in pre-BCR (B-cell receptor) signaling.
Length = 260
Score = 44.1 bits (104), Expect = 2e-06
Identities = 22/46 (47%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS + KI DFGLAR I N+Y +EG
Sbjct: 121 KNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREG 162
>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase,
Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK)
family; Spleen tyrosine kinase (Syk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Syk,
together with Zap-70, form the Syk subfamily of kinases
which are cytoplasmic (or nonreceptor) tyr kinases
containing two Src homology 2 (SH2) domains N-terminal
to the catalytic tyr kinase domain. Syk was first cloned
from the spleen, and its function in hematopoietic cells
is well-established. Syk is involved in the signaling
downstream of activated receptors (including B-cell and
Fc receptors) that contain ITAMs (immunoreceptor tyr
activation motifs), leading to processes such as cell
proliferation, differentiation, survival, adhesion,
migration, and phagocytosis. More recently, Syk
expression has been detected in other cell types
(including epithelial cells, vascular endothelial cells,
neurons, hepatocytes, and melanocytes), suggesting a
variety of biological functions in non-immune cells. Syk
plays a critical role in maintaining vascular integrity
and in wound healing during embryogenesis. It also
regulates Vav3, which is important in osteoclast
function including bone development. In breast
epithelial cells, where Syk acts as a negative regulator
for epidermal growth factor receptor (EGFR) signaling,
loss of Syk expression is associated with abnormal
proliferation during cancer development suggesting a
potential role as a tumor suppressor. In mice, Syk has
been shown to inhibit malignant transformation of
mammary epithelial cells induced with murine mammary
tumor virus (MMTV).
Length = 257
Score = 44.2 bits (104), Expect = 3e-06
Identities = 24/54 (44%), Positives = 34/54 (62%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ + Y KI DFGL++ + ++ YYK + G PV +
Sbjct: 115 NFVHRDLAARNVLL--VTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKW 164
>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine
Kinases. Protein Tyrosine Kinase (PTK) family; Tie
subfamily; catalytic (c) domain. The Tie subfamily
consists of Tie1 and Tie2. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Tie proteins are
receptor tyr kinases (RTKs) containing an extracellular
region, a transmembrane segment, and an intracellular
catalytic domain. The extracellular region contains an
immunoglobulin (Ig)-like domain, three epidermal growth
factor (EGF)-like domains, a second Ig-like domain, and
three fibronectin type III repeats. Tie receptors are
specifically expressed in endothelial cells and
hematopoietic stem cells. The angiopoietins (Ang-1 to
Ang-4) serve as ligands for Tie2, while no specific
ligand has been identified for Tie1. The binding of
Ang-1 to Tie2 leads to receptor autophosphorylation and
activation, promoting cell migration and survival. In
contrast, Ang-2 binding to Tie2 does not result in the
same response, suggesting that Ang-2 may function as an
antagonist. In vivo studies of Tie1 show that it is
critical in vascular development.
Length = 270
Score = 43.9 bits (103), Expect = 3e-06
Identities = 30/66 (45%), Positives = 38/66 (57%), Gaps = 10/66 (15%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
F+HRDLAARN LV + + KI DFGL+R + Y K+ G LPV + + IE
Sbjct: 132 QFIHRDLAARNILVG----ENYVAKIADFGLSRG---QEVYVKKTMGRLPVRW---MAIE 181
Query: 62 SKNRSV 67
S N SV
Sbjct: 182 SLNYSV 187
>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein
Tyrosine Kinase, Janus kinase 1. Protein Tyrosine
Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic
(c) domain (repeat 2). The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Jak1 is a member of the
Janus kinase (Jak) subfamily of proteins, which are
cytoplasmic (or nonreceptor) tyr kinases containing an
N-terminal FERM domain, followed by a Src homology 2
(SH2) domain, a pseudokinase domain, and a C-terminal
tyr kinase domain. Jaks are crucial for cytokine
receptor signaling. They are activated by
autophosphorylation upon cytokine-induced receptor
aggregation, and subsequently trigger downstream
signaling events such as the phosphorylation of signal
transducers and activators of transcription (STATs).
Jak1 is widely expressed in many tissues. Many cytokines
are dependent on Jak1 for signaling, including those
that use the shared receptor subunits common gamma chain
(IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6,
IL-11, oncostatin M, G-CSF, and IFNs, among others). The
many varied interactions of Jak1 and its ubiquitous
expression suggest many biological roles. Jak1 is
important in neurological development, as well as in
lymphoid development and function. It also plays a role
in the pathophysiology of cardiac hypertrophy and heart
failure. A mutation in the ATP-binding site of Jak1 was
identified in a human uterine leiomyosarcoma cell line,
resulting in defective cytokine induction and antigen
presentation, thus allowing the tumor to evade the
immune system.
Length = 284
Score = 43.4 bits (102), Expect = 5e-06
Identities = 21/41 (51%), Positives = 24/41 (58%), Gaps = 4/41 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYY 42
+VHRDLAARN LV VKIGDFGL + I + Y
Sbjct: 129 QYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEY 165
>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase,
Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Lyn is a member of the
Src subfamily of proteins, which are cytoplasmic (or
non-receptor) tyr kinases. Src kinases contain an
N-terminal SH4 domain with a myristoylation site,
followed by SH3 and SH2 domains, a tyr kinase domain,
and a regulatory C-terminal region containing a
conserved tyr. They are activated by autophosphorylation
at the tyr kinase domain, but are negatively regulated
by phosphorylation at the C-terminal tyr by Csk
(C-terminal Src Kinase). Src proteins are involved in
signaling pathways that regulate cytokine and growth
factor responses, cytoskeleton dynamics, cell
proliferation, survival, and differentiation. Lyn is
expressed in B lymphocytes and myeloid cells. It
exhibits both positive and negative regulatory roles in
B cell receptor (BCR) signaling. Lyn, as well as Fyn and
Blk, promotes B cell activation by phosphorylating ITAMs
(immunoreceptor tyr activation motifs) in CD19 and in Ig
components of BCR. It negatively regulates signaling by
its unique ability to phosphorylate ITIMs
(immunoreceptor tyr inhibition motifs) in cell surface
receptors like CD22 and CD5. Lyn also plays an important
role in G-CSF receptor signaling by phosphorylating a
variety of adaptor molecules.
Length = 261
Score = 43.1 bits (101), Expect = 5e-06
Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 4/45 (8%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
+++HRDL A N LVS + + KI DFGLAR I N+Y +EG
Sbjct: 123 NYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREG 163
>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine
Kinase, Apoptosis-associated tyrosine kinase 2. Protein
Tyrosine Kinase (PTK) family; Apoptosis-associated
tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Aatyk2 is
a member of the Aatyk subfamily of proteins, which are
receptor kinases containing a transmembrane segment and
a long C-terminal cytoplasmic tail with a catalytic
domain. Aatyk2 is also called lemur tyrosine kinase 2
(Lmtk2) or brain-enriched kinase (Brek). It is expressed
at high levels in early postnatal brain, and has been
shown to play a role in nerve growth factor (NGF)
signaling. Studies with knockout mice reveal that Aatyk2
is essential for late stage spermatogenesis. Although it
is classified as a tyr kinase based on sequence
similarity and the phylogenetic tree, Aatyk2 has been
characterized as a serine/threonine kinase.
Length = 268
Score = 42.9 bits (101), Expect = 6e-06
Identities = 21/52 (40%), Positives = 31/52 (59%), Gaps = 6/52 (11%)
Query: 2 HFVHRDLAARNC-LVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPV 52
+F+H DLA RNC L S L VK+GD+G+ Y+ DY + E + +P+
Sbjct: 119 NFLHSDLALRNCFLTSDLT-----VKVGDYGIGPSRYKEDYIETEDDKCVPL 165
>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase,
Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps)
kinase subfamily; catalytic (c) domain. The PTKc family
is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Fes
subfamily proteins are cytoplasmic (or nonreceptor) tyr
kinases containing an N-terminal region with FCH
(Fes/Fer/CIP4 homology) and coiled-coil domains,
followed by a SH2 domain, and a C-terminal catalytic
domain. The genes for Fes (feline sarcoma) and Fps
(Fujinami poultry sarcoma) were first isolated from
tumor-causing retroviruses. The viral oncogenes encode
chimeric Fes proteins consisting of Gag sequences at the
N-termini, resulting in unregulated tyr kinase activity.
Fes kinase is expressed in myeloid, vascular
endothelial, epithelial, and neuronal cells. It plays
important roles in cell growth and differentiation,
angiogenesis, inflammation and immunity, and
cytoskeletal regulation. A recent study implicates Fes
kinase as a tumor suppressor in colorectal cancer.
Length = 252
Score = 43.1 bits (101), Expect = 6e-06
Identities = 22/53 (41%), Positives = 32/53 (60%), Gaps = 4/53 (7%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
H +HRDLAARNCLV+ + ++KI DFG++R+ Y G +PV +
Sbjct: 114 HCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162
>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine
Kinase, Zeta-chain-associated protein of 70kDa. Protein
Tyrosine Kinase (PTK) family; Zeta-chain-associated
protein of 70kDa (Zap-70); catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Zap-70 is
a member of the Syk subfamily of kinases, which are
cytoplasmic (or nonreceptor) tyr kinases containing two
Src homology 2 (SH2) domains N-terminal to the catalytic
tyr kinase domain. Zap-70 is primarily expressed in
T-cells and NK cells, and is a crucial component in
T-cell receptor (TCR) signaling. Zap-70 binds the
phosphorylated ITAM (immunoreceptor tyr activation
motif) sequences of the activated TCR zeta-chain through
its SH2 domains, leading to its phosphorylation and
activation. It then phosphorylates target proteins,
which propagate the signals to downstream pathways.
Zap-70 is hardly detected in normal peripheral B-cells,
but is present in some B-cell malignancies. It is used
as a diagnostic marker for chronic lymphocytic leukemia
(CLL) as it is associated with the more aggressive
subtype of the disease.
Length = 257
Score = 42.6 bits (100), Expect = 8e-06
Identities = 24/54 (44%), Positives = 34/54 (62%), Gaps = 5/54 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND-YYKKEGEGLLPVSF 54
+FVHRDLAARN L+ ++ Y KI DFGL++ + +D YYK G P+ +
Sbjct: 115 NFVHRDLAARNVLL--VNQHY--AKISDFGLSKALGADDSYYKARSAGKWPLKW 164
>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine
Kinase, Fungal Cyclin-Dependent protein Kinase Bypass
UAS Requirement 1 and similar proteins.
Serine/Threonine Kinases (STKs), Bypass UAS Requirement
1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
BUR1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. BUR1, also called
SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK)
that is functionally equivalent to mammalian CDK9. It
associates with the cyclin BUR2. BUR genes were
orginally identified in a genetic screen as factors
involved in general transcription. The BUR1/BUR2 complex
phosphorylates the C-terminal domain of RNA polymerase
II. In addition, this complex regulates histone
modification by phosporylating Rad6 and mediating the
association of the Paf1 complex with chromatin.
Length = 311
Score = 42.3 bits (100), Expect = 1e-05
Identities = 29/89 (32%), Positives = 35/89 (39%), Gaps = 15/89 (16%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
H +HRD+ A N L+ I+KI DFGLAR K G G + VV
Sbjct: 135 HILHRDIKAANILID----NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 62 SKNRSVPFR-PEL----CVYGPLADIDSI 85
+R PEL Y DI I
Sbjct: 191 W------YRPPELLLGERRYTTAVDIWGI 213
>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ
cell-Associated Kinase-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Male germ
cell-Associated Kinase (MAK)-like subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAK-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of human MAK and
MAK-related kinase (MRK), Saccharomyces cerevisiae
Ime2p, Schizosaccharomyces pombe Mei4-dependent protein
3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5,
Arabidopsis thaliana MHK, and similar proteins. These
proteins play important roles during meiosis. MAK is
highly expressed in testicular cells specifically in the
meiotic phase, but is not essential for spermatogenesis
and fertility. It functions as a coactivator of the
androgen receptor in prostate cells. MRK, also called
Intestinal Cell Kinase (ICK), is expressed ubiquitously,
with highest expression in the ovary and uterus. A
missense mutation in MRK causes
endocrine-cerebro-osteodysplasia (ECO), suggesting that
this protein plays an important role in the development
of many organs. MAK and MRK may be involved in
regulating cell cycle and cell fate. Ime2p is a
meiosis-specific kinase that is important during meiotic
initiation and during the later stages of meiosis. Mde3
functions downstream of the transcription factor Mei-4
which is essential for meiotic prophase I.
Length = 283
Score = 42.1 bits (100), Expect = 1e-05
Identities = 20/39 (51%), Positives = 24/39 (61%), Gaps = 7/39 (17%)
Query: 1 MH---FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+H F HRDL N LVS + +VKI DFGLAR+I
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAREI 149
>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase,
Src. Protein Tyrosine Kinase (PTK) family; Src kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Src (or c-Src) is a
cytoplasmic (or non-receptor) tyr kinase, containing an
N-terminal SH4 domain with a myristoylation site,
followed by SH3 and SH2 domains, a tyr kinase domain,
and a regulatory C-terminal region with a conserved tyr.
It is activated by autophosphorylation at the tyr kinase
domain, and is negatively regulated by phosphorylation
at the C-terminal tyr by Csk (C-terminal Src Kinase).
c-Src is the vertebrate homolog of the oncogenic protein
(v-Src) from Rous sarcoma virus. Together with other Src
subfamily proteins, it is involved in signaling pathways
that regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Src also play a role in regulating cell
adhesion, invasion, and motility in cancer cells and
tumor vasculature, contributing to cancer progression
and metastasis. Elevated levels of Src kinase activity
have been reported in a variety of human cancers.
Several inhibitors of Src have been developed as
anti-cancer drugs. Src is also implicated in acute
inflammatory responses and osteoclast function.
Length = 262
Score = 42.0 bits (98), Expect = 1e-05
Identities = 21/46 (45%), Positives = 29/46 (63%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
M++VHRDL A N LV + + K+ DFGLAR I N+Y ++G
Sbjct: 121 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQG 162
>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic
domain. Phosphotransferases. Serine or
threonine-specific kinase subfamily.
Length = 254
Score = 41.7 bits (99), Expect = 1e-05
Identities = 16/43 (37%), Positives = 20/43 (46%), Gaps = 4/43 (9%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYK 43
VHRDL N L LD + K+ DFGLAR + +
Sbjct: 116 KGIVHRDLKPENIL---LDEDGHV-KLADFGLARQLDPGEKLT 154
>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase,
Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Yes (or c-Yes) is a
member of the Src subfamily of proteins, which are
cytoplasmic (or non-receptor) tyr kinases. Src kinases
contain an N-terminal SH4 domain with a myristoylation
site, followed by SH3 and SH2 domains, a tyr kinase
domain, and a regulatory C-terminal region containing a
conserved tyr. They are activated by autophosphorylation
at the tyr kinase domain, but are negatively regulated
by phosphorylation at the C-terminal tyr by Csk
(C-terminal Src Kinase). Src proteins are involved in
signaling pathways that regulate cytokine and growth
factor responses, cytoskeleton dynamics, cell
proliferation, survival, and differentiation. c-Yes
kinase is the cellular homolog of the oncogenic protein
(v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma
viruses. It displays functional overlap with other Src
subfamily members, particularly Src. It also shows some
unique functions such as binding to occludins,
transmembrane proteins that regulate extracellular
interactions in tight junctions. Yes also associates
with a number of proteins in different cell types that
Src does not interact with, like JAK2 and gp130 in
pre-adipocytes, and Pyk2 in treated pulmonary vein
endothelial cells. Although the biological function of
Yes remains unclear, it appears to have a role in
regulating cell-cell interactions and vesicle
trafficking in polarized cells.
Length = 260
Score = 42.0 bits (98), Expect = 1e-05
Identities = 21/46 (45%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
M+++HRDL A N LV + KI DFGLAR I N+Y ++G
Sbjct: 121 MNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNEYTARQG 162
>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine
Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK)
family; Fyn and Yrk kinases; catalytic (c) domain. The
PTKc family is part of a larger superfamily that
includes the catalytic domains of other kinases such as
protein serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Fyn and
Yrk are members of the Src subfamily of proteins, which
are cytoplasmic (or non-receptor) tyr kinases. Src
kinases contain an N-terminal SH4 domain with a
myristoylation site, followed by SH3 and SH2 domains, a
tyr kinase domain, and a regulatory C-terminal region
containing a conserved tyr. They are activated by
autophosphorylation at the tyr kinase domain, but are
negatively regulated by phosphorylation at the
C-terminal tyr by Csk (C-terminal Src Kinase). Src
proteins are involved in signaling pathways that
regulate cytokine and growth factor responses,
cytoskeleton dynamics, cell proliferation, survival, and
differentiation. Fyn, together with Lck, plays a
critical role in T-cell signal transduction by
phosphorylating ITAM (immunoreceptor tyr activation
motif) sequences on T-cell receptors, ultimately leading
to the proliferation and differentiation of T-cells. In
addition, Fyn is involved in the myelination of neurons,
and is implicated in Alzheimer's and Parkinson's
diseases. Yrk has been detected only in chickens. It is
primarily found in neuronal and epithelial cells and in
macrophages. It may play a role in inflammation and in
response to injury.
Length = 260
Score = 41.9 bits (98), Expect = 1e-05
Identities = 20/46 (43%), Positives = 28/46 (60%), Gaps = 4/46 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEG 46
M+++HRDL + N LV + KI DFGLAR I N+Y ++G
Sbjct: 121 MNYIHRDLRSANILVG----DGLVCKIADFGLARLIEDNEYTARQG 162
>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine
Kinase, HER2. Protein Tyrosine Kinase (PTK) family;
HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. HER2 is a
member of the EGFR (HER, ErbB) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular EGF-related ligand-binding region, a
transmembrane helix, and a cytoplasmic region with a tyr
kinase domain and a regulatory C-terminal tail. Unlike
other tyr kinases, phosphorylation of the activation
loop of EGFR proteins is not critical to their
activation. Instead, they are activated by
ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. HER2 does not bind to any known EGFR
subfamily ligands, but contributes to the kinase
activity of all possible heterodimers. It acts as the
preferred partner with other ligand-bound EGFR proteins
and functions as a signal amplifier, with the HER2-HER3
heterodimer being the most potent pair in mitogenic
signaling. HER2 plays an important role in cell
development, proliferation, survival and motility.
Overexpression of HER2 results in its activation and
downstream signaling, even in the absence of ligand.
HER2 overexpression, mainly due to gene amplification,
has been shown in a variety of human cancers. Its role
in breast cancer is especially well-documented. HER2 is
up-regulated in about 25% of breast tumors and is
associated with increases in tumor aggressiveness,
recurrence and mortality. HER2 is a target for
monoclonal antibodies and small molecule inhibitors,
which are being developed as treatments for cancer. The
first humanized antibody approved for clinical use is
Trastuzumab (Herceptin), which is being used in
combination with other therapies to improve the survival
rates of patients with HER2-overexpressing breast
cancer.
Length = 279
Score = 41.2 bits (96), Expect = 3e-05
Identities = 25/49 (51%), Positives = 30/49 (61%), Gaps = 6/49 (12%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR--DIYRNDYYKKEGE 47
+ VHRDLAARN LV P + VKI DFGLAR DI +Y+ G+
Sbjct: 128 VRLVHRDLAARNVLVK--SPNH--VKITDFGLARLLDIDETEYHADGGK 172
>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases. Protein Kinases
(PKs), catalytic (c) domain. PKs catalyze the transfer
of the gamma-phosphoryl group from ATP to
serine/threonine or tyrosine residues on protein
substrates. The PK family is part of a larger
superfamily that includes the catalytic domains of RIO
kinases, aminoglycoside phosphotransferase, choline
kinase, phosphoinositide 3-kinase (PI3K), and
actin-fragmin kinase. PKs make up a large family of
serine/threonine kinases, protein tyrosine kinases
(PTKs), and dual-specificity PKs that phosphorylate both
serine/threonine and tyrosine residues of target
proteins. Majority of protein phosphorylation, about
95%, occurs on serine residues while only 1% occurs on
tyrosine residues. Protein phosphorylation is a
mechanism by which a wide variety of cellular proteins,
such as enzymes and membrane channels, are reversibly
regulated in response to certain stimuli. PKs often
function as components of signal transduction pathways
in which one kinase activates a second kinase, which in
turn, may act on other kinases; this sequential action
transmits a signal from the cell surface to target
proteins, which results in cellular responses. The PK
family is one of the largest known protein families with
more than 100 homologous yeast enzymes and 550 human
proteins. A fraction of PK family members are
pseudokinases that lack crucial residues for catalytic
activity. The mutiplicity of kinases allows for specific
regulation according to substrate, tissue distribution,
and cellular localization. PKs regulate many cellular
processes including proliferation, division,
differentiation, motility, survival, metabolism,
cell-cycle progression, cytoskeletal rearrangement,
immunity, and neuronal functions. Many kinases are
implicated in the development of various human diseases
including different types of cancer.
Length = 215
Score = 40.7 bits (96), Expect = 3e-05
Identities = 16/48 (33%), Positives = 22/48 (45%), Gaps = 3/48 (6%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEG 48
+HRDL N L LD VK+ DFGL++ + + K G
Sbjct: 111 NGIIHRDLKPENIL---LDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155
>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain.
Length = 260
Score = 40.7 bits (96), Expect = 3e-05
Identities = 16/48 (33%), Positives = 22/48 (45%), Gaps = 4/48 (8%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEG 48
+HRDL N L LD + KI DFGLA+ + ++ G
Sbjct: 117 NGIIHRDLKPENIL---LDENGVV-KIADFGLAKKLLKSSSSLTTFVG 160
>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine
Kinase, Epidermal Growth Factor Receptor. Protein
Tyrosine Kinase (PTK) family; Epidermal Growth Factor
Receptor (EGFR); catalytic (c) domain. The PTKc family
is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EGFR
(HER1, ErbB1) is a member of the EGFR (HER, ErbB)
subfamily of proteins, which are receptor tyr kinases
(RTKs) containing an extracellular EGF-related
ligand-binding region, a transmembrane helix, and a
cytoplasmic region with a tyr kinase domain and a
regulatory C-terminal tail. Unlike other tyr kinases,
phosphorylation of the activation loop of EGFR proteins
is not critical to their activation. Instead, they are
activated by ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. Ligands for EGFR include EGF, heparin binding
EGF-like growth factor (HBEGF), epiregulin,
amphiregulin, TGFalpha, and betacellulin. Upon ligand
binding, EGFR can form homo- or heterodimers with other
EGFR subfamily members. The EGFR signaling pathway is
one of the most important pathways regulating cell
proliferation, differentiation, survival, and growth.
Overexpression and mutation in the kinase domain of EGFR
have been implicated in the development and progression
of a variety of cancers. A number of monoclonal
antibodies and small molecule inhibitors have been
developed that target EGFR, including the antibodies
Cetuximab and Panitumumab, which are used in combination
with other therapies for the treatment of colorectal
cancer and non-small cell lung carcinoma (NSCLC). The
small molecule inhibitors Gefitinib (Iressa) and
Erlotinib (Tarceva), already used for NSCLC, are
undergoing clinical trials for other types of cancer
including gastrointestinal, breast, head and neck, and
bladder.
Length = 316
Score = 40.7 bits (95), Expect = 4e-05
Identities = 25/54 (46%), Positives = 34/54 (62%), Gaps = 6/54 (11%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY-YKKEGEGLLPVSF 54
VHRDLAARN LV P++ VKI DFGLA+ + ++ Y EG G +P+ +
Sbjct: 129 RLVHRDLAARNVLVK--TPQH--VKITDFGLAKLLGADEKEYHAEG-GKVPIKW 177
>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase,
C-terminal Src kinase. Protein Tyrosine Kinase (PTK)
family; C-terminal Src kinase (Csk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. The Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. To inhibit Src kinases,
Csk is translocated to the membrane via binding to
specific transmembrane proteins, G-proteins, or adaptor
proteins near the membrane. Csk catalyzes the tyr
phosphorylation of the regulatory C-terminal tail of Src
kinases, resulting in their inactivation. Csk is
expressed in a wide variety of tissues. As a negative
regulator of Src, Csk plays a role in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression. In
addition, Csk also shows Src-independent functions. It
is a critical component in G-protein signaling, and
plays a role in cytoskeletal reorganization and cell
migration.
Length = 256
Score = 40.3 bits (94), Expect = 4e-05
Identities = 18/35 (51%), Positives = 24/35 (68%), Gaps = 4/35 (11%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+FVHRDLAARN LVS + + K+ DFGL ++
Sbjct: 122 NFVHRDLAARNVLVS----EDNVAKVSDFGLTKEA 152
>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent
protein Kinase-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase (CDK)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDKs are partly
regulated by their subcellular localization, which
defines substrate phosphorylation and the resulting
specific function. CDK1, CDK2, CDK4, and CDK6 have
well-defined functions in the cell cycle, such as the
regulation of the early G1 phase by CDK4 or CDK6, the
G1/S phase transition by CDK2, or the entry of mitosis
by CDK1. They also exhibit overlapping cyclin
specificity and functions in certain conditions.
Knockout mice with a single CDK deleted remain viable
with specific phenotypes, showing that some CDKs can
compensate for each other. For example, CDK4 can
compensate for the loss of CDK6, however, double
knockout mice with both CDK4 and CDK6 deleted die in
utero. CDK8 and CDK9 are mainly involved in
transcription while CDK5 is implicated in neuronal
function. CDK7 plays essential roles in both the cell
cycle as a CDK-Activating Kinase (CAK) and in
transcription as a component of the general
transcription factor TFIIH.
Length = 282
Score = 40.5 bits (96), Expect = 5e-05
Identities = 13/31 (41%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ + ++K+ DFGLAR
Sbjct: 120 LHRDLKPQNILIN----RDGVLKLADFGLAR 146
>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent
protein Kinase 4 and 6-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase 4 (CDK4) and CDK6-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK4/6-like
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDK4 and CDK6
partner with D-type cyclins to regulate the early G1
phase of the cell cycle. They are the first kinase
activated by mitogenic signals to release cells from the
G0 arrested state. CDK4 and CDK6 are both expressed
ubiquitously, associate with all three D cyclins (D1, D2
and D3), and phosphorylate the retinoblastoma (pRb)
protein. They are also regulated by the INK4 family of
inhibitors which associate with either the CDK alone or
the CDK/cyclin complex. CDK4 and CDK6 show differences
in subcellular localization, sensitivity to some
inhibitors, timing in activation, tumor selectivity, and
possibly substrate profiles. Although CDK4 and CDK6 seem
to show some redundancy, they also have discrete,
nonoverlapping functions. CDK6 plays an important role
in cell differentiation.
Length = 287
Score = 40.3 bits (95), Expect = 5e-05
Identities = 19/38 (50%), Positives = 22/38 (57%), Gaps = 5/38 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY 41
VHRDL +N LV+ VKI DFGLAR IY +
Sbjct: 129 VHRDLKPQNILVTS----DGQVKIADFGLAR-IYSFEM 161
>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine
Kinases, Class EphB Ephrin Receptors. Protein Tyrosine
Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
class EphB receptors; catalytic (c) domain. The PTKc
family is part of a larger superfamily that includes the
catalytic domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). Class EphB receptors bind to transmembrane
ephrin-B ligands. There are six vertebrate EhpB
receptors (EphB1-6), which display promiscuous
interactions with three ephrin-B ligands. One exception
is EphB2, which also interacts with ephrin A5. EphRs
contain an ephrin-binding domain and two fibronectin
repeats extracellularly, a transmembrane segment, and a
cytoplasmic tyr kinase domain. Binding of the ephrin
ligand to EphR requires cell-cell contact since both are
anchored to the plasma membrane. The resulting
downstream signals occur bidirectionally in both
EphR-expressing cells (forward signaling) and
ephrin-expressing cells (reverse signaling). Ephrin/EphR
interaction mainly results in cell-cell repulsion or
adhesion. EphBRs play important roles in synapse
formation and plasticity, spine morphogenesis, axon
guidance, and angiogenesis. In the intestinal
epithelium, EphBRs are Wnt signaling target genes that
control cell compartmentalization. They function as
suppressors of color cancer progression.
Length = 269
Score = 40.2 bits (94), Expect = 6e-05
Identities = 18/34 (52%), Positives = 24/34 (70%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M++VHRDLAARN LV+ + K+ DFGL+R
Sbjct: 125 MNYVHRDLAARNILVN----SNLVCKVSDFGLSR 154
>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine
Kinase, Mitogen-Activated Protein Kinase.
Serine/Threonine Kinases (STKs), Mitogen-Activated
Protein Kinase (MAPK) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The MAPK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. MAPKs serve as important
mediators of cellular responses to extracellular
signals. They control critical cellular functions
including differentiation, proliferation, migration, and
apoptosis. They are also implicated in the pathogenesis
of many diseases including multiple types of cancer,
stroke, diabetes, and chronic inflammation. Typical MAPK
pathways involve a triple kinase core cascade comprising
of the MAPK, which is phosphorylated and activated by a
MAPK kinase (MAP2K or MKK), which itself is
phosphorylated and activated by a MAPK kinase kinase
(MAP3K or MKKK). Each cascade is activated either by a
small GTP-binding protein or by an adaptor protein,
which transmits the signal either directly to a MAP3K to
start the triple kinase core cascade or indirectly
through a mediator kinase, a MAP4K. There are three main
typical MAPK subfamilies: Extracellular signal-Regulated
Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38.
Some MAPKs are atypical in that they are not regulated
by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7.
Length = 330
Score = 39.8 bits (94), Expect = 7e-05
Identities = 17/41 (41%), Positives = 22/41 (53%), Gaps = 11/41 (26%)
Query: 1 MHF---VHRDLAARNCLV--SCLDPKYRIVKIGDFGLARDI 36
+H +HRDL N LV +C +KI DFGLAR +
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCD------LKICDFGLARGV 153
>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase,
Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. Fer kinase is a member
of the Fes subfamily of proteins which are cytoplasmic
(or nonreceptor) tyr kinases containing an N-terminal
region with FCH (Fes/Fer/CIP4 homology) and coiled-coil
domains, followed by a SH2 domain, and a C-terminal
catalytic domain. Fer kinase is expressed in a wide
variety of tissues, and is found to reside in both the
cytoplasm and the nucleus. It plays important roles in
neuronal polarization and neurite development,
cytoskeletal reorganization, cell migration, growth
factor signaling, and the regulation of cell-cell
interactions mediated by adherens junctions and focal
adhesions. Fer kinase also regulates cell cycle
progression in malignant cells.
Length = 250
Score = 39.6 bits (92), Expect = 9e-05
Identities = 17/31 (54%), Positives = 23/31 (74%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDLAARNCLV + ++KI DFG++R
Sbjct: 115 IHRDLAARNCLVG----ENNVLKISDFGMSR 141
>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase,
Csk homologous kinase. Protein Tyrosine Kinase (PTK)
family; Csk homologous kinase (Chk); catalytic (c)
domain. The PTKc family is part of a larger superfamily
that includes the catalytic domains of other kinases
such as protein serine/threonine kinases, RIO kinases,
and phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. Csk
subfamily kinases are cytoplasmic (or nonreceptor) tyr
kinases containing the Src homology domains, SH3 and
SH2, N-terminal to the catalytic tyr kinase domain. They
negatively regulate the activity of Src kinases that are
anchored to the plasma membrane. Chk is also referred to
as megakaryocyte-associated tyrosine kinase (Matk). To
inhibit Src kinases, Chk is translocated to the membrane
via binding to specific transmembrane proteins,
G-proteins, or adaptor proteins near the membrane. Chk
inhibit Src kinases using a noncatalytic mechanism by
simply binding to them. As a negative regulator of Src
kinases, Chk may play important roles in cell
proliferation, survival, and differentiation, and
consequently, in cancer development and progression. Chk
is expressed in brain and hematopoietic cells. Studies
in mice reveal that Chk is not functionally redundant
with Csk and that it plays an important role as a
regulator of immune responses. Chk also plays a role in
neural differentiation in a manner independent of Src by
enhancing Mapk activation via Ras-mediated signaling.
Length = 254
Score = 39.6 bits (92), Expect = 1e-04
Identities = 19/32 (59%), Positives = 22/32 (68%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDLAARN LVS + + K+ DFGLAR
Sbjct: 121 LVHRDLAARNILVS----EDGVAKVSDFGLAR 148
>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent
protein Kinase 8-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 8 (CDK8)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK8-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. This subfamily is
composed of CDK8, CDC2L6, and similar proteins. CDK8
functions as a negative or positive regulator of
transcription, depending on the scenario. Together with
its regulator, cyclin C, it reversibly associates with
the multi-subunit core Mediator complex, a cofactor that
is involved in regulating RNA polymerase II (RNAP
II)-dependent transcription. CDC2L6 also associates with
Mediator in complexes lacking CDK8. In VP16-dependent
transcriptional activation, CDK8 and CDC2L6 exerts
opposing effects by positive and negative regulation,
respectively, in similar conditions.
Length = 316
Score = 39.2 bits (92), Expect = 1e-04
Identities = 17/30 (56%), Positives = 19/30 (63%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
HRDL N LV P+ +VKIGD GLAR
Sbjct: 131 HRDLKPANILVMGEGPERGVVKIGDLGLAR 160
>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine
Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase
(PTK) family; Ephrin Receptor (EphR) subfamily; EphA2
receptor; catalytic (c) domain. The PTKc family is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). In general, class EphA receptors bind
GPI-anchored ephrin-A ligands. There are ten vertebrate
EphA receptors (EphA1-10), which display promiscuous
interactions with six ephrin-A ligands. EphRs contain an
ephrin binding domain and two fibronectin repeats
extracellularly, a transmembrane segment, and a
cytoplasmic tyr kinase domain. Binding of the ephrin
ligand to EphR requires cell-cell contact since both are
anchored to the plasma membrane. The resulting
downstream signals occur bidirectionally in both
EphR-expressing cells (forward signaling) and
ephrin-expressing cells (reverse signaling). Ephrin/EphR
interaction mainly results in cell-cell repulsion or
adhesion, making it important in neural development and
plasticity, cell morphogenesis, cell-fate determination,
embryonic development, tissue patterning, and
angiogenesis. The EphA2 receptor is overexpressed in
tumor cells and tumor blood vessels in a variety of
cancers including breast, prostate, lung, and colon. As
a result, it is an attractive target for drug design
since its inhibition could affect several aspects of
tumor progression.
Length = 268
Score = 39.2 bits (91), Expect = 1e-04
Identities = 18/34 (52%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M++VHRDLAARN LV+ K+ DFGL+R
Sbjct: 126 MNYVHRDLAARNILVN----SNLECKVSDFGLSR 155
>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine
Kinases, Class EphA Ephrin Receptors. Protein Tyrosine
Kinase (PTK) family; Ephrin Receptor (EphR) subfamily;
most class EphA receptors including EphA3, EphA4, EphA5,
and EphA7, but excluding EphA1, EphA2 and EphA10;
catalytic (c) domain. The PTKc family is part of a
larger superfamily that includes the catalytic domains
of other kinases such as protein serine/threonine
kinases, RIO kinases, and phosphoinositide 3-kinase
(PI3K). PTKs catalyze the transfer of the
gamma-phosphoryl group from ATP to tyrosine (tyr)
residues in protein substrates. EphRs comprise the
largest subfamily of receptor tyr kinases (RTKs). In
general, class EphA receptors bind GPI-anchored ephrin-A
ligands. There are ten vertebrate EphA receptors
(EphA1-10), which display promiscuous interactions with
six ephrin-A ligands. One exception is EphA4, which also
binds ephrins-B2/B3. EphRs contain an ephrin-binding
domain and two fibronectin repeats extracellularly, a
transmembrane segment, and a cytoplasmic tyr kinase
domain. Binding of the ephrin ligand to EphR requires
cell-cell contact since both are anchored to the plasma
membrane. The resulting downstream signals occur
bidirectionally in both EphR-expressing cells (forward
signaling) and ephrin-expressing cells (reverse
signaling). Ephrin/EphR interaction mainly results in
cell-cell repulsion or adhesion, making it important in
neural development and plasticity, cell morphogenesis,
cell-fate determination, embryonic development, tissue
patterning, and angiogenesis. EphARs and ephrin-A
ligands are expressed in multiple areas of the
developing brain, especially in the retina and tectum.
They are part of a system controlling retinotectal
mapping.
Length = 267
Score = 38.7 bits (90), Expect = 2e-04
Identities = 18/34 (52%), Positives = 23/34 (67%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
M +VHRDLAARN LV+ + K+ DFGL+R
Sbjct: 125 MGYVHRDLAARNILVN----SNLVCKVSDFGLSR 154
>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine
Kinase, Cell Cycle-Related Kinase. Serine/Threonine
Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
CCRK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CCRK was previously called p42. It is a
Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK)
which is essential for the activation of CDK2. It is
indispensable for cell growth and has been implicated in
the progression of glioblastoma multiforme. In the
heart, a splice variant of CCRK with a different
C-terminal half is expressed, this variant promotes
cardiac cell growth and survival and is significantly
down-regulated during the development of heart failure.
Length = 286
Score = 38.4 bits (90), Expect = 2e-04
Identities = 17/37 (45%), Positives = 21/37 (56%), Gaps = 7/37 (18%)
Query: 1 MH---FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
MH +HRDL N L+S ++KI DFGLAR
Sbjct: 115 MHANGIMHRDLKPANLLISADG----VLKIADFGLAR 147
>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 7.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 7 (CDK7) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK7 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK7
plays essential roles in the cell cycle and in
transcription. It associates with cyclin H and MAT1 and
acts as a CDK-Activating Kinase (CAK) by phosphorylating
and activating cell cycle CDKs (CDK1/2/4/6). In the
brain, it activates CDK5. CDK7 is also a component of
the general transcription factor TFIIH, which
phosphorylates the C-terminal domain (CTD) of RNA
polymerase II when it is bound with unphosphorylated
DNA, as present in the pre-initiation complex. Following
phosphorylation, the CTD dissociates from the DNA which
allows transcription initiation.
Length = 298
Score = 37.9 bits (89), Expect = 3e-04
Identities = 13/33 (39%), Positives = 19/33 (57%), Gaps = 4/33 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARD 35
+HRDL N L++ ++K+ DFGLAR
Sbjct: 123 ILHRDLKPNNLLIA----SDGVLKLADFGLARS 151
>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein
Serine/Threonine Kinase, Mitogen-Activated Protein
Kinase Kinase Kinase. Serine/threonine kinases (STKs),
mitogen-activated protein kinase (MAPK) kinase kinase
(MAPKKK) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MAPKKK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called
MAP/ERK kinase kinases (MEKKs) in some cases. They
phosphorylate and activate MAPK kinases (MAPKKs or MKKs
or MAP2Ks), which in turn phosphorylate and activate
MAPKs during signaling cascades that are important in
mediating cellular responses to extracellular signals.
This subfamily is composed of the Apoptosis
Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or
MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant
and fungal MAPKKKs. Also included in this subfamily are
the cell division control proteins Schizosaccharomyces
pombe Cdc7 and Saccharomyces cerevisiae Cdc15.
Length = 260
Score = 37.9 bits (89), Expect = 3e-04
Identities = 13/36 (36%), Positives = 18/36 (50%), Gaps = 4/36 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRD+ N LV +VK+ DFG A+ +
Sbjct: 120 NGIVHRDIKGANILVDS----DGVVKLADFGCAKRL 151
>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional.
Length = 335
Score = 37.8 bits (88), Expect = 4e-04
Identities = 18/48 (37%), Positives = 24/48 (50%), Gaps = 8/48 (16%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR----DIYRNDYYKKE 45
+F+HRDL+ N ++ I KI DFGLAR Y + K E
Sbjct: 139 YFMHRDLSPANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDE 182
>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine
Kinase, HER4. Protein Tyrosine Kinase (PTK) family;
HER4 (ErbB4); catalytic (c) domain. The PTKc family is
part of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. HER4 is a
member of the EGFR (HER, ErbB) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular EGF-related ligand-binding region, a
transmembrane helix, and a cytoplasmic region with a tyr
kinase domain and a regulatory C-terminal tail. Unlike
other tyr kinases, phosphorylation of the activation
loop of EGFR proteins is not critical to their
activation. Instead, they are activated by
ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. Ligands that bind HER4 fall into two groups,
the neuregulins (or heregulins) and some EGFR (HER1)
ligands including betacellulin, HBEGF, and epiregulin.
All four neuregulins (NRG1-4) interact with HER4. Upon
ligand binding, HER4 forms homo- or heterodimers with
other HER proteins. HER4 is essential in embryonic
development. It is implicated in mammary gland, cardiac,
and neural development. As a postsynaptic receptor of
NRG1, HER4 plays an important role in synaptic
plasticity and maturation. The impairment of NRG1/HER4
signaling may contribute to schizophrenia.
Length = 303
Score = 37.7 bits (87), Expect = 5e-04
Identities = 23/52 (44%), Positives = 30/52 (57%), Gaps = 4/52 (7%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSF 54
VHRDLAARN LV P + VKI DFGLAR + ++ G +P+ +
Sbjct: 130 LVHRDLAARNVLVK--SPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKW 177
>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine
Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases
(STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PFTAIRE-2 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PFTAIRE-2 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PFTAIRE-2 is also
referred to as ALS2CR7 (amyotrophic lateral sclerosis 2
(juvenile) chromosome region candidate 7). It may be
associated with amyotrophic lateral sclerosis 2 (ALS2),
an autosomal recessive form of juvenile ALS. The
function of PFTAIRE-2 is not yet known.
Length = 291
Score = 37.6 bits (87), Expect = 5e-04
Identities = 16/33 (48%), Positives = 21/33 (63%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
H +HRDL +N L+S L +K+ DFGLAR
Sbjct: 123 HILHRDLKPQNLLISYLGE----LKLADFGLAR 151
>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine
Kinase, Cell Division Cycle 2-like 1. Serine/Threonine
Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
CDC2L1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDC2L1, also
called PITSLRE, exists in different isoforms which are
named using the alias CDK11(p). The CDC2L1 gene produces
two protein products, CDK11(p110) and CDK11(p58). CDC2L1
is also represented by the caspase-processed CDK11(p46).
CDK11(p110), the major isoform, associates with cyclin L
and is expressed throughout the cell cycle. It is
involved in RNA processing and the regulation of
transcription. CDK11(p58) associates with cyclin D3 and
is expressed during the G2/M phase of the cell cycle. It
plays roles in spindle morphogenesis, centrosome
maturation, sister chromatid cohesion, and the
completion of mitosis. CDK11(p46) is formed from the
larger isoforms by caspases during TNFalpha- and
Fas-induced apoptosis. It functions as a downstream
effector kinase in apoptotic signaling pathways and
interacts with eukaryotic initiation factor 3f (eIF3f),
p21-activated kinase (PAK1), and Ran-binding protein
(RanBPM).
Length = 293
Score = 36.4 bits (85), Expect = 0.001
Identities = 16/37 (43%), Positives = 21/37 (56%), Gaps = 7/37 (18%)
Query: 1 MH---FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+H +HRDL N L++ I+KI DFGLAR
Sbjct: 122 LHDNWILHRDLKTSNLLLN----NRGILKICDFGLAR 154
>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent
protein Kinase 9-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 9 (CDK9)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK9-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. This subfamily is
composed of CDK9 and CDK12 from higher eukaryotes, yeast
BUR1, C-type plant CDKs (CdkC), and similar proteins.
CDK9, BUR1, and CdkC are functionally equivalent. They
act as a kinase for the C-terminal domain of RNA
polymerase II and participate in regulating mutliple
steps of gene expression including transcription
elongation and RNA processing. CDK9 and CdkC associate
with T-type cyclins while BUR1 associates with the
cyclin BUR2. CDK12 is a unique CDK that contains an
arginine/serine-rich (RS) domain, which is predominantly
found in splicing factors. CDK12 interacts with cyclins
L1 and L2, and participates in regulating transcription
and alternative splicing.
Length = 287
Score = 36.4 bits (85), Expect = 0.001
Identities = 12/34 (35%), Positives = 19/34 (55%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ N L++ ++K+ DFGLAR
Sbjct: 119 NGILHRDIKGSNILINN----DGVLKLADFGLAR 148
>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 9.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 9 (CDK9) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK9 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK9
together with a cyclin partner (cyclin T1, T2a, T2b, or
K) is the main component of distinct positive
transcription elongation factors (P-TEFb), which
function as Ser2 C-terminal domain kinases of RNA
polymerase II. P-TEFb participates in multiple steps of
gene expression including transcription elongation, mRNA
synthesis, processing, export, and translation. It also
plays a role in mediating cytokine induced transcription
networks such as IL6-induced STAT3 signaling. In
addition, the CDK9/cyclin T2a complex promotes muscle
differentiation and enhances the function of some
myogenic regulatory factors.
Length = 310
Score = 35.8 bits (83), Expect = 0.002
Identities = 16/37 (43%), Positives = 23/37 (62%), Gaps = 7/37 (18%)
Query: 1 MHF---VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+H +HRD+ A N L++ K I+K+ DFGLAR
Sbjct: 135 IHRNKILHRDMKAANILIT----KDGILKLADFGLAR 167
>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein
Serine/Threonine Kinase, Phosphoinositide-dependent
kinase 1. Serine/Threonine Kinases (STKs),
Phosphoinositide-dependent kinase 1 (PDK1) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PDK1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase (PI3K). PDK1
carries an N-terminal catalytic domain and a C-terminal
pleckstrin homology (PH) domain that binds
phosphoinositides. It phosphorylates the activation loop
of AGC kinases that are regulated by PI3K such as PKB,
SGK, and PKC, among others, and is crucial for their
activation. Thus, it contributes in regulating many
processes including metabolism, growth, proliferation,
and survival. PDK1 also has the ability to
autophosphorylate and is constitutively active in
mammalian cells. PDK1 is essential for normal embryo
development and is important in regulating cell volume.
Length = 280
Score = 34.1 bits (79), Expect = 0.008
Identities = 17/43 (39%), Positives = 21/43 (48%), Gaps = 7/43 (16%)
Query: 1 MH---FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
+H +HRDL N L LD I KI DFG A+ + N
Sbjct: 118 LHSKGIIHRDLKPENIL---LDKDMHI-KITDFGTAKVLDPNS 156
>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family
Serine/Threonine Kinases. Serine/Threonine Kinases
(STKs), CMGC family, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
CMGC family is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. The CMGC family consists of Cyclin-Dependent
protein Kinases (CDKs), Mitogen-activated protein
kinases (MAPKs) such as Extracellular signal-regulated
kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38,
and similar proteins. CDKs belong to a large subfamily
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. MAPKs
serve as important mediators of cellular responses to
extracellular signals. They control critical cellular
functions including differentiation, proliferation,
migration, and apoptosis. They are also implicated in
the pathogenesis of many diseases including multiple
types of cancer, stroke, diabetes, and chronic
inflammation.
Length = 283
Score = 33.8 bits (78), Expect = 0.009
Identities = 14/41 (34%), Positives = 20/41 (48%), Gaps = 5/41 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIY-RNDYY 42
+HRDL N L++ ++K+ DFGLAR Y
Sbjct: 119 ILHRDLKPENLLIN----TEGVLKLADFGLARSFGSPVRPY 155
>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 8. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek8 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek8 contains an
N-terminal kinase catalytic domain and a C-terminal RCC1
(regulator of chromosome condensation) domain. A double
point mutation in Nek8 causes cystic kidney disease in
mice that genetically resembles human autosomal
recessive polycystic kidney disease (ARPKD). Nek8 is
also associated with a rare form of juvenile renal
cystic disease, nephronophthisis type 9. It has been
suggested that a defect in the ciliary localization of
Nek8 contributes to the development of cysts manifested
by these diseases.
Length = 256
Score = 33.7 bits (77), Expect = 0.009
Identities = 15/31 (48%), Positives = 21/31 (67%), Gaps = 3/31 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L LD +VKIGDFG+++
Sbjct: 123 LHRDLKTQNIL---LDKHKMVVKIGDFGISK 150
>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine
Kinases, Mitogen-Activated Protein Kinases 4 and 6.
Serine/Threonine Kinases (STKs), Mitogen-Activated
Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAPK4/6 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MAPKs are
important mediators of cellular responses to
extracellular signals. MAPK4 is also called ERK4 or
p63MAPK, while MAPK6 is also called ERK3 or p97MAPK.
MAPK4 and MAPK6 are atypical MAPKs that are not
regulated by MAP2Ks. MAPK6 is expressed ubiquitously
with highest amounts in brain and skeletal muscle. It
may be involved in the control of cell differentiation
by negatively regulating cell cycle progression in
certain conditions. It may also play a role in
glucose-induced insulin secretion. MAPK6 and MAPK4
cooperate to regulate the activity of MAPK-activated
protein kinase 5 (MK5), leading to its relocation to the
cytoplasm and exclusion from the nucleus. The MAPK6/MK5
and MAPK4/MK5 pathways may play critical roles in
embryonic and post-natal development.
Length = 342
Score = 33.6 bits (77), Expect = 0.011
Identities = 18/41 (43%), Positives = 23/41 (56%), Gaps = 4/41 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N ++ D ++KIGDFGLAR I Y K
Sbjct: 136 LHRDLKPANVFINTED---LVLKIGDFGLAR-IVDPHYSHK 172
>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine
Kinase, Mitogen-Activated Protein Kinase 15.
Serine/Threonine Kinases (STKs), Mitogen-Activated
Protein Kinase 15 (MAPK15) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAPK15 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MAPKs are
important mediators of cellular responses to
extracellular signals. Human MAPK15 is also called
Extracellular signal Regulated Kinase 8 (ERK8) while the
rat protein is called ERK7. ERK7 and ERK8 display both
similar and different biochemical properties. They
autophosphorylate and activate themselves and do not
require upstream activating kinases. ERK7 is
constitutively active and is not affected by
extracellular stimuli whereas ERK8 shows low basal
activity and is activated by DNA-damaging agents. ERK7
and ERK8 also have different substrate profiles. Genome
analysis shows that they are orthologs with similar gene
structures. ERK7 and ERK 8 may be involved in the
signaling of some nuclear receptor transcription
factors. ERK7 regulates hormone-dependent degradation of
estrogen receptor alpha while ERK8 down-regulates the
transcriptional co-activation androgen and
glucocorticoid receptors.
Length = 337
Score = 33.7 bits (78), Expect = 0.012
Identities = 15/36 (41%), Positives = 20/36 (55%), Gaps = 8/36 (22%)
Query: 4 VHRDLAARNCLVS--CLDPKYRIVKIGDFGLARDIY 37
+HRDL N L++ C VK+ DFGLAR +
Sbjct: 129 IHRDLKPSNILLNSDCR------VKLADFGLARSLS 158
>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine
Kinase, HER3. Protein Tyrosine Kinase (PTK) family;
HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic
domain) family to which this subfamily belongs, is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. HER3 is a
member of the EGFR (HER, ErbB) subfamily of proteins,
which are receptor tyr kinases (RTKs) containing an
extracellular EGF-related ligand-binding region, a
transmembrane helix, and a cytoplasmic region with a tyr
kinase domain and a regulatory C-terminal tail. Unlike
other tyr kinases, phosphorylation of the activation
loop of EGFR proteins is not critical to their
activation. Instead, they are activated by
ligand-induced dimerization, leading to the
phosphorylation of tyr residues in the C-terminal tail,
which serve as binding sites for downstream signaling
molecules. HER3 binds the neuregulin ligands, NRG1 and
NRG2. HER3 contains an impaired tyr kinase domain and
relies on its heterodimerization partners for activity
following ligand binding. The HER2-HER3 heterodimer
constitutes a high affinity co-receptor capable of
potent mitogenic signaling. HER3 participates in a
signaling pathway involved in the proliferation,
survival, adhesion, and motility of tumor cells.
Length = 279
Score = 33.0 bits (75), Expect = 0.018
Identities = 18/37 (48%), Positives = 24/37 (64%), Gaps = 4/37 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
VHR+LAARN L+ IV+I DFG+A +Y +D
Sbjct: 131 VHRNLAARNILLK----SDSIVQIADFGVADLLYPDD 163
>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal
Bck1-like MAP Kinase Kinase Kinases. Serine/threonine
kinases (STKs), mitogen-activated protein kinase (MAPK)
kinase kinase (MAPKKK) subfamily, fungal Bck1-like
proteins, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MAPKKK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this group include the MAPKKKs
Saccharomyces cerevisiae Bck1 and Schizosaccharomyces
pombe Mkh1, and related proteins. MAPKKKs phosphorylate
and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks),
which in turn phosphorylate and activate MAPKs during
signaling cascades that are important in mediating
cellular responses to extracellular signals. Budding
yeast Bck1 is part of the cell integrity MAPK pathway,
which is activated by stresses and aggressions to the
cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and
the MAPK Slt2 make up the cascade that is important in
the maintenance of cell wall homeostasis. Fission yeast
Mkh1 is involved in MAPK cascades regulating cell
morphology, cell wall integrity, salt resistance, and
filamentous growth in response to stress.
Length = 272
Score = 32.8 bits (75), Expect = 0.021
Identities = 20/40 (50%), Positives = 24/40 (60%), Gaps = 7/40 (17%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR---DIYRND 40
+HRDL A N LV D I KI DFG+++ DIY ND
Sbjct: 130 LHRDLKADNLLVD-ADG---ICKISDFGISKKSDDIYDND 165
>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 2. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek2 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. The Nek2
subfamily includes Aspergillus nidulans NIMA kinase, the
founding member of the Nek family, which was identified
in a screen for cell cycle mutants prevented from
entering mitosis. NIMA is essential for mitotic entry
and progression through mitosis, and its degradation is
essential for mitotic exit. NIMA is involved in nuclear
membrane fission. Vertebrate Nek2 is a cell
cycle-regulated STK, localized in centrosomes and
kinetochores, that regulates centrosome splitting at the
G2/M phase. It also interacts with other mitotic kinases
such as Polo-like kinase 1 and may play a role in
spindle checkpoint. An increase in the expression of the
human NEK2 gene is strongly associated with the
progression of non-Hodgkin lymphoma.
Length = 265
Score = 32.6 bits (75), Expect = 0.022
Identities = 16/42 (38%), Positives = 22/42 (52%), Gaps = 4/42 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKK 44
+HRDL N LD VK+GDFGLA+ + + + K
Sbjct: 131 VLHRDLKPANIF---LDAN-NNVKLGDFGLAKILGHDSSFAK 168
>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 4. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek4 subfamily is
one of a family of 11 different Neks (Nek1-11). The Nek
family is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Neks are involved in the regulation of
downstream processes following the activation of Cdc2,
and many of their functions are cell cycle-related. They
play critical roles in microtubule dynamics during
ciliogenesis and mitosis. Nek4 is highly abundant in the
testis. Its specific function is unknown.
Length = 257
Score = 32.6 bits (74), Expect = 0.022
Identities = 13/33 (39%), Positives = 21/33 (63%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
H +HRDL +N ++ + I+K+GD G+AR
Sbjct: 122 HILHRDLKTQNVFLT----RTNIIKVGDLGIAR 150
>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine
Kinase, Never In Mitosis gene A-related kinase.
Serine/Threonine Kinases (STKs), Never In Mitosis gene A
(NIMA)-related kinase (Nek) family, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. The Nek family is
composed of 11 different mammalian members (Nek1-11)
with similarity to the catalytic domain of Aspergillus
nidulans NIMA kinase, the founding member of the Nek
family which was identified in a screen for cell cycle
mutants that were prevented from entering mitosis. Neks
contain a conserved N-terminal catalytic domain and a
more divergent C-terminal regulatory region of various
sizes and structures. They are involved in the
regulation of downstream processes following the
activation of Cdc2, and many of their functions are cell
cycle-related. They play critical roles in microtubule
dynamics during ciliogenesis and mitosis.
Length = 258
Score = 32.5 bits (75), Expect = 0.023
Identities = 10/33 (30%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ +N ++ +VK+GDFG+++
Sbjct: 123 KILHRDIKPQNIFLT----SNGLVKLGDFGISK 151
>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein
Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1.
Serine/threonine kinases (STKs), plant MAP/ERK kinase
kinase 1 (MEKK1)-like subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The plant MEKK1 subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein STKs, protein tyrosine kinases, RIO
kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. This subfamily is
composed of plant mitogen-activated protein kinase
(MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks)
including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1
is a MAPKKK that phosphorylates and activates MAPK
kinases (MAPKKs or MKKs or MAP2Ks), which in turn
phosphorylate and activate MAPKs during signaling
cascades that are important in mediating cellular
responses to extracellular signals. Arabidopsis thaliana
MEKK1 activates MPK4, a MAPK that regulates systemic
acquired resistance. MEKK1 also participates in the
regulation of temperature-sensitive and tissue-specific
cell death.
Length = 258
Score = 32.4 bits (74), Expect = 0.026
Identities = 15/42 (35%), Positives = 23/42 (54%), Gaps = 4/42 (9%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYK 43
+ VHRD+ N LV D +VK+ DFG+A+ + + K
Sbjct: 122 NTVHRDIKGANILV---DTN-GVVKLADFGMAKQVVEFSFAK 159
>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 11. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 11 (Nek11)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
Nek11 subfamily is one of a family of 11 different Neks
(Nek1-11) that are involved in cell cycle control. The
Nek family is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Nek11 is involved, through direct
phosphorylation, in regulating the degradation of Cdc25A
(Cell Division Cycle 25 homolog A), which plays a role
in cell cycle progression and in activating cyclin
dependent kinases. Nek11 is activated by CHK1
(CHeckpoint Kinase 1) and may be involved in the G2/M
checkpoint. Nek11 may also play a role in the S-phase
checkpoint as well as in DNA replication and genotoxic
stress responses.
Length = 260
Score = 32.2 bits (73), Expect = 0.032
Identities = 16/37 (43%), Positives = 23/37 (62%), Gaps = 8/37 (21%)
Query: 1 MH---FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
MH +HRDL A+N + K ++KIGDFG++R
Sbjct: 122 MHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSR 153
>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear
Dbf2-Related kinase-like Protein Serine/Threonine
Kinases. Serine/Threonine Kinases (STKs), NDR kinase
subfamily, fungal NDR-like proteins, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The NDR subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. This group is
composed of fungal NDR-like proteins including
Saccharomyces cerevisiae CBK1 (or CBK1p),
Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago
maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like
NDR kinase, group members contain an N-terminal
regulatory (NTR) domain and an insert within the
catalytic domain that contains an auto-inhibitory
sequence. CBK1 is an essential component in the RAM
(regulation of Ace2p activity and cellular
morphogenesis) network. CBK1 and Orb6 play similar roles
in coordinating cell morphology with cell cycle
progression. Ukc1 is involved in morphogenesis,
pathogenicity, and pigment formation. Cot1 plays a role
in polar tip extension.
Length = 377
Score = 31.7 bits (72), Expect = 0.046
Identities = 17/51 (33%), Positives = 28/51 (54%), Gaps = 7/51 (13%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYR---NDYYKKEGEG 48
+ F+HRD+ N L +D I K+ DFGL+ ++ + YY+K +G
Sbjct: 120 LGFIHRDIKPDNIL---IDRGGHI-KLSDFGLSTGFHKQHDSAYYQKLLQG 166
>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein
Serine/Threonine Kinase, MAP/ERK kinase kinase 1.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1
(MEKK1) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MEKK1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MEKK1 is a mitogen-activated protein kinase
(MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
phosphorylates and activates MAPK kinases (MAPKKs or
MKKs or MAP2Ks), which in turn phosphorylate and
activate MAPKs during signaling cascades that are
important in mediating cellular responses to
extracellular signals. MEKK1 activates the extracellular
signal-regulated kinase 1/2 (ERK1/2) and c-Jun
N-terminal kinase (JNK) pathways by activating their
respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively.
MEKK1 is important in regulating cell survival and
apoptosis. MEKK1 also plays a role in cell migration,
tissue maintenance and homeostasis, and wound healing.
Length = 268
Score = 31.8 bits (72), Expect = 0.048
Identities = 19/69 (27%), Positives = 31/69 (44%), Gaps = 11/69 (15%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFG----LARDIYRNDYYKKEGEGLLPVSFAITVV 59
+HRD+ N L+ D + ++I DFG LA ++ G+ L ++F V
Sbjct: 125 IHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQ--GQLLGTIAFMAPEV 179
Query: 60 I--ESKNRS 66
+ E RS
Sbjct: 180 LRGEQYGRS 188
>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function
prediction only / Signal transduction mechanisms /
Transcription / DNA replication, recombination, and
repair].
Length = 384
Score = 31.6 bits (70), Expect = 0.062
Identities = 15/41 (36%), Positives = 21/41 (51%), Gaps = 3/41 (7%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDY 41
+HRD+ N L LD R+VK+ DFGLA+ +
Sbjct: 120 KGIIHRDIKPENIL---LDRDGRVVKLIDFGLAKLLPDPGS 157
>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional.
Length = 294
Score = 31.3 bits (71), Expect = 0.075
Identities = 14/31 (45%), Positives = 20/31 (64%), Gaps = 3/31 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L+ D + +K+ DFGLAR
Sbjct: 124 LHRDLKPQNLLI---DRRTNALKLADFGLAR 151
>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases.
Protein Kinases (PKs), STE family, catalytic (c) domain.
PKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine or tyrosine residues on
protein substrates. The STE family is part of a larger
superfamily that includes the catalytic domains of other
protein serine/threonine kinases (STKs), protein
tyrosine kinases (PTKs), RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase (PI3K). This family is composed of STKs, and
some dual-specificity PKs that phosphorylate both
threonine and tyrosine residues of target proteins. Most
members are kinases involved in mitogen-activated
protein kinase (MAPK) signaling cascades, acting as MAPK
kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK
kinase kinase kinases (MAP4Ks). The MAPK signaling
pathways are important mediators of cellular responses
to extracellular signals. The pathways involve a triple
kinase core cascade comprising of the MAPK, which is
phosphorylated and activated by a MAPKK, which itself is
phosphorylated and activated by a MAPKKK. Each MAPK
cascade is activated either by a small GTP-binding
protein or by an adaptor protein, which transmits the
signal either directly to a MAPKKK to start the triple
kinase core cascade or indirectly through a mediator
kinase, a MAP4K. Other STE family members include
p21-activated kinases (PAKs) and class III myosins,
among others. PAKs are Rho family GTPase-regulated
kinases that serve as important mediators in the
function of Cdc42 (cell division cycle 42) and Rac.
Class III myosins are motor proteins containing an
N-terminal kinase catalytic domain and a C-terminal
actin-binding domain, which can phosphorylate several
cytoskeletal proteins, conventional myosin regulatory
light chains, as well as autophosphorylate the
C-terminal motor domain. They play an important role in
maintaining the structural integrity of photoreceptor
cell microvilli.
Length = 253
Score = 31.0 bits (71), Expect = 0.078
Identities = 13/36 (36%), Positives = 21/36 (58%), Gaps = 4/36 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ A N L++ D + VK+ DFGL+ +
Sbjct: 117 NGIIHRDIKAANILLT-SDGE---VKLIDFGLSAQL 148
>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine
Kinase, Extracellular signal-Regulated Kinase 5.
Serine/Threonine Kinases (STKs), Extracellular
signal-Regulated Kinase 5 (ERK5) subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The ERK5 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. MAPKs are
important mediators of cellular responses to
extracellular signals. ERK5, also called Big MAPK1
(BMK1) or MAPK7, has a unique C-terminal extension,
making it approximately twice as big as other MAPKs.
This extension contains transcriptional activation
capability which is inhibited by the N-terminal half.
ERK5 is activated in response to growth factors and
stress by a cascade that leads to its phosphorylation by
the MAP2K MEK5, which in turn is regulated by the MAP3Ks
MEKK2 and MEKK3. Activated ERK5 phosphorylates its
targets including myocyte enhancer factor 2 (MEF2),
Sap1a, c-Myc, and RSK. It plays a role in EGF-induced
cell proliferation during the G1/S phase transition.
Studies on knockout mice revealed that ERK5 is essential
for cardiovascular development and plays an important
role in angiogenesis. It is also critical for neural
differentiation and survival. The ERK5 pathway has been
implicated in the pathogenesis of many diseases
including cancer, cardiac hypertrophy, and
atherosclerosis.
Length = 334
Score = 31.1 bits (71), Expect = 0.080
Identities = 15/33 (45%), Positives = 20/33 (60%), Gaps = 8/33 (24%)
Query: 4 VHRDLAARNCLVS--CLDPKYRIVKIGDFGLAR 34
+HRDL N LV+ C ++IGDFG+AR
Sbjct: 129 IHRDLKPSNLLVNEDCE------LRIGDFGMAR 155
>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase,
MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine
Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The MOK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MOK, also called Renal tumor antigen 1
(RAGE-1), is widely expressed and is enriched in testis,
kidney, lung, and brain. It is expressed in
approximately 50% of renal cell carcinomas (RCC) and is
a potential target for immunotherapy. MOK is stabilized
by its association with the HSP90 molecular chaperone.
It is induced by the transcription factor Cdx2 and may
be involved in regulating intestinal epithelial
development and differentiation.
Length = 282
Score = 31.1 bits (71), Expect = 0.086
Identities = 14/33 (42%), Positives = 18/33 (54%), Gaps = 5/33 (15%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDIY 37
HRD+ N L+ K I+K+ DFG R IY
Sbjct: 123 HRDIKPENILI-----KDDILKLADFGSCRGIY 150
>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase;
Provisional.
Length = 353
Score = 30.9 bits (70), Expect = 0.088
Identities = 14/33 (42%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
H VHRD+ N L++ + VKI DFG++R
Sbjct: 188 HIVHRDIKPSNLLIN----SAKNVKIADFGVSR 216
>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine
Kinase, Plant B-type Cyclin-Dependent protein Kinase.
Serine/Threonine Kinases (STKs), Plant B-type
Cyclin-Dependent protein Kinase (CdkB) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CdkB subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. The plant-specific B-type CDKs are expressed
from the late S to the M phase of the cell cycle. They
are characterized by the cyclin binding motif
PPT[A/T]LRE. They play a role in controlling mitosis and
integrating developmental pathways, such as stomata and
leaf development. CdkB has been shown to associate with
both cyclin B, which controls G2/M transition, and
cyclin D, which acts as a mediator in linking
extracellular signals to the cell cycle.
Length = 295
Score = 30.9 bits (70), Expect = 0.089
Identities = 14/31 (45%), Positives = 19/31 (61%), Gaps = 3/31 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N LV D + ++KI D GL R
Sbjct: 132 MHRDLKPQNLLV---DKQKGLLKIADLGLGR 159
>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like
Serine/Threonine Kinases. Serine/Threonine Kinases
(STKs), PCTAIRE-like subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The PCTAIRE-like subfamily is part of a
larger superfamily that includes the catalytic domains
of other protein STKs, protein tyrosine kinases, RIO
kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Members of this
subfamily share sequence similarity with
Cyclin-Dependent Kinases (CDKs), which belong to a large
family of STKs that are regulated by their cognate
cyclins. Together, CDKs and cyclins are involved in the
control of cell-cycle progression, transcription, and
neuronal function. The association of PCTAIRE-like
proteins with cyclins has not been widely studied,
although PFTAIRE-1 has been shown to function as a CDK
which is regulated by cyclin D3 as well as the
membrane-associated cyclin Y. PCTAIRE-like proteins show
unusual expression patterns with high levels in
post-mitotic tissues, suggesting that they may be
involved in regulating post-mitotic cellular events.
Length = 291
Score = 30.8 bits (70), Expect = 0.089
Identities = 14/33 (42%), Positives = 19/33 (57%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L+S +K+ DFGLAR
Sbjct: 123 RVLHRDLKPQNLLISERGE----LKLADFGLAR 151
>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 10.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein Kinase 10 (CDK10) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK10 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. CDK10, also called PISSLRE, is essential for
cell growth and proliferation, and acts through the G2/M
phase of the cell cycle. CDK10 has also been identified
as an important factor in endocrine therapy resistance
in breast cancer. CDK10 silencing increases the
transcription of c-RAF and the activation of the p42/p44
MAPK pathway, which leads to antiestrogen resistance.
Patients who express low levels of CDK10 relapse early
on tamoxifen.
Length = 309
Score = 30.8 bits (70), Expect = 0.092
Identities = 15/34 (44%), Positives = 20/34 (58%), Gaps = 5/34 (14%)
Query: 2 HF-VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+F +HRDL N L++ +KI DFGLAR
Sbjct: 127 NFIIHRDLKVSNLLLT----DKGCLKIADFGLAR 156
>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine
Kinase, Fungal Cyclin-Dependent protein Kinase Pho85.
Serine/Threonine Kinases (STKs), Pho85 subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Pho85 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Pho85 is a
multifunctional Cyclin-Dependent protein Kinase (CDK) in
yeast. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. Pho85 is regulated
by 10 different cyclins (Pcls) and plays a role in G1
progression, cell polarity, phosphate and glycogen
metabolism, gene expression, and in signaling changes in
the environment. It is not essential for yeast viability
and is the functional homolog of mammalian CDK5, which
plays a role in central nervous system development.
Length = 284
Score = 30.9 bits (70), Expect = 0.093
Identities = 14/31 (45%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ K +K+ DFGLAR
Sbjct: 122 LHRDLKPQNLLIN----KRGELKLADFGLAR 148
>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant
dual-specificity MAP kinase kinases and similar
proteins. Protein kinases (PKs), MAP kinase kinase
(MAPKK) subfamily, Plant MAPKKs and similar proteins,
catalytic (c) domain. PKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine or
tyrosine residues on protein substrates. The MAPKK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein serine/threonine
kinases, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. The mitogen-activated protein
(MAP) kinase signaling pathways are important mediators
of cellular responses to extracellular signals. The
pathways involve a triple kinase core cascade comprising
of the MAP kinase (MAPK), which is phosphorylated and
activated by a MAPK kinase (MAPKK or MKK), which itself
is phosphorylated and activated by a MAPK kinase kinase
(MAPKKK or MKKK). Members of this group include MAPKKs
from plants, kinetoplastids, alveolates, and mycetozoa.
The MAPKK, LmxPK4, from Leishmania mexicana, is
important in differentiation and virulence.
Dictyostelium discoideum MEK1 is required for proper
chemotaxis. MEK1 null mutants display severe defects in
cell polarization and directional movement. Plants
contain multiple MAPKKs like other eukaryotes. The
Arabidopsis genome encodes for 10 MAPKKs while poplar
and rice contain 13 MAPKKs each. The functions of these
proteins have not been fully elucidated. There is
evidence to suggest that MAPK cascades are involved in
plant stress responses. In Arabidopsis, MKK3 plays a
role in pathogen signaling, MKK2 is involved in cold and
salt stress signaling, MKK4/MKK5 participates in innate
immunity, and MKK7 regulates basal and systemic acquired
resistance.
Length = 264
Score = 30.6 bits (70), Expect = 0.10
Identities = 23/84 (27%), Positives = 34/84 (40%), Gaps = 17/84 (20%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVVIE 61
H +HRD+ N L++ VKI DFG+++ + +F TV
Sbjct: 120 HIIHRDIKPSNLLIN----SKGEVKIADFGISKVLENTLDQCN--------TFVGTVTYM 167
Query: 62 SKNRSVPFRPELCVYGPLADIDSI 85
S R + E Y ADI S+
Sbjct: 168 SPER---IQGES--YSYAADIWSL 186
>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent
protein Kinase 1-like Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 1 (CDK1)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. This subfamily is composed of CDK1 from higher
eukaryotes, plants, and yeasts, as well as CDK2 and
CDK3. CDK1 is also called Cell division control protein
2 (Cdc2) or p34 protein kinase, and is regulated by
cyclins A, B, and E. The CDK1/cyclin A complex controls
G2 phase entry and progression while the CDK1/cyclin B
complex is critical for G2 to M phase transition. CDK2
is regulated by cyclin E or cyclin A. Upon activation by
cyclin E, it phosphorylates the retinoblastoma (pRb)
protein which activates E2F mediated transcription and
allows cells to move into S phase. The CDK2/cyclin A
complex plays a role in regulating DNA replication.
Studies in knockout mice revealed that CDK1 can
compensate for the loss of the cdk2 gene as it can also
bind cyclin E and drive G1 to S phase transition. CDK3
is regulated by cyclin C and it phosphorylates pRB
specifically during the G0/G1 transition. This
phosphorylation is required for cells to exit G0
efficiently and enter the G1 phase.
Length = 283
Score = 30.7 bits (70), Expect = 0.10
Identities = 13/30 (43%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
HRDL +N L+ + +K+ DFGLAR
Sbjct: 122 HRDLKPQNLLID----REGALKLADFGLAR 147
>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine
Kinase, Fungal Mitogen-Activated Protein Kinase MPK1.
Serine/Threonine Kinases (STKs), Fungal
Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MPK1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. This subfamily is
composed of the MAPKs MPK1 from Saccharomyces
cerevisiae, Pmk1 from Schizosaccharomyces pombe, and
similar proteins. MAPKs are important mediators of
cellular responses to extracellular signals. MPK1 (also
called Slt2) and Pmk1 (also called Spm1) are
stress-activated MAPKs that regulate the cell wall
integrity (CWI) pathway, and are therefore important in
the maintainance of cell shape, cell wall construction,
morphogenesis, and ion homeostasis. MPK1 is activated in
response to cell wall stress including heat stimulation,
osmotic shock, UV irradiation, and any agents that
interfere with cell wall biogenesis such as chitin
antagonists, caffeine, or zymolase. MPK1 is regulated by
the MAP2Ks Mkk1/2, which are regulated by the MAP3K
Bck1. Pmk1 is also activated by multiple stresses
including elevated temperatures, hyper- or hypotonic
stress, glucose deprivation, exposure to cell-wall
damaging compounds, and oxidative stress. It is
regulated by the MAP2K Pek1, which is regulated by the
MAP3K Mkh1.
Length = 332
Score = 30.8 bits (70), Expect = 0.11
Identities = 19/47 (40%), Positives = 24/47 (51%), Gaps = 7/47 (14%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLL 50
+HRDL N LV+ D + +KI DFGLAR N E G +
Sbjct: 127 LHRDLKPGNLLVN-ADCE---LKICDFGLARGFSEN---PGENAGFM 166
>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine
Kinases, Cyclin-Dependent protein Kinase Like 2 and 3.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase like 2 (CDKL2) and CDKL3 subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDKL2 and CDKL3
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDKL2, also called
p56 KKIAMRE, is expressed in testis, kidney, lung, and
brain. It functions mainly in mature neurons and plays
an important role in learning and memory. Inactivation
of CDKL3, also called NKIAMRE (NKIATRE in rat), by
translocation is associated with mild mental
retardation. It has been reported that CDKL3 is lost in
leukemic cells having a chromosome arm 5q deletion, and
may contribute to the transformed phenotype.
Length = 286
Score = 30.8 bits (70), Expect = 0.11
Identities = 14/33 (42%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N LVS + +VK+ DFG AR +
Sbjct: 122 IHRDIKPENILVS----QSGVVKLCDFGFARTL 150
>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase Like 5.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase like 5 (CDKL5) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDKL5 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. Mutations in the gene encoding CDKL5,
previously called STK9, are associated with early onset
epilepsy and severe mental retardation [X-linked
infantile spasm syndrome (ISSX) or West syndrome]. In
addition, CDKL5 mutations also sometimes cause a
phenotype similar to Rett syndrome (RTT), a progressive
neurodevelopmental disorder. These pathogenic mutations
are located in the N-terminal portion of the protein
within the kinase domain.
Length = 287
Score = 30.7 bits (69), Expect = 0.12
Identities = 14/33 (42%), Positives = 21/33 (63%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
VHRD+ N L+S D ++K+ DFG AR++
Sbjct: 122 VHRDIKPENLLISHND----VLKLCDFGFARNL 150
>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR
kinase-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), Rho-associated
coiled-coil containing protein kinase (ROCK) and Nuclear
Dbf2-Related (NDR)-like kinase subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The ROCK- and NDR-like
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this subfamily include ROCK and
ROCK-like proteins such as DMPK, MRCK, and CRIK, as well
as NDR and NDR-like proteins such as LATS, CBK1 and
Sid2p. ROCK and CRIK are effectors of the small GTPase
Rho, while MRCK is an effector of the small GTPase
Cdc42. NDR and NDR-like kinases contain an N-terminal
regulatory (NTR) domain and an insert within the
catalytic domain that contains an auto-inhibitory
sequence. Proteins in this subfamily are involved in
regulating many cellular functions including
contraction, motility, division, proliferation,
apoptosis, morphogenesis, and cytokinesis.
Length = 350
Score = 30.7 bits (70), Expect = 0.13
Identities = 13/40 (32%), Positives = 21/40 (52%), Gaps = 4/40 (10%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
+ F+HRD+ N L +D I K+ DFGL + + +
Sbjct: 120 LGFIHRDIKPDNIL---IDADGHI-KLADFGLCKKMNKAK 155
>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine
Kinases, Cyclin-Dependent protein Kinase Like 1 and 4.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase like 1 (CDKL1) and CDKL4 subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDKL1 and CDKL4
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. CDKL1, also called
p42 KKIALRE, is a glial protein that is upregulated in
gliosis. It is present in neuroblastoma and A431 human
carcinoma cells, and may be implicated in neoplastic
transformation. The function of CDKL4 is unknown.
Length = 286
Score = 30.4 bits (69), Expect = 0.14
Identities = 14/43 (32%), Positives = 20/43 (46%), Gaps = 9/43 (20%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR-----DIYRNDY 41
+HRD+ N L++ K +K+ DFG AR DY
Sbjct: 122 IHRDVKPENILIT----KQGQIKLCDFGFARILTGPGDDYTDY 160
>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the
Serine/Threonine Kinases, TEY Mitogen-Activated Protein
Kinases from Plants. Serine/Threonine Kinases (STKs),
Plant TEY Mitogen-Activated Protein Kinase (MAPK)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The TEY
MAPK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MAPKs are important mediators of cellular
responses to extracellular signals. In plants, MAPKs are
associated with physiological, developmental, hormonal,
and stress responses. Some plants show numerous gene
duplications of MAPKs. Arabidopsis thaliana harbors at
least 20 MAPKs, named AtMPK1-20. There are two subtypes
of plant MAPKs based on the conserved phosphorylation
motif present in the activation loop, TEY and TDY. This
subfamily represents the TEY subtype and is further
subdivided into three groups (A, B, and C). Group A is
represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4
(NtNTF4), among others. They are mostly involved in
environmental and hormonal responses. AtMPK3 and AtMPK6
are also key regulators for stomatal development and
patterning. Group B is represented by AtMPK4, AtMPK13,
and NtNTF6, among others. They may be involved in both
cell division and environmental stress response. AtMPK4
also participates in regulating innate immunity. Group C
is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa
MAPK4 (OsMAPK4), among others. They may also be involved
in stress responses. AtMPK1 and AtMPK2 are activated
following mechanical injury and in the presence of
stress chemicals such as jasmonic acid, hydrogen
peroxide and abscisic acid. OsMAPK4 is also called
OsMSRMK3 for Multiple Stress-Responsive MAPK3.
Length = 337
Score = 30.4 bits (69), Expect = 0.15
Identities = 15/32 (46%), Positives = 18/32 (56%), Gaps = 8/32 (25%)
Query: 5 HRDLAARNCLV--SCLDPKYRIVKIGDFGLAR 34
HRDL N L+ +C +KI DFGLAR
Sbjct: 131 HRDLKPSNLLLNANCD------LKICDFGLAR 156
>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 12.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 12 (CDK12) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK12 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. CDK12 is also called Cdc2-related protein
kinase 7 (CRK7) or Cdc2-related kinase
arginine/serine-rich (CrkRS). It is a unique CDK that
contains an arginine/serine-rich (RS) domain, which is
predominantly found in splicing factors. CDK12 is widely
expressed in tissues. It interacts with cyclins L1 and
L2, and plays roles in regulating transcription and
alternative splicing.
Length = 302
Score = 30.5 bits (69), Expect = 0.15
Identities = 16/33 (48%), Positives = 22/33 (66%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+F+HRD+ N L L+ K +I K+ DFGLAR
Sbjct: 136 NFLHRDIKCSNIL---LNNKGQI-KLADFGLAR 164
>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein
Kinase Like Serine/Threonine Kinases. Serine/Threonine
Kinases (STKs), Cyclin-dependent protein kinase like
(CDKL) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
CDKL subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CDKs belong to a large family of STKs that are
regulated by their cognate cyclins. Together, they are
involved in the control of cell-cycle progression,
transcription, and neuronal function. This subfamily is
composed of CDKL1-5 and similar proteins. Some CDKLs,
like CDKL1 and CDKL3, may be implicated in
transformation and others, like CDKL3 and CDKL5, are
associated with mental retardation when impaired. CDKL2
plays a role in learning and memory.
Length = 288
Score = 30.4 bits (69), Expect = 0.15
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ N LVS + ++K+ DFG AR
Sbjct: 122 IHRDIKPENILVS----ESGVLKLCDFGFAR 148
>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 5.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 5 (CDK5) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK5 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK5
is unusual in that it is regulated by non-cyclin
proteins, p35 and p39. It is highly expressed in the
nervous system and is critical in normal neural
development and function. It plays a role in neuronal
migration and differentiation, and is also important in
synaptic plasticity and learning. CDK5 also participates
in protecting against cell death and promoting
angiogenesis. Impaired CDK5 activity is implicated in
Alzheimer's disease, amyotrophic lateral sclerosis,
Parkinson's disease, Huntington's disease and acute
neuronal injury.
Length = 284
Score = 30.1 bits (68), Expect = 0.19
Identities = 14/33 (42%), Positives = 21/33 (63%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+ +HRDL +N L++ K +K+ DFGLAR
Sbjct: 119 NVLHRDLKPQNLLIN----KNGELKLADFGLAR 147
>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 4.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase 4 (CDK4) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK4 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK4
partners with all three D-type cyclins (D1, D2, and D3)
and is also regulated by INK4 inhibitors. It is active
towards the retinoblastoma (pRb) protein and plays a
role in regulating the early G1 phase of the cell cycle.
It is expressed ubiquitously and is localized in the
nucleus. CDK4 also shows kinase activity towards Smad3,
a signal transducer of transforming growth factor
(TGF)-beta signaling which modulates transcription and
plays a role in cell proliferation and apoptosis. CDK4
is inhibited by the p21 inhibitor and is specifically
mutated in human melanoma.
Length = 288
Score = 29.9 bits (67), Expect = 0.20
Identities = 18/34 (52%), Positives = 20/34 (58%), Gaps = 5/34 (14%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIY 37
VHRDL N LV+ VK+ DFGLAR IY
Sbjct: 130 VHRDLKPENILVTSGGQ----VKLADFGLAR-IY 158
>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 1 from higher
eukaryotes-like. Serine/Threonine Kinases (STKs),
Cyclin-Dependent protein Kinase 1 (CDK1) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. This subfamily is composed of CDK1 from higher
eukaryotes. CDK1 is also called Cell division control
protein 2 (Cdc2) or p34 protein kinase, and is regulated
by cyclins A, B, and E. The CDK1/cyclin A complex
controls G2 phase entry and progression. CDK1/cyclin A2
has also been implicated as an important regulator of S
phase events. The CDK1/cyclin B complex is critical for
G2 to M phase transition. It induces mitosis by
activating nuclear enzymes that regulate chromatin
condensation, nuclear membrane degradation,
mitosis-specific microtubule and cytoskeletal
reorganization. CDK1 also associates with cyclin E and
plays a role in the entry into S phase. CDK1
transcription is stable throughout the cell cycle but is
modulated in some pathological conditions. It may play a
role in regulating apoptosis under these conditions. In
breast cancer cells, HER2 can mediate apoptosis by
inactivating CDK1. Activation of CDK1 may contribute to
HIV-1 induced apoptosis and neuronal apoptosis in
neurodegenerative diseases.
Length = 285
Score = 29.7 bits (67), Expect = 0.24
Identities = 15/31 (48%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L+ D K ++K+ DFGLAR
Sbjct: 123 LHRDLKPQNLLI---DNK-GVIKLADFGLAR 149
>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase,
Nemo-Like Kinase. Serine/Threonine Kinases (STKs),
Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The NLK subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. Mitogen-activated protein
kinases (MAPKs) are important mediators of cellular
responses to extracellular signals. NLK is an atypical
MAPK that is not regulated by a MAPK kinase. It
functions downstream of the MAPK kinase kinase Tak1,
which also plays a role in activating the JNK and p38
MAPKs. The Tak1/NLK pathways are regulated by Wnts, a
family of secreted proteins that is critical in the
control of asymmetric division and cell polarity. NLK
can phosphorylate transcription factors from the TCF/LEF
family, inhibiting their ability to activate the
transcription of target genes. In prostate cancer cells,
NLK is involved in regulating androgen receptor-mediated
transcription and its expression is altered during
cancer progression.
Length = 372
Score = 29.7 bits (67), Expect = 0.26
Identities = 15/35 (42%), Positives = 20/35 (57%), Gaps = 8/35 (22%)
Query: 2 HFVHRDLAARNCLVS--CLDPKYRIVKIGDFGLAR 34
+HRD+ N LV+ C ++KI DFGLAR
Sbjct: 123 GILHRDIKPGNLLVNSNC------VLKICDFGLAR 151
>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control
protein 7-like Protein Serine/Threonine Kinases.
Serine/threonine kinases (STKs), (Cdc7)-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Cdc7-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this subfamily include
Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae
Cdc15, Arabidopsis thaliana mitogen-activated protein
kinase (MAPK) kinase kinase (MAPKKK) epsilon, and
related proteins. MAPKKKs phosphorylate and activate
MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
phosphorylate and activate MAPKs during signaling
cascades that are important in mediating cellular
responses to extracellular signals. Fission yeast Cdc7
is essential for cell division by playing a key role in
the initiation of septum formation and cytokinesis.
Budding yeast Cdc15 functions to coordinate mitotic exit
with cytokinesis. Arabidopsis MAPKKK epsilon is required
for pollen development in the plasma membrane.
Length = 254
Score = 29.5 bits (67), Expect = 0.29
Identities = 13/37 (35%), Positives = 20/37 (54%), Gaps = 4/37 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
+HRD+ A N L + K +VK+ DFG+A +
Sbjct: 121 IHRDIKAANILTT----KDGVVKLADFGVATKLNDVS 153
>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular
signal-Regulated Kinase 1 and 2-like Serine/Threonine
Kinases. Serine/Threonine Kinases (STKs), Extracellular
signal-regulated kinases 1 and 2 (ERK1/2) and Fus3
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. This
ERK1/2-like subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. This subfamily is composed of
the mitogen-activated protein kinases (MAPKs) ERK1,
ERK2, baker's yeast Fus3, and similar proteins. MAPK
pathways are important mediators of cellular responses
to extracellular signals. ERK1/2 activation is
preferentially by mitogenic factors, differentiation
stimuli, and cytokines, through a kinase cascade
involving the MAPK kinases MEK1/2 and a MAPK kinase
kinase from the Raf family. ERK1/2 have numerous
substrates, many of which are nuclear and participate in
transcriptional regulation of many cellular processes.
They regulate cell growth, cell proliferation, and cell
cycle progression from G1 to S phase. Although the
distinct roles of ERK1 and ERK2 have not been fully
determined, it is known that ERK2 can maintain most
functions in the absence of ERK1, and that the deletion
of ERK2 is embryonically lethal. The MAPK, Fus3,
regulates yeast mating processes including
mating-specific gene expression, G1 arrest, mating
projection, and cell fusion.
Length = 336
Score = 29.2 bits (66), Expect = 0.34
Identities = 16/33 (48%), Positives = 20/33 (60%), Gaps = 8/33 (24%)
Query: 4 VHRDLAARNCLV--SCLDPKYRIVKIGDFGLAR 34
+HRDL N L+ +C D +KI DFGLAR
Sbjct: 128 LHRDLKPSNLLLNTNC-D-----LKICDFGLAR 154
>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 6.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase 6 (CDK6) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK6 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK6
is regulated by D-type cyclins and INK4 inhibitors. It
is active towards the retinoblastoma (pRb) protein,
implicating it to function in regulating the early G1
phase of the cell cycle. It is expressed ubiquitously
and is localized in the cytoplasm. It is also present in
the ruffling edge of spreading fibroblasts and may play
a role in cell spreading. It binds to the p21 inhibitor
without any effect on its own activity and it is
overexpressed in squamous cell carcinomas and
neuroblastomas. CDK6 has also been shown to inhibit cell
differentiation in many cell types.
Length = 290
Score = 29.2 bits (65), Expect = 0.36
Identities = 17/34 (50%), Positives = 21/34 (61%), Gaps = 5/34 (14%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIY 37
VHRDL +N LV+ +K+ DFGLAR IY
Sbjct: 132 VHRDLKPQNILVTSSGQ----IKLADFGLAR-IY 160
>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like
protein kinase 3-like Protein Serine/Threonine Kinases.
Serine/threonine kinases (STKs), mammalian Ste20-like
protein kinase 3 (MST3)-like subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MST3-like subfamily
is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of MST3, MST4,
STK25, Schizosaccharomyces pombe Nak1 and Sid1,
Saccharomyces cerevisiae sporulation-specific protein 1
(SPS1), and related proteins. Nak1 is required by
fission yeast for polarizing the tips of actin
cytoskeleton and is involved in cell growth, cell
separation, cell morphology and cell-cycle progression.
Sid1 is a component in the septation initiation network
(SIN) signaling pathway, and plays a role in
cytokinesis. SPS1 plays a role in regulating proteins
required for spore wall formation. MST4 plays a role in
mitogen-activated protein kinase (MAPK) signaling during
cytoskeletal rearrangement, morphogenesis, and
apoptosis. MST3 phosphorylates the STK NDR and may play
a role in cell cycle progression and cell morphology.
STK25 may play a role in the regulation of cell
migration and polarization.
Length = 274
Score = 29.1 bits (66), Expect = 0.38
Identities = 12/30 (40%), Positives = 19/30 (63%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRD+ A N L+S + VK+ DFG++
Sbjct: 120 IHRDIKAANILLS----EEGDVKLADFGVS 145
>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein
Serine/Threonine Kinase, Large Tumor Suppressor 2.
Serine/Threonine Kinases (STKs), Large Tumor Suppressor
(LATS) subfamily, LATS2 isoform, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The LATS subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. LATS functions as a tumor
suppressor and is implicated in cell cycle regulation.
LATS2 is an essential mitotic regulator responsible for
coordinating accurate cytokinesis completion and
governing the stabilization of other mitotic regulators.
It is also critical in the maintenance of proper
chromosome number, genomic stability, mitotic fidelity,
and the integrity of centrosome duplication.
Downregulation of LATS2 is associated with poor
prognosis in acute lymphoblastic leukemia and breast
cancer.
Length = 381
Score = 29.2 bits (65), Expect = 0.41
Identities = 18/47 (38%), Positives = 26/47 (55%), Gaps = 7/47 (14%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLA---RDIYRNDYYKK 44
M F+HRD+ N L+ LD +K+ DFGL R + + YY+K
Sbjct: 120 MGFIHRDIKPDNILID-LDGH---IKLTDFGLCTGFRWTHNSKYYQK 162
>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal
Byr2-like MAP Kinase Kinase Kinases. Serine/threonine
kinases (STKs), mitogen-activated protein kinase (MAPK)
kinase kinase (MAPKKK) subfamily, fungal Byr2-like
proteins, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MAPKKK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this group include the MAPKKKs
Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae
and Cryptococcus neoformans Ste11, and related proteins.
They contain an N-terminal SAM (sterile alpha-motif)
domain, which mediates protein-protein interaction, and
a C-terminal catalytic domain. MAPKKKs phosphorylate and
activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which
in turn phosphorylate and activate MAPKs during
signaling cascades that are important in mediating
cellular responses to extracellular signals. Fission
yeast Byr2 is regulated by Ras1. It responds to
pheromone signaling and controls mating through the MAPK
pathway. Budding yeast Ste11 functions in MAPK cascades
that regulate mating, high osmolarity glycerol, and
filamentous growth responses.
Length = 267
Score = 29.0 bits (65), Expect = 0.41
Identities = 15/36 (41%), Positives = 21/36 (58%), Gaps = 4/36 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN 39
+HRD+ N LV D K I KI DFG+++ + N
Sbjct: 128 IHRDIKGANILV---DNKGGI-KISDFGISKKLEAN 159
>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 9. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek9 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek9, also called
Nercc1, is primarily a cytoplasmic protein but can also
localize in the nucleus. It is involved in modulating
chromosome alignment and splitting during mitosis. It
interacts with the gamma-tubulin ring complex and the
Ran GTPase, and is implicated in microtubule
organization. Nek9 associates with FACT (FAcilitates
Chromatin Transcription) and modulates interphase
progression. It also interacts with Nek6, and Nek7,
during mitosis, resulting in their activation.
Length = 256
Score = 28.9 bits (65), Expect = 0.44
Identities = 10/31 (32%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ N ++ K ++K+GDFG+++
Sbjct: 123 LHRDIKTLNIFLT----KAGLIKLGDFGISK 149
>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase,
Cell Division Cycle 2-like 6. Serine/Threonine Kinases
(STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDC2L6 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. CDC2L6 is also called CDK8-like and was
previously referred to as CDK11. However, this is a
confusing nomenclature as CDC2L6 is distinct from
CDC2L1, which is represented by the two protein products
from its gene, called CDK11(p110) and CDK11(p58), as
well as the caspase-processed CDK11(p46). CDK11(p110),
CDK11(p58), and CDK11(p46)do not belong to this
subfamily. CDC2L6 is an associated protein of Mediator,
a multiprotein complex that provides a platform to
connect transcriptional and chromatin regulators and
cofactors, in order to activate and mediate RNA
polymerase II transcription. CDC2L6 is localized mainly
in the nucleus amd exerts an opposing effect to CDK8 in
VP16-dependent transcriptional activation by being a
negative regulator.
Length = 317
Score = 28.9 bits (64), Expect = 0.50
Identities = 15/31 (48%), Positives = 17/31 (54%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N LV P+ VKI D G AR
Sbjct: 130 LHRDLKPANILVMGEGPERGRVKIADMGFAR 160
>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine
Kinase, Cyclin-Dependent protein Kinase 8.
Serine/Threonine Kinases (STKs), Cyclin-Dependent
protein Kinase 8 (CDK8) subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The CDK8 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. CDKs belong to a large family
of STKs that are regulated by their cognate cyclins.
Together, they are involved in the control of cell-cycle
progression, transcription, and neuronal function. CDK8
can act as a negative or positive regulator of
transcription, depending on the scenario. Together with
its regulator, cyclin C, it reversibly associates with
the multi-subunit core Mediator complex, a cofactor that
is involved in regulating RNA polymerase II (RNAP
II)-dependent transcription. CDK8 phosphorylates cyclin
H, a subunit of the general transcription factor TFIIH,
which results in the inhibition of TFIIH-dependent
phosphorylation of the C-terminal domain (CTD) of RNAP
II, facilitating the inhibition of transcription. It has
also been shown to promote transcription by a mechanism
that is likely to involve RNAP II phosphorylation. CDK8
also functions as a stimulus-specific positive
coregulator of p53 transcriptional responses.
Length = 317
Score = 28.9 bits (64), Expect = 0.53
Identities = 15/31 (48%), Positives = 17/31 (54%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N LV P+ VKI D G AR
Sbjct: 130 LHRDLKPANILVMGEGPERGRVKIADMGFAR 160
>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine
Kinases, Cyclin-Dependent protein Kinase 2 and 3.
Serine/Threonine Kinases (STKs), Cyclin-dependent
protein kinase 2 (CDK2) and CDK3 subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The CDK2/3 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. CDKs belong to a
large family of STKs that are regulated by their cognate
cyclins. Together, they are involved in the control of
cell-cycle progression, transcription, and neuronal
function. CDK2 is regulated by cyclin E or cyclin A.
Upon activation by cyclin E, it phosphorylates the
retinoblastoma (pRb) protein which activates E2F
mediated transcription and allows cells to move into S
phase. The CDK2/cyclin A complex plays a role in
regulating DNA replication. CDK2, together with CDK4,
also regulates embryonic cell proliferation. Despite
these important roles, mice deleted for the cdk2 gene
are viable and normal except for being sterile. This may
be due to compensation provided by CDK1 (also called
Cdc2), which can also bind cyclin E and drive the G1 to
S phase transition. CDK3 is regulated by cyclin C and it
phosphorylates pRB specifically during the G0/G1
transition. This phosphorylation is required for cells
to exit G0 efficiently and enter the G1 phase.
Length = 284
Score = 28.6 bits (64), Expect = 0.58
Identities = 13/31 (41%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ +K+ DFGLAR
Sbjct: 122 LHRDLKPQNLLINTEGA----IKLADFGLAR 148
>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and
Dbf2p-like Protein Serine/Threonine Kinases.
Serine/Threonine Kinases (STKs), ROCK- and NDR-like
subfamily, fungal Sid2p- and Dbf2p-like proteins,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Sid2p- and
Dbf2p-like group is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This group contains fungal kinases including
Schizosaccharomyces pombe Sid2p and Saccharomyces
cerevisiae Dbf2p. Group members show similarity to NDR
kinases in that they contain an N-terminal regulatory
(NTR) domain and an insert within the catalytic domain
that contains an auto-inhibitory sequence. Sid2p plays a
crucial role in the septum initiation network (SIN) and
in the initiation of cytokinesis. Dbf2p is important in
regulating the mitotic exit network (MEN) and in
cytokinesis.
Length = 333
Score = 28.5 bits (64), Expect = 0.61
Identities = 12/36 (33%), Positives = 20/36 (55%), Gaps = 4/36 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+ ++HRDL N L+ +K+ DFGL++ I
Sbjct: 120 LGYIHRDLKPENFLIDASGH----IKLTDFGLSKGI 151
>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine
Kinase, Thousand-and-one amino acids proteins.
Serine/threonine kinases (STKs), thousand-and-one amino
acids (TAO) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The TAO subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. TAO proteins possess mitogen-activated protein
kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK)
activity. They activate the MAPKs, p38 and c-Jun
N-terminal kinase (JNK), by phosphorylating and
activating the respective MAP/ERK kinases (MEKs, also
known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK
signaling cascades are important in mediating cellular
responses to extracellular signals. Vertebrates contain
three TAO subfamily members, named TAO1, TAO2, and TAO3.
Length = 307
Score = 28.6 bits (64), Expect = 0.62
Identities = 13/30 (43%), Positives = 19/30 (63%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRD+ A N L++ +P VK+ DFG A
Sbjct: 137 IHRDIKAGNILLT--EPG--TVKLADFGSA 162
>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 1. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek1 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek1 is
associated with centrosomes throughout the cell cycle.
It is involved in the formation of primary cilium and in
the maintenance of centrosomes. It cycles through the
nucleus and may be capable of relaying signals between
the cilium and the nucleus. Nek1 is implicated in the
development of polycystic kidney disease, which is
characterized by benign polycystic tumors formed by
abnormal overgrowth of renal epithelial cells. It
appears also to be involved in DNA damage response, and
may be important for both correct DNA damage checkpoint
activation and DNA repair.
Length = 256
Score = 28.6 bits (64), Expect = 0.67
Identities = 12/31 (38%), Positives = 21/31 (67%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ ++N ++ K +K+GDFG+AR
Sbjct: 123 LHRDIKSQNIFLT----KDGTIKLGDFGIAR 149
>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 10. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 10 (Nek10)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
Nek10 subfamily is one of a family of 11 different Neks
(Nek1-11) that are involved in cell cycle control. The
Nek family is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. No function has yet been ascribed to Nek10.
The gene encoding Nek10 is a putative causative gene for
breast cancer; it is located within a breast cancer
susceptibility loci on chromosome 3p24.
Length = 269
Score = 28.6 bits (64), Expect = 0.67
Identities = 14/40 (35%), Positives = 17/40 (42%), Gaps = 4/40 (10%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYK 43
VHRDL N ++ D V I DFGLA+
Sbjct: 136 VHRDLTPNNIMLGEDDK----VTITDFGLAKQKQPESKLT 171
>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 5. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek5 subfamily is
one of a family of 11 different Neks (Nek1-11). The Nek
family is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Neks are involved in the regulation of
downstream processes following the activation of Cdc2,
and many of their functions are cell cycle-related. They
play critical roles in microtubule dynamics during
ciliogenesis and mitosis. The specific function of Nek5
is unknown.
Length = 257
Score = 28.4 bits (63), Expect = 0.73
Identities = 12/31 (38%), Positives = 20/31 (64%), Gaps = 3/31 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ ++N +S + K+GDFG+AR
Sbjct: 123 LHRDIKSQNIFLS---KNGMVAKLGDFGIAR 150
>gnl|CDD|235499 PRK05550, PRK05550, bifunctional methionine sulfoxide reductase B/A
protein; Provisional.
Length = 283
Score = 28.3 bits (64), Expect = 0.73
Identities = 16/53 (30%), Positives = 22/53 (41%), Gaps = 8/53 (15%)
Query: 3 FVHRDLAAR--NCLVSCLDPKY-----RIVKIGDFGLARDIYRNDYYKKEGEG 48
F H D + L++ L K + G F A D Y DYY+K G+
Sbjct: 224 FYHDDEQKQIAEKLIAELTKKGYPVVTEVEAAGPFYPAED-YHQDYYEKHGKQ 275
>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional.
Length = 440
Score = 28.5 bits (63), Expect = 0.79
Identities = 13/32 (40%), Positives = 20/32 (62%), Gaps = 3/32 (9%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
HRDL +N L+ DP +K+ DFG A+++
Sbjct: 193 HRDLKPQNLLI---DPNTHTLKLCDFGSAKNL 221
>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein
Serine/Threonine Kinases, Oxidative stress response
kinase and Ste20-related proline alanine-rich kinase.
Serine/threonine kinases (STKs), oxidative stress
response kinase (OSR1) and Ste20-related proline
alanine-rich kinase (SPAK) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The OSR1 and SPAK
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. SPAK is also referred to as STK39 or PASK
(proline-alanine-rich STE20-related kinase). OSR1 and
SPAK regulate the activity of cation-chloride
cotransporters through direct interaction and
phosphorylation. They are also implicated in
cytoskeletal rearrangement, cell differentiation,
transformation and proliferation. OSR1 and SPAK contain
a conserved C-terminal (CCT) domain, which recognizes a
unique motif ([RK]FX[VI]) present in their activating
kinases (WNK1/WNK4) and their substrates.
Length = 267
Score = 28.1 bits (63), Expect = 0.85
Identities = 13/36 (36%), Positives = 19/36 (52%), Gaps = 4/36 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN 39
+HRD+ A N L+ D VKI DFG++ +
Sbjct: 124 IHRDIKAGNILL-GEDGS---VKIADFGVSASLADG 155
>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein
Serine/Threonine Kinase, Large Tumor Suppressor.
Serine/Threonine Kinases (STKs), Large Tumor Suppressor
(LATS) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
LATS subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. LATS was originally identified in Drosophila
using a screen for genes whose inactivation led to
overproliferation of cells. In tetrapods, there are two
LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in
mice results in the development of various tumors,
including sarcomas and ovarian cancer. LATS functions as
a tumor suppressor and is implicated in cell cycle
regulation.
Length = 376
Score = 28.2 bits (63), Expect = 0.90
Identities = 16/47 (34%), Positives = 25/47 (53%), Gaps = 7/47 (14%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLA---RDIYRNDYYKK 44
M F+HRD+ N L+ + +K+ DFGL R + + YY+K
Sbjct: 120 MGFIHRDIKPDNILID----RDGHIKLTDFGLCTGFRWTHDSKYYQK 162
>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional.
Length = 496
Score = 28.3 bits (63), Expect = 0.94
Identities = 13/33 (39%), Positives = 22/33 (66%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
H +HRD+ + N L+ C + +VK+GDFG ++
Sbjct: 163 HMIHRDIKSANILL-CSNG---LVKLGDFGFSK 191
>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine
Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases
(STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PFTAIRE-1 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PFTAIRE-1 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PFTAIRE-1 is
widely expressed except in the spleen and thymus. It is
highly expressed in the brain, heart, pancreas, testis,
and ovary, and is localized in the cytoplasm. It is
regulated by cyclin D3 and is inhibited by the p21 cell
cycle inhibitor. It has also been shown to interact with
the membrane-associated cyclin Y, which recruits the
protein to the plasma membrane.
Length = 303
Score = 28.1 bits (62), Expect = 0.99
Identities = 14/33 (42%), Positives = 20/33 (60%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+ +HRDL +N L+S +K+ DFGLAR
Sbjct: 123 YILHRDLKPQNLLISDTGE----LKLADFGLAR 151
>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein
Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2,
and similar domains. Serine/Threonine Kinases (STKs),
Chlamydomonas reinhardtii Never In Mitosis gene A
(NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Chlamydomonas
reinhardtii CNK2-like subfamily belongs to the
(NIMA)-related kinase (Nek) family. The Nek family
includes seven different Chlamydomonas Neks (CNKs 1-6
and Fa2). This subfamily includes CNK1, and -2. The Nek
family is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Chlamydomonas reinhardtii CNK2 has both
cilliary and cell cycle functions. It influences
flagellar length through promoting flagellar
disassembly, and it regulates cell size, through
influencing the size threshold at which cells commit to
mitosis.
Length = 256
Score = 27.8 bits (62), Expect = 1.0
Identities = 13/34 (38%), Positives = 20/34 (58%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL + N L+ D +VKIGD G+++
Sbjct: 122 QKILHRDLKSANILLVAND----LVKIGDLGISK 151
>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the
Serine/Threonine Kinases, TDY Mitogen-Activated Protein
Kinases from Plants. Serine/Threonine Kinases (STKs),
Plant TDY Mitogen-Activated Protein Kinase (MAPK)
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The TDY
MAPK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MAPKs are important mediators of cellular
responses to extracellular signals. In plants, MAPKs are
associated with physiological, developmental, hormonal,
and stress responses. Some plants show numerous gene
duplications of MAPKs. Arabidopsis thaliana harbors at
least 20 MAPKs, named AtMPK1-20. Oryza sativa contains
at least 17 MAPKs. There are two subtypes of plant MAPKs
based on the conserved phosphorylation motif present in
the activation loop, TEY and TDY. Arabidopsis thaliana
contains more TEY-type MAPKs than TDY-type, whereas the
reverse is true for Oryza sativa. This subfamily
represents the TDY subtype and is composed of Group D
plant MAPKs including Arabidopsis thaliana MPK18
(AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1
(OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1),
Zea mays MPK6, and the Medicago sativa TDY1 gene
product. OsBWMK1 enhances resistance to pathogenic
infections. It mediates stress-activated defense
responses by activating a transcription factor that
affects the expression of stress-related genes. AtMPK18
is involved in microtubule-related functions.
Length = 338
Score = 27.8 bits (62), Expect = 1.0
Identities = 16/30 (53%), Positives = 19/30 (63%), Gaps = 4/30 (13%)
Query: 5 HRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
HRDL +N L + D K +KI DFGLAR
Sbjct: 126 HRDLKPKNILANA-DCK---LKICDFGLAR 151
>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine
Kinases, Fungal Mitogen-Activated Protein Kinases Sty1
and Hog1. Serine/Threonine Kinases (STKs), Fungal
Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
Sty1/Hog1 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of the MAPKs Sty1
from Schizosaccharomyces pombe, Hog1 from Saccharomyces
cerevisiae, and similar proteins. MAPKs are important
mediators of cellular responses to extracellular
signals. Sty1 and Hog1 are stress-activated MAPKs that
partipate in transcriptional regulation in response to
stress. Sty1 is activated in response to oxidative
stress, osmotic stress, and UV radiation. Sty1 is
regulated by the MAP2K Wis1, which is activated by the
MAP3Ks Wis4 and Win1, which receive signals of the
stress condition from membrane-spanning histidine
kinases Mak1-3. Activated Sty1 stabilizes the Atf1
transcription factor and induces transcription of
Atf1-dependent genes of the core environmetal stress
response (CESR). Hog1 is the key element in the high
osmolarity glycerol (HOG) pathway and is activated upon
hyperosmotic stress. Activated Hog1 accumulates in the
nucleus and regulates stress-induced transcription. The
HOG pathway is mediated by two transmembrane
osmosensors, Sln1 and Sho1.
Length = 328
Score = 27.9 bits (62), Expect = 1.1
Identities = 16/33 (48%), Positives = 19/33 (57%), Gaps = 8/33 (24%)
Query: 4 VHRDLAARNCLV--SCLDPKYRIVKIGDFGLAR 34
VHRDL N L+ +C +KI DFGLAR
Sbjct: 130 VHRDLKPSNILINENC------DLKICDFGLAR 156
>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase,
c-Jun N-terminal Kinase. Serine/Threonine Kinases
(STKs), c-Jun N-terminal kinase (JNK) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The JNK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. JNKs are
mitogen-activated protein kinases (MAPKs) that are
involved in many stress-activated responses including
those during inflammation, neurodegeneration, apoptosis,
and persistent pain sensitization, among others. They
are also essential regulators of physiological and
pathological processes and are involved in the
pathogenesis of several diseases such as diabetes,
atherosclerosis, stroke, Parkinson's and Alzheimer's.
Vetebrates harbor three different JNK genes (Jnk1, Jnk2,
and Jnk3) that are alternatively spliced to produce at
least 10 isoforms. JNKs are specifically activated by
the MAPK kinases MKK4 and MKK7, which are in turn
activated by upstream MAPK kinase kinases as a result of
different stimuli including stresses such as ultraviolet
(UV) irradiation, hyperosmolarity, heat shock, or
cytokines. JNKs activate a large number of different
substrates based on specific stimulus, cell type, and
cellular condition, and may be implicated in seemingly
contradictory functions.
Length = 353
Score = 27.8 bits (62), Expect = 1.3
Identities = 15/33 (45%), Positives = 18/33 (54%), Gaps = 8/33 (24%)
Query: 4 VHRDLAARNCLVS--CLDPKYRIVKIGDFGLAR 34
+HRDL N +V C +KI DFGLAR
Sbjct: 140 IHRDLKPSNIVVKSDC------TLKILDFGLAR 166
>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein
Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2
and similar domains. Serine/Threonine Kinases (STKs),
Chlamydomonas reinhardtii FA2-like subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Chlamydomonas
reinhardtii FA2-like subfamily belongs to the
(NIMA)-related kinase (Nek) family. The Nek family
includes seven different Chlamydomonas Neks (CNKs 1-6
and Fa2). This subfamily includes FA2 and CNK4. The Nek
family is part of a larger superfamily that includes the
catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Chlamydomonas reinhardtii FA2 was discovered
in a genetic screen for deflagellation-defective
mutants. It is essential for
basal-body/centriole-associated microtubule severing,
and plays a role in cell cycle progression. No cellular
function has yet been ascribed to CNK4.
Length = 256
Score = 27.5 bits (61), Expect = 1.4
Identities = 12/31 (38%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRD+ + N + Y VKIGD G+A+
Sbjct: 123 LHRDIKSLNLFLD----AYDNVKIGDLGVAK 149
>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein
Serine/Threonine Kinases, Mammalian Ste20-like protein
kinase 1 and 2. Serine/threonine kinases (STKs),
mammalian Ste20-like protein kinase 1 (MST1) and MST2
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MST1/2 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily is composed of MST1, MST2, and
related proteins including Drosophila Hippo and
Dictyostelium discoideum Krs1 (kinase responsive to
stress 1). MST1/2 and Hippo are involved in a conserved
pathway that governs cell contact inhibition, organ size
control, and tumor development. MST1 activates the
mitogen-activated protein kinases (MAPKs) p38 and c-Jun
N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and
MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase
kinase kinase (MAPKKKK). Activation of JNK by MST1 leads
to caspase activation and apoptosis. MST1 has also been
implicated in cell proliferation and differentiation.
Krs1 may regulate cell growth arrest and apoptosis in
response to cellular stress.
Length = 256
Score = 27.2 bits (61), Expect = 1.6
Identities = 10/33 (30%), Positives = 18/33 (54%), Gaps = 4/33 (12%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRD+ A N L++ + K+ DFG++
Sbjct: 118 NKKIHRDIKAGNILLN----EEGQAKLADFGVS 146
>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein
Serine/Threonine Kinases. Serine/Threonine Kinases
(STKs), AGC (Protein Kinases A, G and C) family,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The AGC family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and Phosphoinositide 3-Kinase (PI3K). Members of
this family include cAMP-dependent Protein Kinase (PKA),
cGMP-dependent Protein Kinase (PKG), Protein Kinase C
(PKC), Protein Kinase B (PKB), G protein-coupled
Receptor Kinase (GRK), Serum- and Glucocorticoid-induced
Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase
(p70S6K or S6K), among others. AGC kinases share an
activation mechanism based on the phosphorylation of up
to three sites: the activation loop (A-loop), the
hydrophobic motif (HM) and the turn motif.
Phosphorylation at the A-loop is required of most AGC
kinases, which results in a disorder-to-order transition
of the A-loop. The ordered conformation results in the
access of substrates and ATP to the active site. A
subset of AGC kinases with C-terminal extensions
containing the HM also requires phosphorylation at this
site. Phosphorylation at the HM allows the C-terminal
extension to form an ordered structure that packs into
the hydrophobic pocket of the catalytic domain, which
then reconfigures the kinase into an active bi-lobed
state. In addition, growth factor-activated AGC kinases
such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require
phosphorylation at the turn motif (also called tail or
zipper site), located N-terminal to the HM at the
C-terminal extension. AGC kinases regulate many cellular
processes including division, growth, survival,
metabolism, motility, and differentiation. Many are
implicated in the development of various human diseases.
Length = 250
Score = 27.1 bits (61), Expect = 1.7
Identities = 14/39 (35%), Positives = 20/39 (51%), Gaps = 4/39 (10%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRND 40
++RDL N L LD I K+ DFGLA+++
Sbjct: 113 GIIYRDLKPENIL---LDADGHI-KLTDFGLAKELSSEG 147
>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine
Kinase, p21-activated kinase. Serine/threonine kinases
(STKs), p21-activated kinase (PAK) subfamily, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PAK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PAKs are Rho
family GTPase-regulated kinases that serve as important
mediators in the function of Cdc42 (cell division cycle
42) and Rac. PAKs are implicated in the regulation of
many cellular processes including growth factor
receptor-mediated proliferation, cell polarity, cell
motility, cell death and survival, and actin
cytoskeleton organization. PAK deregulation is
associated with tumor development. PAKs from higher
eukaryotes are classified into two groups (I and II),
according to their biochemical and structural features.
Group I PAKs contain a PBD (p21-binding domain)
overlapping with an AID (autoinhibitory domain), a
C-terminal catalytic domain, SH3 binding sites and a
non-classical SH3 binding site for PIX (PAK-interacting
exchange factor). Group II PAKs contain a PBD and a
catalytic domain, but lack other motifs found in group I
PAKs. Since group II PAKs do not contain an obvious AID,
they may be regulated differently from group I PAKs.
Group I PAKs interact with the SH3 containing proteins
Nck, Grb2 and PIX; no such binding has been demonstrated
for group II PAKs.
Length = 286
Score = 27.2 bits (61), Expect = 1.9
Identities = 13/33 (39%), Positives = 19/33 (57%), Gaps = 4/33 (12%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+ +HRD+ + N L+S K VK+ DFG A
Sbjct: 135 QNVIHRDIKSDNILLS----KDGSVKLADFGFA 163
>gnl|CDD|223162 COG0084, TatD, Mg-dependent DNase [DNA replication, recombination,
and repair].
Length = 256
Score = 27.2 bits (61), Expect = 2.1
Identities = 10/37 (27%), Positives = 15/37 (40%), Gaps = 2/37 (5%)
Query: 9 AARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKE 45
L + ++V IG+ GL D Y + KE
Sbjct: 74 EDLEELEQLAEHHPKVVAIGEIGL--DYYWDKEPDKE 108
>gnl|CDD|180232 PRK05748, PRK05748, replicative DNA helicase; Provisional.
Length = 448
Score = 27.2 bits (61), Expect = 2.1
Identities = 12/35 (34%), Positives = 18/35 (51%), Gaps = 9/35 (25%)
Query: 36 IYRNDYYKKEGE--GLLPVSFAITVVIESKNRSVP 68
+YR+DYY +E E I ++I K R+ P
Sbjct: 397 LYRDDYYDEETENKNT------IEIIIA-KQRNGP 424
>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein.
This model represents proteins of 1350 in length, in
multiple species of Burkholderia, in Acidovorax avenae
subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1,
and in multiple copies in Sorangium cellulosum, in
genomic neighborhoods that include a
cyclodehydratase/docking scaffold fusion protein
(TIGR03882) and a member of the thiazole/oxazole
modified metabolite (TOMM) precursor family TIGR03795.
It has a kinase domain in the N-terminal 300 amino
acids, followed by a cyclase homology domain, followed
by regions without named domain definitions. It is a
probable bacteriocin-like metabolite biosynthesis
protein [Cellular processes, Toxin production and
resistance].
Length = 1266
Score = 27.1 bits (60), Expect = 2.2
Identities = 12/29 (41%), Positives = 17/29 (58%), Gaps = 1/29 (3%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGL 32
VHRDL +N +VS + K+ DFG+
Sbjct: 101 VHRDLKPQNIMVSQTGVR-PHAKVLDFGI 128
>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase,
p38 Mitogen-Activated Protein Kinase. Serine/Threonine
Kinases (STKs), p38 subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The p38 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. p38 kinases are
mitogen-activated protein kinases (MAPKs), serving as
important mediators of cellular responses to
extracellular signals. They function in the regulation
of the cell cycle, cell development, cell
differentiation, senescence, tumorigenesis, apoptosis,
pain development and pain progression, and immune
responses. p38 kinases are activated by the MAPK kinases
MKK3 and MKK6, which in turn are activated by upstream
MAPK kinase kinases including TAK1, ASK1, and MLK3, in
response to cellular stresses or inflammatory cytokines.
p38 substrates include other protein kinases and factors
that regulate transcription, nuclear export, mRNA
stability and translation. p38 kinases are drug targets
for the inflammatory diseases psoriasis, rheumatoid
arthritis, and chronic pulmonary disease. Vertebrates
contain four isoforms of p38, named alpha, beta, gamma,
and delta, which show varying substrate specificity and
expression patterns. p38alpha and p38beta are
ubiquitously expressed, p38gamma is predominantly found
in skeletal muscle, and p38delta is found in the heart,
lung, testis, pancreas, and small intestine.
Length = 343
Score = 26.9 bits (60), Expect = 2.2
Identities = 15/35 (42%), Positives = 18/35 (51%), Gaps = 8/35 (22%)
Query: 2 HFVHRDLAARNCLVS--CLDPKYRIVKIGDFGLAR 34
+HRDL N V+ C +KI DFGLAR
Sbjct: 138 GIIHRDLKPSNIAVNEDCE------LKILDFGLAR 166
>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase
3-like Protein Serine/Threonine Kinases.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3
(MEKK3)-like subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The MEKK3-like subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. This subfamily is composed of
MEKK3, MEKK2, and related proteins, all containing an
N-terminal PB1 domain, which mediates oligomerization,
and a C-terminal catalytic domain. MEKK2 and MEKK3 are
mitogen-activated protein kinase (MAPK) kinase kinases
(MAPKKKs or MKKKs or MAP3Ks), proteins that
phosphorylate and activate MAPK kinases (MAPKKs or MKKs
or MAP2Ks), which in turn phosphorylate and activate
MAPKs during signaling cascades that are important in
mediating cellular responses to extracellular signals.
MEKK2 and MEKK3 activate MEK5 (also called MKK5), which
activates extracellular signal-regulated kinase 5
(ERK5). The ERK5 cascade plays roles in promoting cell
proliferation, differentiation, neuronal survival, and
neuroprotection. MEKK3 plays an essential role in
embryonic angiogenesis and early heart development.
MEKK2 and MEKK3 can also activate the MAPKs, c-Jun
N-terminal kinase (JNK) and p38, through their
respective MAPKKs.
Length = 263
Score = 26.7 bits (59), Expect = 2.4
Identities = 12/33 (36%), Positives = 16/33 (48%), Gaps = 4/33 (12%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRD+ N L VK+GDFG ++
Sbjct: 124 MIVHRDIKGANILRD----SAGNVKLGDFGASK 152
>gnl|CDD|226439 COG3926, zliS, Lysozyme family protein [General function
prediction only].
Length = 252
Score = 26.7 bits (59), Expect = 2.4
Identities = 11/26 (42%), Positives = 15/26 (57%), Gaps = 2/26 (7%)
Query: 33 ARDIYRNDYYKKEGEGLLP--VSFAI 56
A IYR +Y+ K G LP V +A+
Sbjct: 59 ATAIYREEYWNKVGGDDLPAGVDYAV 84
>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein
Serine/Threonine Kinase, Citron Rho-interacting kinase.
Serine/Threonine Kinases (STKs), Citron Rho-interacting
kinase (CRIK) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The CRIK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. CRIK is also called citron kinase. It contains
a catalytic domain, a central coiled-coil domain, and a
C-terminal region containing a Rho-binding domain (RBD),
a zinc finger, and a pleckstrin homology (PH) domain, in
addition to other motifs. CRIK, an effector of the small
GTPase Rho, plays an important function during
cytokinesis and affects its contractile process.
CRIK-deficient mice show severe ataxia and epilepsy as a
result of abnormal cytokinesis and massive apoptosis in
neuronal precursors. A Down syndrome critical region
protein TTC3 interacts with CRIK and inhibits
CRIK-dependent neuronal differentiation and neurite
extension.
Length = 330
Score = 26.7 bits (59), Expect = 2.6
Identities = 13/39 (33%), Positives = 20/39 (51%), Gaps = 4/39 (10%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN 39
M +VHRD+ N L+ + +K+ DFG A + N
Sbjct: 121 MGYVHRDIKPENVLID----RTGHIKLADFGSAARLTAN 155
>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein
Serine/Threonine Kinase, MAP/ERK kinase kinase 4.
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4
(MEKK4) subfamily, catalytic (c) domain. STKs catalyze
the transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
MEKK4 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MEKK4 is a mitogen-activated protein kinase
(MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that
phosphorylates and activates MAPK kinases (MAPKKs or
MKKs or MAP2Ks), which in turn phosphorylate and
activate MAPKs during signaling cascades that are
important in mediating cellular responses to
extracellular signals. MEKK4 activates the c-Jun
N-terminal kinase (JNK) and p38 MAPK signaling pathways
by directly activating their respective MAPKKs,
MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively
known as stress-activated MAPKs, as they are activated
in response to a variety of environmental stresses and
pro-inflammatory cytokines. MEKK4 also plays roles in
the re-polarization of the actin cytoskeleton in
response to osmotic stress, in the proper closure of the
neural tube, in cardiovascular development, and in
immune responses.
Length = 264
Score = 26.5 bits (59), Expect = 3.1
Identities = 14/38 (36%), Positives = 19/38 (50%), Gaps = 4/38 (10%)
Query: 2 HFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN 39
VHRD+ N LD ++K+GDFG A + N
Sbjct: 119 GIVHRDIKPANIF---LD-HNGVIKLGDFGCAVKLKNN 152
>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein
Serine/Threonine Kinase, Microtubule-associated
serine/threonine kinase. Serine/Threonine Kinases
(STKs), Microtubule-associated serine/threonine (MAST)
kinase subfamily, MAST, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The MAST kinase subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. MAST kinases contain an
N-terminal domain of unknown function, a central
catalytic domain, and a C-terminal PDZ domain that
mediates protein-protein interactions. There are four
mammalian MAST kinases, named MAST1-MAST4. MAST1 is also
referred to as syntrophin-associated STK (SAST), while
MAST2 is also called MAST205. MAST kinases are
cytoskeletal associated kinases of unknown function that
are also expressed at neuromuscular junctions and
postsynaptic densities. MAST1, MAST2, and MAST3 bind and
phosphorylate the tumor suppressor PTEN, and may
contribute to the regulation and stabilization of PTEN.
MAST2 is involved in the regulation of the Fc-gamma
receptor of the innate immune response in macrophages,
and may also be involved in the regulation of the Na+/H+
exchanger NHE3.
Length = 305
Score = 26.7 bits (59), Expect = 3.1
Identities = 12/31 (38%), Positives = 19/31 (61%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRDL N L++ + +K+ DFGL++
Sbjct: 123 VHRDLKPDNLLITSMGH----IKLTDFGLSK 149
>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated
serine/threonine kinase-like proteins. Serine/Threonine
Kinases (STKs), Microtubule-associated serine/threonine
(MAST) kinase subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The MAST kinase subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. The MAST kinase subfamily
includes MAST kinases, MAST-like (MASTL) kinases, and
fungal kinases with similarity to Saccharomyces
cerevisiae Rim15 and Schizosaccharomyces pombe cek1.
MAST kinases contain an N-terminal domain of unknown
function, a central catalytic domain, and a C-terminal
PDZ domain that mediates protein-protein interactions.
MASTL kinases carry only a catalytic domain which
contains a long insert relative to other kinases. The
fungal kinases in this subfamily harbor other domains in
addition to a central catalytic domain, which also
contains an insert relative to MAST kinases like MASTL.
Rim15 contains a C-terminal signal receiver (REC) domain
while cek1 contains an N-terminal PAS domain. MAST
kinases are cytoskeletal associated kinases of unknown
function that are also expressed at neuromuscular
junctions and postsynaptic densities. The fungal
proteins Rim15 and cek1 are involved in the regulation
of meiosis and mitosis, respectively.
Length = 265
Score = 26.4 bits (59), Expect = 3.4
Identities = 11/32 (34%), Positives = 17/32 (53%), Gaps = 4/32 (12%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N L+ +K+ DFGL++
Sbjct: 114 IIHRDLKPDNILID----SNGHLKLTDFGLSK 141
>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine
Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases
(STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PCTAIRE-3 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PCTAIRE-3 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PCTAIRE-3 shows a
restricted pattern of expression and is present in
brain, kidney, and intestine. It is elevated in
Alzheimer's disease (AD) and has been shown to associate
with paired helical filaments (PHFs) and stimulate Tau
phosphorylation. As AD progresses, phosphorylated Tau
aggregates and forms PHFs, which leads to the formation
of neurofibrillary tangles (NFTs). In human glioma
cells, PCTAIRE-3 induces cell cycle arrest and cell
death.
Length = 288
Score = 26.1 bits (57), Expect = 3.9
Identities = 13/31 (41%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ + +K+ DFGLAR
Sbjct: 125 LHRDLKPQNLLIN----EKGELKLADFGLAR 151
>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine
Kinase, Apoptosis signal-regulating kinase.
Serine/threonine kinases (STKs), Apoptosis
signal-regulating kinase (ASK) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The ASK subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Subfamily members
are mitogen-activated protein kinase (MAPK) kinase
kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1,
ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate
MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn
phosphorylate and activate MAPKs during signaling
cascades that are important in mediating cellular
responses to extracellular signals. ASK1 (also called
MAPKKK5) functions in the c-Jun N-terminal kinase (JNK)
and p38 MAPK signaling pathways by directly activating
their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It
plays important roles in cytokine and stress responses,
as well as in reactive oxygen species (ROS)-mediated
cellular responses. ASK1 is implicated in various
diseases mediated by oxidative stress including
inschemic heart disease, hypertension, vessel injury,
brain ischemia, Fanconi anemia, asthma, and pulmonary
edema, among others. ASK2 (also called MAPKKK6)
functions only in a heteromeric complex with ASK1, and
can activate ASK1 by direct phosphorylation. The
function of MAPKKK15 is still unknown.
Length = 268
Score = 26.3 bits (58), Expect = 4.2
Identities = 13/31 (41%), Positives = 18/31 (58%), Gaps = 3/31 (9%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VHRD+ N LV+ +VKI DFG ++
Sbjct: 130 VHRDIKGDNVLVNTYSG---VVKISDFGTSK 157
>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine
Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases
(STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PCTAIRE-1 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PCTAIRE-1 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PCTAIRE-1 is
expressed ubiquitously and is localized in the
cytoplasm. Its kinase activity is cell cycle dependent
and peaks at the S and G2 phases. PCTAIRE-1 is highly
expressed in the brain and may play a role in regulating
neurite outgrowth. It can also associate with Trap
(Tudor repeat associator with PCTAIRE-2), a
physiological partner of PCTAIRE-2; with p11, a small
dimeric protein with similarity to S100; and with 14-3-3
proteins, mediators of phosphorylation-dependent
interactions in many different proteins.
Length = 301
Score = 26.1 bits (57), Expect = 4.2
Identities = 13/31 (41%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ + +K+ DFGLAR
Sbjct: 126 LHRDLKPQNLLIN----ERGELKLADFGLAR 152
>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family. This family
consists of bacterial antibiotic resistance proteins,
which confer resistance to various aminoglycosides they
include: aminoglycoside 3'-phosphotransferase or
kanamycin kinase / neomycin-kanamycin phosphotransferase
and streptomycin 3''-kinase or streptomycin
3''-phosphotransferase. The aminoglycoside
phosphotransferases inactivate aminoglycoside
antibiotics via phosphorylation. This family also
includes homoserine kinase. This family is related to
fructosamine kinase pfam03881.
Length = 238
Score = 26.0 bits (57), Expect = 4.4
Identities = 13/32 (40%), Positives = 15/32 (46%), Gaps = 3/32 (9%)
Query: 3 FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
VH DL N LV DP R+ + DF A
Sbjct: 167 LVHGDLHPGNLLV---DPGGRVTGVIDFEDAG 195
>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine
Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases
(STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The PCTAIRE-2 subfamily is part of a larger superfamily
that includes the catalytic domains of other protein
STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. PCTAIRE-2 shares sequence
similarity with Cyclin-Dependent Kinases (CDKs), which
belong to a large family of STKs that are regulated by
their cognate cyclins. Together, CDKs and cyclins are
involved in the control of cell-cycle progression,
transcription, and neuronal function. PCTAIRE-2 is
specifically expressed in neurons in the central nervous
system, mainly in terminally differentiated neurons. It
associates with Trap (Tudor repeat associator with
PCTAIRE-2) and could play a role in regulating
mitochondrial function in neurons.
Length = 309
Score = 26.1 bits (57), Expect = 4.4
Identities = 13/31 (41%), Positives = 20/31 (64%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL +N L++ + +K+ DFGLAR
Sbjct: 126 LHRDLKPQNLLIN----ERGELKLADFGLAR 152
>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein
Serine/Threonine Kinase, Yank1. Serine/Threonine
Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Yank1 subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. This subfamily
contains uncharacterized STKs with similarity to the
human protein designated Yank1 or STK32A.
Length = 258
Score = 26.1 bits (58), Expect = 4.6
Identities = 12/35 (34%), Positives = 16/35 (45%), Gaps = 4/35 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARD 35
+HRD+ N L LD + V I DF +A
Sbjct: 119 KGIIHRDIKPDNIL---LDEQGH-VHITDFNIATK 149
>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein
Serine/Threonine Kinase, Rho-associated coiled-coil
containing protein kinase. Serine/Threonine Kinases
(STKs), Rho-associated coiled-coil containing protein
kinase (ROCK) subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The ROCK subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. ROCK is also referred to as Rho-associated
kinase or simply as Rho kinase. It contains an
N-terminal extension, a catalytic kinase domain, and a
long C-terminal extension, which contains a coiled-coil
region encompassing a Rho-binding domain (RBD) and a
pleckstrin homology (PH) domain. ROCK is auto-inhibited
by the RBD and PH domain interacting with the catalytic
domain. It is activated via interaction with Rho GTPases
and is involved in many cellular functions including
contraction, adhesion, migration, motility,
proliferation, and apoptosis. The ROCK subfamily
consists of two isoforms, ROCK1 and ROCK2, which may be
functionally redundant in some systems, but exhibit
different tissue distributions. Both isoforms are
ubiquitously expressed in most tissues, but ROCK2 is
more prominent in brain and skeletal muscle while ROCK1
is more pronounced in the liver, testes, and kidney.
Studies in knockout mice result in different phenotypes,
suggesting that the two isoforms do not compensate for
each other during embryonic development.
Length = 370
Score = 25.9 bits (57), Expect = 4.8
Identities = 12/31 (38%), Positives = 17/31 (54%), Gaps = 4/31 (12%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFG 31
M F+HRD+ N L+ K +K+ DFG
Sbjct: 161 MGFIHRDVKPDNMLLD----KSGHLKLADFG 187
>gnl|CDD|213184 cd03217, ABC_FeS_Assembly, ABC-type transport system involved in
Fe-S cluster assembly, ATPase component. Biosynthesis
of iron-sulfur clusters (Fe-S) depends on multi-protein
systems. The SUF system of E. coli and Erwinia
chrysanthemi is important for Fe-S biogenesis under
stressful conditions. The SUF system is made of six
proteins: SufC is an atypical cytoplasmic ABC-ATPase,
which forms a complex with SufB and SufD; SufA plays the
role of a scaffold protein for assembly of iron-sulfur
clusters and delivery to target proteins; SufS is a
cysteine desulfurase which mobilizes the sulfur atom
from cysteine and provides it to the cluster; SufE has
no associated function yet.
Length = 200
Score = 26.0 bits (58), Expect = 4.8
Identities = 10/19 (52%), Positives = 12/19 (63%)
Query: 23 RIVKIGDFGLARDIYRNDY 41
RIVK GD LA +I + Y
Sbjct: 182 RIVKSGDKELALEIEKKGY 200
>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine
Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase
(PTK) family; Ephrin Receptor (EphR) subfamily; EphA10
receptor; catalytic (c) domain. The PTKc family is part
of a larger superfamily that includes the catalytic
domains of other kinases such as protein
serine/threonine kinases, RIO kinases, and
phosphoinositide 3-kinase (PI3K). PTKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
tyrosine (tyr) residues in protein substrates. EphRs
comprise the largest subfamily of receptor tyr kinases
(RTKs). In general, class EphA receptors bind
GPI-anchored ephrin-A ligands. There are ten vertebrate
EphA receptors (EphA1-10), which display promiscuous
interactions with six ephrin-A ligands. EphRs contain an
ephrin binding domain and two fibronectin repeats
extracellularly, a transmembrane segment, and a
cytoplasmic tyr kinase domain. Binding of the ephrin
ligand to EphR requires cell-cell contact since both are
anchored to the plasma membrane. The resulting
downstream signals occur bidirectionally in both
EphR-expressing cells (forward signaling) and
ephrin-expressing cells (reverse signaling). EphA10,
which contains an inactive tyr kinase domain, may
function to attenuate signals of co-clustered active
receptors. EphA10 is mainly expressed in the testis.
Ephrin/EphR interaction results in cell-cell repulsion
or adhesion, making it important in neural development
and plasticity, cell morphogenesis, cell-fate
determination, embryonic development, tissue patterning,
and angiogenesis.
Length = 266
Score = 26.0 bits (57), Expect = 4.9
Identities = 8/16 (50%), Positives = 11/16 (68%)
Query: 1 MHFVHRDLAARNCLVS 16
M +VH+ LAA LV+
Sbjct: 126 MGYVHKGLAAHKVLVN 141
>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein
Serine/Threonine Kinase, STK10 or Lymphocyte-oriented
kinase. Serine/threonine kinases (STKs), STK10
subfamily, catalytic (c) domain. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The
STK10 subfamily is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Other names for STK10 include
lymphocyte-oriented kinase (LOK) and Xenopus polo-like
kinase kinase 1 (xPlkk1). STK10 is highly expressed in
lymphocytes and is responsible in regulating leukocyte
function associated antigen (LFA-1)-mediated lymphocyte
adhesion. It plays a role in regulating the CD28
responsive element in T cells, and may also function as
a regulator of polo-like kinase 1 (Plk1), a protein
which is overexpressed in multiple tumor types.
Length = 292
Score = 25.8 bits (56), Expect = 5.5
Identities = 14/33 (42%), Positives = 21/33 (63%), Gaps = 4/33 (12%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
M +HRDL A N L++ LD +K+ DFG++
Sbjct: 129 MKIIHRDLKAGNVLLT-LDGD---IKLADFGVS 157
>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like
Protein Serine/Threonine Kinases. Serine/threonine
kinases (STKs), Nak1 subfamily, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The Nak1 subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. This subfamily is composed of
Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae
Kic1p (kinase that interacts with Cdc31p) and related
proteins. Nak1 (also known as N-rich kinase 1), is
required by fission yeast for polarizing the tips of
actin cytoskeleton and is involved in cell growth, cell
separation, cell morphology and cell-cycle progression.
Kic1p is required by budding yeast for cell integrity
and morphogenesis. Kic1p interacts with Cdc31p, the
yeast homologue of centrin, and phosphorylates
substrates in a Cdc31p-dependent manner.
Length = 277
Score = 25.9 bits (57), Expect = 6.2
Identities = 13/30 (43%), Positives = 18/30 (60%), Gaps = 4/30 (13%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLA 33
+HRD+ A N LV+ VK+ DFG+A
Sbjct: 123 IHRDIKAANILVTNTGN----VKLCDFGVA 148
>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine
Kinase, Protein Kinase N. Serine/Threonine Kinases
(STKs), Protein Kinase N (PKN) subfamily, catalytic (c)
domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The PKN subfamily is
part of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. PKN has a
C-terminal catalytic domain that is highly homologous to
PKCs. Its unique N-terminal regulatory region contains
antiparallel coiled-coil (ACC) domains. In mammals,
there are three PKN isoforms from different genes
(designated PKN-alpha, beta, and gamma), which show
different enzymatic properties, tissue distribution, and
varied functions. PKN can be activated by the small
GTPase Rho, and by fatty acids such as arachidonic and
linoleic acids. It is involved in many biological
processes including cytokeletal regulation, cell
adhesion, vesicle transport, glucose transport,
regulation of meiotic maturation and embryonic cell
cycles, signaling to the nucleus, and tumorigenesis.
Length = 324
Score = 25.8 bits (57), Expect = 6.6
Identities = 15/32 (46%), Positives = 19/32 (59%), Gaps = 4/32 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARD 35
V+RDL N L LD + VKI DFGL ++
Sbjct: 123 VYRDLKLDNLL---LDTE-GFVKIADFGLCKE 150
>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like
Protein Serine/Threonine Kinases. Serine/Threonine
Kinases (STKs), Microtubule-associated serine/threonine
(MAST) kinase subfamily, fungal Rim15-like kinases,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAST kinase
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Members of this group include Saccharomyces
cerevisiae Rim15, Schizosaccharomyces pombe cek1, and
similar fungal proteins. They contain a central
catalytic domain, which contains an insert relative to
MAST kinases. In addition, Rim15 contains a C-terminal
signal receiver (REC) domain while cek1 contains an
N-terminal PAS domain. Rim15 (or Rim15p) functions as a
regulator of meiosis. It acts as a downstream effector
of PKA and regulates entry into stationary phase (G0).
Thus, it plays a crucial role in regulating yeast
proliferation, differentiation, and aging. Cek1 may
facilitate progression of mitotic anaphase.
Length = 260
Score = 25.5 bits (56), Expect = 6.8
Identities = 12/36 (33%), Positives = 20/36 (55%), Gaps = 4/36 (11%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRN 39
+HRD+ N L+ + +K+ DFGL+R+ N
Sbjct: 119 IHRDIKPENLLID----QTGHLKLTDFGLSRNGLEN 150
>gnl|CDD|233080 TIGR00665, DnaB, replicative DNA helicase. This model describes
the helicase DnaB, a homohexameric protein required for
DNA replication. The homohexamer can form a ring around
a single strand of DNA near a replication fork. An
intein of > 400 residues is found at a conserved
location in DnaB of Synechocystis PCC6803, Rhodothermus
marinus (both experimentally confirmed), and
Mycobacterium tuberculosis. The intein removes itself by
a self-splicing reaction. The seed alignment contains
inteins so that the model built from the seed alignment
will model a low cost at common intein insertion sites
[DNA metabolism, DNA replication, recombination, and
repair].
Length = 434
Score = 25.5 bits (57), Expect = 7.1
Identities = 10/33 (30%), Positives = 17/33 (51%), Gaps = 5/33 (15%)
Query: 36 IYRNDYYKKEGEGLLPVSFAITVVIESKNRSVP 68
+YR++YY + E I +I +K R+ P
Sbjct: 387 LYRDEYYNPDSE-----DKGIAEIIIAKQRNGP 414
>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family
protein/serine/threonine protein kinase; Validated.
Length = 535
Score = 25.6 bits (57), Expect = 7.3
Identities = 13/37 (35%), Positives = 17/37 (45%), Gaps = 8/37 (21%)
Query: 1 MH---FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+H VH DL N +V R+ I DFGL +
Sbjct: 444 LHKAGIVHGDLTTSNFIVR----DDRLYLI-DFGLGK 475
>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated
protein kinase kinase kinase kinase-like Protein
Serine/Threonine Kinases. Serine/threonine kinases
(STKs), mitogen-activated protein kinase (MAPK) kinase
kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAP4K3-like
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. This subfamily includes MAP4K3, MAP4K1,
MAP4K2, MAP4K5, and related proteins. Vertebrate members
contain an N-terminal catalytic domain and a C-terminal
citron homology (CNH) regulatory domain, similar to
MAP4K4/6. MAP4Ks are involved in some MAPK signaling
pathways that are important in mediating cellular
responses to extracellular signals by activating a MAPK
kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK
cascade is activated either by a small GTP-binding
protein or by an adaptor protein, which transmits the
signal either directly to a MAP3K to start the triple
kinase core cascade or indirectly through a mediator
kinase, a MAP4K. MAP4K1, also called haematopoietic
progenitor kinase 1 (HPK1), is a hematopoietic-specific
STK involved in many cellular signaling cascades
including MAPK, antigen receptor, apoptosis, growth
factor, and cytokine signaling. It participates in the
regulation of T cell receptor signaling and T
cell-mediated immune responses. MAP4K2 was referred to
as germinal center (GC) kinase because of its preferred
location in GC B cells. MAP4K3 plays a role in the
nutrient-responsive pathway of mTOR (mammalian target of
rapamycin) signaling. It is required in the activation
of S6 kinase by amino acids and for the phosphorylation
of the mTOR-regulated inhibitor of eukaryotic initiation
factor 4E. MAP4K5, also called germinal center
kinase-related enzyme (GCKR), has been shown to activate
the MAPK c-Jun N-terminal kinase (JNK).
Length = 262
Score = 25.3 bits (56), Expect = 7.6
Identities = 10/36 (27%), Positives = 19/36 (52%), Gaps = 4/36 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
+HRD+ N L++ + VK+ DFG++ +
Sbjct: 120 TGKIHRDIKGANILLT----EDGDVKLADFGVSAQL 151
>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein
Serine/Threonine Kinase, Never In Mitosis gene A-related
kinase 3. Serine/Threonine Kinases (STKs), Never In
Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily,
catalytic (c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The Nek3 subfamily is
one of a family of 11 different Neks (Nek1-11) that are
involved in cell cycle control. The Nek family is part
of a larger superfamily that includes the catalytic
domains of other protein STKs, protein tyrosine kinases,
RIO kinases, aminoglycoside phosphotransferase, choline
kinase, and phosphoinositide 3-kinase. Nek3 is primarily
localized in the cytoplasm and shows no cell
cycle-dependent changes in its activity. It is present
in the axons of neurons and affects morphogenesis and
polarity through its regulation of microtubule
acetylation. Nek3 modulates the signaling of the
prolactin receptor through its activation of Vav2 and
contributes to prolactin-mediated motility of breast
cancer cells.
Length = 255
Score = 25.3 bits (55), Expect = 7.7
Identities = 16/56 (28%), Positives = 27/56 (48%), Gaps = 16/56 (28%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDIYRNDYYKKEGEGLLPVSFAITVV 59
+HRD+ ++N ++ + VK+GDFG AR + P ++A T V
Sbjct: 122 LHRDIKSKNIFLT----QNGKVKLGDFGSARLLTS------------PGAYACTYV 161
>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit;
Provisional.
Length = 329
Score = 25.5 bits (56), Expect = 8.2
Identities = 13/33 (39%), Positives = 19/33 (57%), Gaps = 4/33 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLARDI 36
++RDL N L LD K + K+ DFG A+ +
Sbjct: 140 IYRDLKPENLL---LDNKGHV-KVTDFGFAKKV 168
>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein
Serine/Threonine Kinase, Microtubule-associated
serine/threonine-like kinase. Serine/Threonine Kinases
(STKs), Microtubule-associated serine/threonine (MAST)
kinase subfamily, MAST-like (MASTL) kinases, catalytic
(c) domain. STKs catalyze the transfer of the
gamma-phosphoryl group from ATP to serine/threonine
residues on protein substrates. The MAST kinase
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. MAST kinases contain an N-terminal domain of
unknown function, a central catalytic domain, and a
C-terminal PDZ domain that mediates protein-protein
interactions. The MASTL kinases in this group carry only
a catalytic domain, which contains a long insertion
relative to MAST kinases. The human MASTL gene has also
been labelled FLJ14813. A missense mutation in FLJ14813
is associated with autosomal dominant thrombocytopenia.
To date, the function of MASTL is unknown.
Length = 669
Score = 25.6 bits (56), Expect = 8.2
Identities = 12/31 (38%), Positives = 18/31 (58%), Gaps = 4/31 (12%)
Query: 4 VHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+HRDL N L+S +K+ DFGL++
Sbjct: 126 IHRDLKPDNMLIS----NEGHIKLTDFGLSK 152
>gnl|CDD|224971 COG2060, KdpA, K+-transporting ATPase, A chain [Inorganic ion
transport and metabolism].
Length = 560
Score = 25.3 bits (56), Expect = 8.3
Identities = 15/56 (26%), Positives = 26/56 (46%), Gaps = 15/56 (26%)
Query: 49 LLPVSFAITVVIESKNRSVP--FRPELCV-----------YGPLADIDSIKKVGIN 91
LLP+S + +++ S+ VP + V GP+A ++IK +G N
Sbjct: 181 LLPLSLVVAILLVSQ--GVPQTLGGYITVTTLEGAKQTIPLGPVASQEAIKMLGTN 234
>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine
Kinase, cAMP-dependent protein kinase. Serine/Threonine
Kinases (STKs), cAMP-dependent protein kinase (PKA)
subfamily, catalytic (c) subunit. STKs catalyze the
transfer of the gamma-phosphoryl group from ATP to
serine/threonine residues on protein substrates. The PKA
subfamily is part of a larger superfamily that includes
the catalytic domains of other protein STKs, protein
tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase (PI3K). This subfamily is composed of the
cAMP-dependent proteins kinases, PKA and PRKX. The
inactive PKA holoenzyme is a heterotetramer composed of
two phosphorylated and active catalytic (C) subunits
with a dimer of regulatory (R) subunits. Activation is
achieved through the binding of the important second
messenger cAMP to the R subunits, which leads to the
dissociation of PKA into the R dimer and two active C
subunits. PKA is present ubiquitously in cells and
interacts with many different downstream targets. It
plays a role in the regulation of diverse processes such
as growth, development, memory, metabolism, gene
expression, immunity, and lipolysis.
Length = 290
Score = 25.2 bits (56), Expect = 8.5
Identities = 14/34 (41%), Positives = 18/34 (52%), Gaps = 4/34 (11%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
+ V+RDL N L LD +KI DFG A+
Sbjct: 120 LDIVYRDLKPENLL---LD-SDGYIKITDFGFAK 149
>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein
Serine/Threonine Kinases, Never In Mitosis gene
A-related kinase 6 and 7. Serine/Threonine Kinases
(STKs), Never In Mitosis gene A (NIMA)-related kinase 6
(Nek6) and Nek7 subfamily, catalytic (c) domain. STKs
catalyze the transfer of the gamma-phosphoryl group from
ATP to serine/threonine residues on protein substrates.
The Nek6/7 subfamily is part of a family of 11 different
Neks (Nek1-11) that are involved in cell cycle control.
The Nek family is part of a larger superfamily that
includes the catalytic domains of other protein STKs,
protein tyrosine kinases, RIO kinases, aminoglycoside
phosphotransferase, choline kinase, and phosphoinositide
3-kinase. Nek6 and Nek7 are the shortest Neks,
consisting only of the catalytic domain and a very short
N-terminal extension. They show distinct expression
patterns and both appear to be downstream substrates of
Nek9. They are required for mitotic spindle formation
and cytokinesis. They may also be regulators of the p70
ribosomal S6 kinase.
Length = 267
Score = 25.1 bits (55), Expect = 8.7
Identities = 13/37 (35%), Positives = 19/37 (51%), Gaps = 7/37 (18%)
Query: 1 MH---FVHRDLAARNCLVSCLDPKYRIVKIGDFGLAR 34
MH +HRD+ N ++ +VK+GD GL R
Sbjct: 122 MHSKRIMHRDIKPANVFITATG----VVKLGDLGLGR 154
>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein
Serine/Threonine Kinase, Large Tumor Suppressor 1.
Serine/Threonine Kinases (STKs), Large Tumor Suppressor
(LATS) subfamily, LATS1 isoform, catalytic (c) domain.
STKs catalyze the transfer of the gamma-phosphoryl group
from ATP to serine/threonine residues on protein
substrates. The LATS subfamily is part of a larger
superfamily that includes the catalytic domains of other
protein STKs, protein tyrosine kinases, RIO kinases,
aminoglycoside phosphotransferase, choline kinase, and
phosphoinositide 3-kinase. LATS functions as a tumor
suppressor and is implicated in cell cycle regulation.
Inactivation of LATS1 in mice results in the development
of various tumors, including sarcomas and ovarian
cancer. Promoter methylation, loss of heterozygosity,
and missense mutations targeting the LATS1 gene have
also been found in human sarcomas and ovarian cancers.
In addition, decreased expression of LATS1 is associated
with an aggressive phenotype and poor prognosis. LATS1
induces G2 arrest and promotes cytokinesis. It may be a
component of the mitotic exit network in higher
eukaryotes.
Length = 382
Score = 25.3 bits (55), Expect = 9.2
Identities = 15/46 (32%), Positives = 24/46 (52%), Gaps = 7/46 (15%)
Query: 1 MHFVHRDLAARNCLVSCLDPKYRIVKIGDFGLA---RDIYRNDYYK 43
M F+HRD+ N L+ + +K+ DFGL R + + YY+
Sbjct: 120 MGFIHRDIKPDNILID----RDGHIKLTDFGLCTGFRWTHDSKYYQ 161
Database: CDD.v3.10
Posted date: Mar 20, 2013 7:55 AM
Number of letters in database: 10,937,602
Number of sequences in database: 44,354
Lambda K H
0.326 0.145 0.452
Gapped
Lambda K H
0.267 0.0807 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 5,873,536
Number of extensions: 503880
Number of successful extensions: 784
Number of sequences better than 10.0: 1
Number of HSP's gapped: 654
Number of HSP's successfully gapped: 215
Length of query: 113
Length of database: 10,937,602
Length adjustment: 77
Effective length of query: 36
Effective length of database: 7,522,344
Effective search space: 270804384
Effective search space used: 270804384
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 15 ( 7.1 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.6 bits)
S2: 53 (24.0 bits)